
<html lang="en"     class="pb-page"  data-request-id="6334d8f5-228e-479b-bc08-0224fc0c8606"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-16;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm300601d;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of a Potent Sodium Hydrogen Exchanger Isoform 1 (NHE1) Inhibitor with a Suitable Profile for Chronic Dosing and Demonstrated Cardioprotective Effects in a Preclinical Model of Myocardial Infarction in the Rat" /></meta><meta name="dc.Creator" content="John D.  Huber" /></meta><meta name="dc.Creator" content="Jörg  Bentzien" /></meta><meta name="dc.Creator" content="Stephen J.  Boyer" /></meta><meta name="dc.Creator" content="Jennifer  Burke" /></meta><meta name="dc.Creator" content="Stéphane  De Lombaert" /></meta><meta name="dc.Creator" content="Christian  Eickmeier" /></meta><meta name="dc.Creator" content="Xin  Guo" /></meta><meta name="dc.Creator" content="James V.  Haist" /></meta><meta name="dc.Creator" content="Eugene R.  Hickey" /></meta><meta name="dc.Creator" content="Paul  Kaplita" /></meta><meta name="dc.Creator" content="Morris  Karmazyn" /></meta><meta name="dc.Creator" content="Raymond  Kemper" /></meta><meta name="dc.Creator" content="Charles A.  Kennedy" /></meta><meta name="dc.Creator" content="Thomas  Kirrane" /></meta><meta name="dc.Creator" content="Jeffrey B.  Madwed" /></meta><meta name="dc.Creator" content="Elizabeth  Mainolfi" /></meta><meta name="dc.Creator" content="Nelamangara  Nagaraja" /></meta><meta name="dc.Creator" content="Fariba  Soleymanzadeh" /></meta><meta name="dc.Creator" content="Alan  Swinamer" /></meta><meta name="dc.Creator" content="Anne B.  Eldrup" /></meta><meta name="dc.Description" content="Sodium–hydrogen exchanger isoform 1 (NHE1) is a ubiquitously expressed transmembrane ion channel responsible for intracellular pH regulation. During myocardial ischemia, low pH activates NHE1 and c..." /></meta><meta name="Description" content="Sodium–hydrogen exchanger isoform 1 (NHE1) is a ubiquitously expressed transmembrane ion channel responsible for intracellular pH regulation. During myocardial ischemia, low pH activates NHE1 and c..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 6, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300601d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300601d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300601d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300601d" /></link>
        
    
    

<title>Identification of a Potent Sodium Hydrogen Exchanger Isoform 1 (NHE1) Inhibitor with a Suitable Profile for Chronic Dosing and Demonstrated Cardioprotective Effects in a Preclinical Model of Myocardial Infarction in the Rat | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300601d" /></meta><meta property="og:title" content="Identification of a Potent Sodium Hydrogen Exchanger Isoform 1 (NHE1) Inhibitor with a Suitable Profile for Chronic Dosing and Demonstrated Cardioprotective Effects in a Preclinical Model of Myocardial Infarction in the Rat" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0018.jpeg" /></meta><meta property="og:description" content="Sodium–hydrogen exchanger isoform 1 (NHE1) is a ubiquitously expressed transmembrane ion channel responsible for intracellular pH regulation. During myocardial ischemia, low pH activates NHE1 and causes increased intracellular calcium levels and aberrant cellular processes, leading to myocardial stunning, arrhythmias, and ultimately cell damage and death. The role of NHE1 in cardiac injury has prompted interest in the development of NHE1 inhibitors for the treatment of heart failure. This report outlines our efforts to identify a compound suitable for once daily, oral administration with low drug–drug interaction potential starting from NHE1 inhibitor sabiporide. Substitution of a piperidine for the piperazine of sabiporide followed by replacement of the pyrrole moiety and subsequent optimization to improve potency and eliminate off-target activities resulted in the identification of N-[4-(1-acetyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (60). Pharmacological evaluation of 60 revealed a remarkable ability to prevent ischemic damage in an ex vivo model of ischemia reperfusion injury in isolated rat hearts." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300601d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300601d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300601d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300601d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300601d&amp;href=/doi/10.1021/jm300601d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7114-7140</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3005288" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300603y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of a Potent Sodium Hydrogen Exchanger Isoform 1 (NHE1) Inhibitor with a Suitable Profile for Chronic Dosing and Demonstrated Cardioprotective Effects in a Preclinical Model of Myocardial Infarction in the Rat</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Huber">John D. Huber</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Bentzien">Jörg Bentzien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+J.++Boyer">Stephen J. Boyer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Burke">Jennifer Burke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=St%C3%A9phane++De+Lombaert">Stéphane De Lombaert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Eickmeier">Christian Eickmeier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Guo">Xin Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+V.++Haist">James V. Haist</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugene+R.++Hickey">Eugene R. Hickey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Kaplita">Paul Kaplita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Morris++Karmazyn">Morris Karmazyn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raymond++Kemper">Raymond Kemper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+A.++Kennedy">Charles A. Kennedy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Kirrane">Thomas Kirrane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+B.++Madwed">Jeffrey B. Madwed</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Mainolfi">Elizabeth Mainolfi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nelamangara++Nagaraja">Nelamangara Nagaraja</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fariba++Soleymanzadeh">Fariba Soleymanzadeh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Swinamer">Alan Swinamer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+B.++Eldrup">Anne B. Eldrup</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co KG, 88397 Biberach an der Riss, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Physiology & Pharmacology, University of Western Ontario, Medical Sciences Building, London, Ontario N6A 5C1,Canada</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Drug Discovery Support, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Non-Clinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Cardiometabolic-Disease Research, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (203) 778-7354. E-mail: <a href="/cdn-cgi/l/email-protection#7f1510171151170a1d1a0d3f1d101a170d1611181a0d521611181a13171a1612511c1012"><span class="__cf_email__" data-cfemail="9af0f5f2f4b4f2eff8ffe8daf8f5fff2e8f3f4fdffe8b7f3f4fdfff6f2fff3f7b4f9f5f7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300601d&amp;href=/doi/10.1021%2Fjm300601d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7114–7140</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 17, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 May 2012</li><li><span class="item_label"><b>Published</b> online</span>6 August 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 August 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300601d" title="DOI URL">https://doi.org/10.1021/jm300601d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7114%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJohn%2BD.%2BHuber%252C%2BJ%25C3%25B6rg%2BBentzien%252C%2BStephen%2BJ.%2BBoyer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D16%26contentID%3Djm300601d%26title%3DIdentification%2Bof%2Ba%2BPotent%2BSodium%2BHydrogen%2BExchanger%2BIsoform%2B1%2B%2528NHE1%2529%2BInhibitor%2Bwith%2Ba%2BSuitable%2BProfile%2Bfor%2BChronic%2BDosing%2Band%2BDemonstrated%2BCardioprotective%2BEffects%2Bin%2Ba%2BPreclinical%2BModel%2Bof%2BMyocardial%2BInfarction%2Bin%2Bthe%2BRat%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7140%26publicationDate%3DAugust%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300601d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2036</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300601d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of a Potent Sodium Hydrogen Exchanger Isoform 1 (NHE1) Inhibitor with a Suitable Profile for Chronic Dosing and Demonstrated Cardioprotective Effects in a Preclinical Model of Myocardial Infarction in the Rat&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Huber&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Bentzien&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;J. Boyer&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Burke&quot;},{&quot;first_name&quot;:&quot;Stéphane&quot;,&quot;last_name&quot;:&quot;De Lombaert&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Eickmeier&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;V. Haist&quot;},{&quot;first_name&quot;:&quot;Eugene&quot;,&quot;last_name&quot;:&quot;R. Hickey&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Kaplita&quot;},{&quot;first_name&quot;:&quot;Morris&quot;,&quot;last_name&quot;:&quot;Karmazyn&quot;},{&quot;first_name&quot;:&quot;Raymond&quot;,&quot;last_name&quot;:&quot;Kemper&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;A. Kennedy&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Kirrane&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;B. Madwed&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Mainolfi&quot;},{&quot;first_name&quot;:&quot;Nelamangara&quot;,&quot;last_name&quot;:&quot;Nagaraja&quot;},{&quot;first_name&quot;:&quot;Fariba&quot;,&quot;last_name&quot;:&quot;Soleymanzadeh&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Swinamer&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;B. Eldrup&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;7114-7140&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300601d&quot;},&quot;abstract&quot;:&quot;Sodium–hydrogen exchanger isoform 1 (NHE1) is a ubiquitously expressed transmembrane ion channel responsible for intracellular pH regulation. During myocardial ischemia, low pH activates NHE1 and causes increased intracellular calcium levels and aberrant cellular processes, leading to myocardial stunning, arrhythmias, and ultimately cell damage and death. The role of NHE1 in cardiac injury has prompted interest in the development of NHE1 inhibitors for the treatment of heart failure. This report outlines our efforts to identify a compound suitable for once daily, oral administration with low drug–drug interaction potential starting from NHE1 inhibitor sabiporide. Substitution of a piperidine for the piperazine of sabiporide followed by replacement of the pyrrole moiety and subsequent optimization to improve potency and eliminate off-target activities resulted in the identification of N-[4-(1-acetyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (60). Pharmacological evaluation of 60 revealed a remarkabl&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300601d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300601d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300601d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300601d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300601d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300601d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300601d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300601d&amp;href=/doi/10.1021/jm300601d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300601d" /></input><a href="/doi/pdf/10.1021/jm300601d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300601d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300601d%26sid%3Dliteratum%253Aachs%26pmid%3D22803959%26genre%3Darticle%26aulast%3DHuber%26date%3D2012%26atitle%3DIdentification%2Bof%2Ba%2BPotent%2BSodium%2BHydrogen%2BExchanger%2BIsoform%2B1%2B%2528NHE1%2529%2BInhibitor%2Bwith%2Ba%2BSuitable%2BProfile%2Bfor%2BChronic%2BDosing%2Band%2BDemonstrated%2BCardioprotective%2BEffects%2Bin%2Ba%2BPreclinical%2BModel%2Bof%2BMyocardial%2BInfarction%2Bin%2Bthe%2BRat%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D16%26spage%3D7114%26epage%3D7140%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jmcmar.2012.55.issue-16/production/jmcmar.2012.55.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Sodium–hydrogen exchanger isoform 1 (NHE1) is a ubiquitously expressed transmembrane ion channel responsible for intracellular pH regulation. During myocardial ischemia, low pH activates NHE1 and causes increased intracellular calcium levels and aberrant cellular processes, leading to myocardial stunning, arrhythmias, and ultimately cell damage and death. The role of NHE1 in cardiac injury has prompted interest in the development of NHE1 inhibitors for the treatment of heart failure. This report outlines our efforts to identify a compound suitable for once daily, oral administration with low drug–drug interaction potential starting from NHE1 inhibitor sabiporide. Substitution of a piperidine for the piperazine of sabiporide followed by replacement of the pyrrole moiety and subsequent optimization to improve potency and eliminate off-target activities resulted in the identification of <i>N</i>-[4-(1-acetyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>60</b>). Pharmacological evaluation of <b>60</b> revealed a remarkable ability to prevent ischemic damage in an ex vivo model of ischemia reperfusion injury in isolated rat hearts.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>▽</span> Author Present Address</h4><p class="last">Global Regulatory Sciences, Bristol-Myers Squibb, 5 Research Parkway, Wallingford, Connecticut 06492, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>○</span> Author Present Address</h4><p class="last">Karos Pharmaceuticals, 5 Science Park, 401 Winchester Avenue, New Haven, Connecticut 06511, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>◆</span> Author Present Address</h4><p class="last">Massachusetts College of Pharmacy and Health Sciences, Department of Pharmaceutical Sciences, School of Pharmacy—Worchester/Manchester, 19 Foster Street, Worchester, Massachusetts 01608, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>¶</span> Author Present Address</h4><p class="last">Mechanistic Safety—US Early and Investigative Safety, Hoffmann La Roche, Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>+</span> Author Present Address</h4><p class="last">Department of Cardiovascular Diseases, Merck Research Laboratories, 126 E. Lincoln Avenue, Building 80T-128, Rahway, New Jersey 07065, United States.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18743" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18743" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sodium–hydrogen exchanger isoform 1 (NHE1) is a ubiquitously expressed transmembrane ion channel responsible for the regulation of intracellular pH via the electroneutral exchange of sodium ions and protons.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> NHE1 is a member of a family of such proteins which encompasses nine variously expressed isoforms. While NHE1 is ubiquitously expressed,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> it is the predominant NHE present in myocardial tissue<a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">(3a)</a> where it plays a central role in the regulation of intracellular pH in cardiomyocytes. Under conditions of ischemia-induced acidosis, a decrease in intracellular pH leads to the activation of NHE1, which functions to restore pH to normal levels through the efflux of protons with concomitant influx of sodium ions. Under normal conditions, the elevation of sodium ion concentration is counteracted by a number of transporters and exchangers, primarily the ATP-driven sodium/potassium exchanger and the sodium/bicarbonate exchanger (which also plays a role in regulating pH). However, under hypoxic conditions, reduced ATP levels decrease the activity of the sodium/potassium exchanger, resulting in prolonged increases in intracellular sodium ions levels, which in turn causes the sodium calcium exchanger (NCX), normally a calcium extruder, to run in reverse, resulting in an increase in intracellular calcium ion levels.<a onclick="showRef(event, 'cit3b cit3c cit3d cit3e cit3f'); return false;" href="javascript:void(0);" class="ref cit3b cit3c cit3d cit3e cit3f">(3b-3f)</a> This increased calcium ion level results in aberrant cellular processes leading to myocardial stunning, arrhythmias, and ultimately cell damage and death. Inhibition of NHE1 is expected to prevent the initial influx of sodium ions, block the resultant calcium overload due to NCX activity, and thereby prevent subsequent cellular damage.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">The central role of NHE1 in myocardial pH regulation has prompted considerable interest in the development of NHE1 inhibitors for the treatment of ischemia-reperfusion injury. However, despite strong preclinical validation,<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> clinical trials have provided mixed results in this indication. The recent emergence of data to support a role for NHE1 inhibition in heart failure<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15">(9-15)</a> led to our interest in pursuing NHE1 inhibition as a mechanism to treat chronic heart failure. However, the shift in focus from an acute to a chronic indication prompted us to re-evaluate the profiles of the compounds evaluated in clinical studies as prospective starting points for optimization. Four NHE1 inhibitors, sabiporide<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<b>1</b>), zoniporide<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<b>2</b>), cariporide<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<b>3</b>), and eniporide<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (<b>4</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were advanced to clinical evaluation for the treatment of ischemia reperfusion injury. Compound <b>1</b> was discovered in our laboratories in a discovery program directed toward the identification of NHE1 inhibitors for the treatment of neuronal injury following ischemic stroke. Subsequently, <b>1</b> was demonstrated to have significant cardioprotective effects in vivo in a variety of animal studies and was advanced into phase I studies as an oral agent for the treatment of acute myocardial infarction (MI).<a onclick="showRef(event, 'ref8 ref16 ref20'); return false;" href="javascript:void(0);" class="ref ref8 ref16 ref20">(8, 16, 20)</a> The other three clinical compounds, <b>2</b>–<b>4</b>, were advanced to clinical evaluation for acute MI, and were studied as iv formulations. These compounds display pharmacokinetic properties that would render them unsuitable for oral administration (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), with mean residence times (MRTs) markedly lower than that of <b>1</b>. Considering the intrinsic advantage provided by the pharmacokinetic profile of sabiporide, we chose to take this molecule as the starting point for our optimization efforts to identify a compound for the treatment of chronic heart failure.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0020.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Clinically investigated NHE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Rat Pharmacokinetics of Clinical NHE1 Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">clearance (%<i>Q</i><sub>H</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th><th class="colsep0 rowsep0" align="center" char=".">Vdss (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr></tbody></table></div></div><div class="NLM_p">The minimization of the potential for drug–drug interactions (DDIs) is of importance for chronic indications, in particular indications such as heart failure for which patients are typically receiving a large number of comedications. <b>1</b> is a moderate inhibitor of CYP 3A4 (IC<sub>50</sub> 7 μM) and 2C19 (IC<sub>50</sub> 9 μM), and it was deemed desirable to decrease the inhibitory potency against these isoforms. In addition, an improvement in potency was viewed to be desirable as another means to decrease the potential for off-target activity. It was also desirable to further improve the pharmacokinetic profile to enable once-daily dosing. A final goal for optimization efforts was the replacement of the pyrrole substructure, as this substructure may be oxidatively metabolized to electrophilic species implicated in adverse drug reactions.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div class="NLM_p last">We describe here the discovery of <i>N</i>-[4-(1-acetyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>60</b>), a potent NHE1 inhibitor with a pharmacokinetic profile suitable for chronic administration in humans and remarkable efficacy in a preclinical model of MI in the rat. Discovery efforts leading ultimately to compound <b>60</b> initiated from sabiporide. From this starting point, a change of the piperazine linker to a piperidine was found to provide uncompromised potency against NHE1. Subsequent replacement of the pyrrole amide substituent to avoid a potential for formation of reactive metabolites was followed by optimization focused on improvements in potency and elimination of off-target activities, including CYP inhibition. Optimization resulted in the identification of <b>60</b>, the pharmacological evaluation of which revealed a remarkable ability to prevent ischemic damage in an isolated heart model of ischemia reperfusion injury (Langendorff isolated heart preparation).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The arylacylguanidine substructure of compounds <b>1</b>–<b>4</b> is considered a privileged pharmacophore for NHE1 inhibition and was left unaltered in the optimization efforts described herein.</div><div class="NLM_p">Taking <b>1</b> as our starting point, our first set of compounds examined the effect of a change to the piperazine substructure. The piperazine was replaced with racemic 3-aminopyrrolidine, racemic 3-aminopiperidine, or 4-aminopiperidine (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Compounds <b>5</b>–<b>7</b> were synthesized by a nucleophilic aromatic substitution of the methyl ester <b>8</b> with the BOC-protected amines <b>9a</b>–<b>c</b> to provide the BOC-protected amino esters <b>10a</b>–<b>c</b>. The BOC group was removed under standard acidic conditions, and the amine was coupled with 1<i>H</i>-pyrrole-2-carboxylic acid chloride to provide the pyrrole amides <b>11a</b>–<b>c</b>. The esters of compounds <b>11a</b>–<b>c</b> were hydrolyzed to the free acids <b>12a</b>–<b>c</b>, which were subsequently coupled with CBZ-guanidine or BOC-guanidine using a Mukuyama coupling.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The resulting CBZ- or BOC-protected acylguanidines <b>13a</b>–<b>c</b> were deprotected under standard conditions to afford the desired 3-aminopyrrolidine, 3-aminopiperidine, and 4-aminopiperidine derivatives <b>5</b>–<b>7</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0021.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) diisopropylethylamine (DIEA), DMSO, 90 °C; (ii) NaOH, MeOH, reflux, 2.5 h; (iii) 1-methyl-2-chloropyridinium iodide, 1-methyl pyrrolidinone (NMP), 90 min, then CBZ-guanidine, DIEA, 16 h; (iv) HCl, dioxane, methanol, 4.5 h; (v) 1<i>H</i>-pyrrole-2-carboxylic acid chloride, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 16 h; (vi) Pd/C, 1 atm H<sub>2</sub>, EtOH, 16 h.</p></p></figure><div class="NLM_p">The further examination of the effect of changes to the sabiporide piperazine substructure was enabled by the synthesis of the corresponding piperidine derivative <b>14</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The synthesis of <b>14</b> took its starting point in the methyl ester <b>15</b>, which underwent Suzuki coupling with commercially available pinacol boronate <b>16</b> to provide the BOC-protected tetrahydropyridine <b>17</b>. Catalytic hydrogenation using platinum(IV) oxide in acetic acid afforded the BOC-protected piperidine <b>18</b>, which was hydrolyzed to provide the corresponding carboxylic acid derivative <b>19</b>. Condensation with CBZ-protected guanidine and subsequent removal of the BOC protecting group provided the amino derivative <b>20a</b>. Condensation of the amine <b>20a</b> with pyrrole-2-carboxylic acid, using carbonyl diimidazole (CDI) in dimethylformamide, was followed by the removal of the CBZ protecting group under standard conditions to provide the piperidine <b>14</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0022.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, 140 °C, 4 h; (ii) PtO<sub>2</sub>, 1 atm H<sub>2</sub>, acetic acid, 60 h; (iii) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (10/1), 60 °C, 2 h; (iv) 1-methyl-2-chloropyridinium iodide, NMP, 90 min, then CBZ-guanidine, DIEA, 16 h; (v) HCl, 1,4-dioxane, CH<sub>2</sub>Cl<sub>2</sub>, 2 h; (vi) 2-pyrrole-carboxylic acid, CDI, DMF, 90 min, then <b>20a</b>, DIEA, 16 h; (vii) Pd/C, 1 atm H<sub>2</sub>, EtOH, 4–16 h.</p></p></figure><div class="NLM_p">In a next set of compounds (<b>21</b>–<b>62</b>) the effect of a replacement of the pyrrole substructure with unsubstituted or substituted aryl was examined. The majority of these compounds were synthesized using a similar strategy as that used in the synthesis of compound <b>14</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). However, for compounds <b>23</b>, <b>31</b>, <b>36</b>, <b>37</b>, and <b>47</b>–<b>49</b>, the intermediate <b>17</b> was carried forward with its alkene functionality intact to provide the tetrahydropyridine intermediate <b>20b</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), which was acylated under the conditions used for compound <b>14</b>, followed by the hydrogenation of the CBZ group and alkene moieties in the final step. This synthetic sequence, however, suffered from low synthetic reproducibility, likely a result of the poorly reactive alkene being extremely difficult to hydrogenate completely. For the alkyl amide compounds <b>55</b>–<b>60</b>, a synthetic strategy similar to that employed for compound <b>14</b> was used, albeit using an acid chloride in place of the CDI-mediated coupling of the acid derivative.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0023.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (10/1), 60 °C, 2 h; (ii) 1-methyl-2-chloropyridinium iodide, NMP, 90 min, then CBZ-guanidine, DIEA, 16 h; (iii) HCl, 1,4-dioxane, CH<sub>2</sub>Cl<sub>2</sub>, 2 h; (iv) RCO<sub>2</sub>H, CDI, DMF, 90 min, then <b>20b</b>, DIEA, 16 h; (v) Pd/C, 1 atm H<sub>2</sub>, EtOH, 4–48 h.</p></p></figure><div class="NLM_p">To enable the further exploration of changes to the pyrrole in a parallel format, the BOC-protected acylguanidine intermediates <b>63a</b> and <b>63b</b> were prepared. These intermediates were synthesized starting from the intermediate <b>18</b> by the conversion of this BOC-protected piperidine to the corresponding CBZ-protected piperidine <b>61</b>. Hydrolysis of <b>61</b> under basic conditions and subsequent subjection to a Mukuyama type coupling with BOC-guanidine provided the CBZ-protected acylguanidine <b>62</b>, which was deprotected by hydrogenation to give the desired intermediate amino derivative <b>63a</b>. This intermediate or its hydrochloride salt <b>63b</b> was condensed with a variety of aryl acids using TBTU to give the BOC-protected amides <b>64a</b>–<b>i</b>, which upon BOC removal provided the desired compounds <b>24</b>–<b>29</b> and <b>52</b>–<b>54</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0024.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HCl, 1,4-dioxane, 18 h, then 50 °C, 6 h; (ii) benzyl chloroformate, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 16 h; (iii) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (3/1), 16 h; (iv) 1-methyl-2-chloropyridinium iodide, NMP, 90 min, then BOC-guanidine, DIEA, 16 h; (v) Pd(OH)<sub>2</sub>/C, 1 atm H<sub>2</sub>, EtOH, 16 h, then for <b>63b</b>:HCl in ether; (vi) RCO<sub>2</sub>H, TBTU, NMM, DMA, 1 h; (vii) 4N HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>. For R groups see tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</p></p></figure><div class="NLM_p">To examine the effect of aryl core substitution, compounds <b>78</b>–<b>83</b> were prepared from their corresponding carboxylic acid ester intermediates <b>69a</b>–<b>c</b> using a similar synthetic strategy as applied for compound <b>14</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). The 2-methyl-5-trifluoromethyl core of <b>69a</b> was synthesized by initiating from the iodophenol <b>65</b>, which was converted to its benzyl protected derivative <b>66</b>. Subjection of <b>66</b> to a copper-promoted trifluoromethylation provided <b>67,</b> which was deprotected by hydrogenation to provide the phenol derivative <b>68</b>. Conversion of <b>68</b> to the corresponding triflate followed by a Suzuki coupling with <b>16</b> provided the tetrahydropyridine intermediate <b>69a</b>. The 2-methyl-5-methylsulfonyl core of compounds <b>69b</b> was synthesized by initiating from the benzoic acid <b>70</b>. Methsulfonylation to provide the arylmethylsulfone <b>71</b> was followed by esterification to provide the bromo ester intermediate <b>72</b>, which was subsequently subjected to Suzuki coupling with <b>16</b> to provide the tetrahydropyridine intermediate <b>69b</b>. The 2-methoxy-5-trifluoromethyl core of <b>69c</b> was synthesized from the ester <b>73</b>. Selective benzyl protection of the phenol to give the benzyloxy compound <b>74</b> followed by bromination to provide the bromophenyl <b>75</b>, which was methylated to provide the methoxy bromide <b>76</b>. Subsequent trifluoromethylation and deprotection gave the phenol <b>77</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>), which was subjected to triflation and Suzuki reaction with <b>16</b> to provide the tetrahydropyridine intermediate <b>69c</b>. The required intermediate for the 5-methylsulfonyl core was synthesized according to literature procedures.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0025.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 2h; (ii) KOC(O)CF<sub>3</sub>, CuI, NMP, 150 °C, 5h; (iii) Pd/C, H<sub>2</sub>, EtOH, o/n; (iv) <i>N</i>-phenyltrifluoromethanesulfonimide, DIEA, DMF, o/n; (v) <b>16</b>, 2M K<sub>2</sub>CO<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, 110 °C, 30 min; (vi) ClSO<sub>3</sub>H, 0 to 100 °C, 2h; (vii) Na<sub>2</sub>SO<sub>3</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, THF, 70 °C, 1 h then MeI, 50 °C, o/n; (viii) AcCl, MeOH, 50 °C, o/n; (ix) Br<sub>2</sub>, CHCl<sub>3</sub>, 30 min; (x) KOtBu, MeI, THF, 72 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The superior pharmacokinetic profile of <b>1</b> led us to take this molecule as the starting point for discovery of an NHE1 inhibitor suitable for once daily, oral administration with minimal potential for drug–drug interactions. <b>1</b> can be viewed as consisting of four structural domains: a left-hand side heteroaryl amide, a piperazine linker, a substituted aryl core, and an acylguanidine headgroup (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Although some NHE1 inhibitors incorporate replacements for the aryl core and acylguanidine,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> the aryl core and right-hand side acylguanidine is present in the vast majority of NHE1 inhibitors and hence can be considered to be a privileged pharmacophore for NHE1 inhibition. During the discovery of <b>1</b>, the trifluoromethylphenyl core was demonstrated to provide good pharmacokinetic properties. In light of this experience, and considering the extensive prior art for arylacylguanidines, which includes a vast number of claims to aryl core structures other than phenyl, our initial efforts focused on the exploration of changes to the piperazine substructure with the goal to identify structural changes likely to provide patentability and address the optimization goals outlined above.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0026.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of the NHE1 inhibitor <b>1</b> illustrating its four structural domains. From left to right, these are the heteroaryl amide (yellow), piperazine linker (red), aryl core (green), and the acylguanidine (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Close examination of the minimized structures of the clinical benchmark compounds <b>1</b>–<b>4</b>, assuming identical positioning of the aryl acylguanidine moiety, revealed different positioning of the substituents of the core aryl, hence suggesting some flexibility with respect to the identity of the core aryl substituents (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Initial optimization efforts therefore focused on changes to the piperazine linker in order to identify an alternative to the piperazine while maintaining or improving the favorable properties of sabiporide. A change of the piperazine substructure to aminopyrrolidine, 3-aminopiperidine, and 4-aminopiperidine was investigated by the synthesis of compounds <b>5</b>, <b>6</b>, and <b>7</b>. The overlay of the minimized conformations of these compounds with that of <b>1</b> suggested a relatively close agreement in the placement of their left and right-hand sides (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). However, these compounds (EC<sub>50</sub> 172 nM) resulted in reduced potency in the functional platelet swelling assay (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>), with EC<sub>50</sub>s ranging from 950 to 3477 nM for compounds <b>5</b>–<b>7</b> as compared to 172 nM for <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In contrast, IC<sub>50</sub> values in the pH<sub>i</sub> assay were largely uncompromised, with IC<sub>50</sub>s ranging from 36 to 172 nM for compounds <b>5</b>–<b>7</b> compared to the 28 nM IC<sub>50</sub> for <b>1</b>. More radical departures from the piperazine core such as those based on bicyclic systems, rings fused to the aryl ring, or bridged heterocycles resulted in compounds which completely lacked inhibitory potency in the human platelet-swelling assay (data not shown). Examination of structural overlays again did not reveal the basis for the complete lack of inhibitory potency displayed by these compounds. In contrast, our evaluation of the piperidine derivative <b>14</b> revealed a near-perfect overlay with sabiporide and the compound displayed comparable potency to sabiporide in the platelet swelling assay as well as in the pH<sub>i</sub> assay (IC<sub>50</sub> 45 nM and EC<sub>50</sub> 241 nM for compound <b>14</b> compared to IC<sub>50</sub> 28 nM and EC<sub>50</sub> 172 nM for <b>1</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). For the majority of poorly active compounds (such as <b>5</b>, <b>6</b>, and <b>7</b>), the activity in the human platelet swelling assay was markedly inferior to that of sabiporide, while a significant degree of potency frequently was still observed in the pH<sub>i</sub> assay. Various possibilities were examined in an effort to understand the basis for the differences in potencies observed in these assays. The observed differences could be due to protein binding in the human platelet swelling assay which would not occur in the pH<sub>i</sub> assay. To examine this possibility, the pH<sub>i</sub> assay was conducted with plasma protein (data not shown). However, the potencies observed in this assay did not shift remarkably from those observed without plasma, hence suggesting that plasma protein binding is not the underlying reason for the observed differences in potencies observed in the pH<sub>i</sub> and platelet swelling assays. Examination of physiochemical properties of the molecules that displayed significant differences in potency in the pH<sub>i</sub> and human platelet swelling assays, such as polar surface area, log <i>P</i>, log <i>D</i>, and hydrogen bond acceptor/donor count, also did not reveal a correlation that might explain the observed shift in potencies between the assays.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of the minimized conformations of the four NHE-1 inhibitors <b>1</b> (turquoise), <b>2</b> (green), <b>3</b> (yellow), and <b>4</b> (pink), illustrating the different positioning of the left-hand side aryl moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the minimized conformations of <b>1</b> (turquoise) with <b>5</b> (salmon), <b>6</b> (beige), and <b>7</b> (gray), illustrating the relatively good overlap of the core aryl and far left-hand side substructures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of the minimized conformations of the piperidine derivative <b>14</b> (gray) with <b>1</b> (turquoise), illustrating near-perfect overlay for both the right-hand side aryl acylgaunidine and the left-hand side aryl amide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. pH<sub>i</sub> and Human Platelet Swelling Inhibition Potencies for Piperazine Replacements <b>5</b>–<b>7</b> and <b>14</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0004.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0005.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Consequently, our further optimization efforts were driven by the human platelet swelling assay as this assay was viewed to provide a greater extent of physiologically relevance in its measure of NHE1 inhibition (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). However, the platelet swelling assay measures the inhibition of osmotic swelling due to increased intracellular sodium concentration. Therefore, this indirect measurement of NHE1 activity was complemented by potency assessments in the pH<sub>i</sub> assay to ensure a mechanistic link to the intracellular pH restoration.</div><div class="NLM_p">Having identified the piperidine derivative <b>14</b> as a novel replacement of the piperazine structure of sabiporide, which provided uncompromised potency in both the pH<sub>i</sub> and platelet swelling assays, we shifted our attention to the optimization of the heteroaryl left-hand side. We initially sought to replace the pyrrole moiety as this substructure has been associated with adverse drug reactions.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div class="NLM_p">In our examination of potential aryl replacements for the pyrrole substructure, the phenyl derivative <b>21</b> was found to provide a slight potency improvement in the platelet swelling assay (EC<sub>50</sub> 109 nM compared to EC<sub>50</sub> 241 nM for <b>1</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Evaluation of derivatives in which the aryl was substituted in the 4-position with nonpolar substituents, or which incorporated a biphenyl moiety, revealed reduced potency in the platelet swelling assay (EC<sub>50</sub> 539, 1130, and 989 nM for compounds <b>23</b>, <b>24</b>, and <b>27</b>, respectively) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In contrast, compounds <b>28</b>, <b>29</b>, and <b>30</b>, where the additional ring in biphenyl <b>27</b> was replaced by more polar five-membered heterocycles, showed improvement in potency relative to <b>27</b> (EC<sub>50</sub> 368, 353, and 169 nM for <b>28</b>, <b>29</b>, and <b>30</b>, respectively), suggesting the low potency of the larger nonpolar substituents is due to a polarity mismatch rather than a steric clash with the ion channel. On the basis of this data, it was hypothesized that increased polarity (as can be measured by xlogP,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) may improve the potency. Following this hypothesis, the compounds <b>31</b> through <b>43</b> were evaluated to reveal modest improvements in potency, with the compounds incorporating the most polar left-hand sides being the most potent compounds in this class (EC<sub>50</sub> 36, 25, and 23 nM, for <b>41</b>, <b>42</b>, and <b>43</b> compared to sabiporide EC<sub>50</sub> 172 nM). Several five-membered heterocycle replacements were also explored, giving modestly improved potency (<b>44</b>–<b>46</b>). To determine if there was any regioisomeric preference for the aryl substitution, several compounds were synthesized in all three regioisomers. The potencies of these compounds suggested no strong preference for placement of the left-hand side aryl substituent (compounds <b>24</b>–<b>26</b>, <b>32</b>–<b>34</b>, and <b>35</b>–<b>37</b>). The apparent flat structure–activity relationship suggested to us a lack of specific interactions such as hydrogen bonds or dipole–dipole attractions between the left-hand side aryl moiety and the NHE1 channel.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. pH<sub>i</sub> and hPSA Potencies for Aryl Replacements for the Pyrrole Moiety in <b>14</b> and xLogP Values Illustrating the Improvement in Potency for More Polar Left-Hand Sides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0006.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">Compounds with potencies in the platelet swelling assay of less than 200 nM were examined for their propensity to inhibit cytochrome P450 enzymes (CYP 450) and for their metabolic stability in human and rat liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In general, selectivity against CYP 450 enzyme inhibition and metabolic stability in liver microsomal fractions was improved with increasing polarity of the amide substituent. Notable exceptions were provided by the pyrazole <b>44</b> (likely due to facile pyrazole <i>N</i>-demethylation in microsomes) and the pyridine <b>38</b> (for which the pyridine moiety was likely a source of potent CYP inhibition).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The 4-methylsulfonyl derivative <b>35</b> was selected as a class representative for evaluation of its pharmacokinetic profile in the rat based on its low degree of CYP450 inhibition (IC<sub>50</sub>s >30, >30, >30, and 15 μM for the 2C19, 2C9, 2D6, and 3A4 isoforms, respectively), acceptable potency (EC<sub>50</sub> 93 nM), and high metabolic stability in microsomes (<5.6% <i>Q</i><sub>h</sub> in rat liver microsomes and <11 <i>Q</i><sub>h</sub> in human liver microsomes). Surprisingly, <b>35</b> was rapidly cleared in the rat with a rate of 66% of hepatic blood flow (<i>Q</i><sub>h</sub>) and its bioavailability (<i>F</i>) was somewhat low at 15%. A lack of cellular permeability, possibly due to the polar left-hand side, could explain the observed low bioavailability of <b>35</b>. To test this hypothesis, <b>35</b> was profiled in the PAMPA and Caco-2 permeability assays, which revealed low permeability and a high efflux ratio of 8 for this methylsulfonyl derivative. Subsequently, compounds with good metabolic stability and CYP inhibition were therefore tested in the PAMPA assay, and it was found that the more polar analogues generally displayed low permeability (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. CYP450 Isoform Inhibition, Stability in Rat and Human Liver Microsomes, and PAMPA Permeability Rating for Pyrrole Replacement Compounds with Potency 200 nM or Better in the hPSA Assay Showing Improved Overall Profiles with Increasing Polarity of Left-Hand Side Amide</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0007.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">PAMPA rating was assigned as LOW if the permeation velocity was <10<sup>–6</sup> cm/s.</p></div></div><div></div></div><div class="NLM_p">At this point, we faced the rather discouraging proposition that the SAR for NHE-1 potency appeared to be divergent with that of acceptable membrane permeability and oral bioavailability. The examination of the compounds for which permeability in the PAMPA assay was poor (<b>31</b>, <b>35</b>, <b>36</b>, <b>41</b>–<b>44</b>, and <b>46</b>) revealed that the majority of these contained hydrogen bond donor moieties such as sulfonamides and amides. Analogues of these compounds were therefore synthesized in which these NH and OH groups were “capped” with methyl groups to determine if permeability could be rescued without negatively affecting potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). However, in cases where the permeability was in fact restored, potency was found to be attenuated to unacceptable levels (<b>47</b> and <b>51</b> methyl capped analogues of <b>31</b> and <b>43</b>). In the other cases, an improvement in permeability was not achieved with capping of the hydrogen-bond donor group.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. pH<sub>i</sub> and hPSA Potencies and PAMPA Permeability Ratings for Methylated Analogues of Phenol <b>31</b>, Primary Amide <b>41</b>, and Sulfonamide <b>43</b> Illustrating That Capping of the Hydrogen-Bond Donor Group Failed to Balance Potency and Permeability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0008.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0009.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">Increased polarity of substituents on the left-hand side arylamide afforded improvements in CYP inhibition and microsomal stability and resulted in more potent inhibition of NHE1. However, polarity on the left-hand side was found to negatively affect the permeability and oral bioavailability. Attempts to modify compounds with low permeability had not resulted in compounds with acceptable potency and permeability, and therefore a change in strategy was necessary. Considering the totality of the data available, we hypothesized that moving away from the aryl amides to alkyl amides may offer an advantage. The alkyl amides should allow for more compact structures that would allow for higher polarity, as was seen to be beneficial for potency, without large increases in polar surface area which was likely a contributor to the permeability problems faced by the more polar aryl amides.</div><div class="NLM_p">To examine the effect of alkyl amides as a replacement for the left-hand side pyrrole of <b>1</b>, compounds <b>52</b>–<b>60</b> were evaluated in the platelet swelling assay and the pH<sub>i</sub> assay. More extended alkyl amides exhibited only moderate potency (EC<sub>50</sub> 201–416 nM for compounds <b>52</b>–<b>54</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). However, our evaluation of truncated alkyl amides revealed these to be potent inhibitors of NHE1 both in the platelet swelling assay and in the pH<sub>i</sub> assay (EC<sub>50</sub> 127, 79, 50, 31, and 31 nM for compounds <b>55</b>, <b>56</b>, <b>57</b>, <b>59</b>, and <b>60</b>, respectively) with the methyl and ethyl amides (<b>59</b> and <b>60</b>) exhibiting the most potent inhibition of NHE1 so far observed. To understand the potential of the alkyl amide derivatives to provide acceptable permeability, these compounds were evaluated in the PAMPA assay, which revealed permeability to be high for all compounds tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Interestingly, once again, the inhibitory potency against NHE1 as assessed in the platelet swelling assay could be improved modestly by the addition of polarity to the lipophilic alkyl group as in the case of the methoxyacetyl <b>58</b> (EC<sub>50</sub> 48 nM) versus the <i>n</i>-propyl compound <b>54</b> (EC<sub>50</sub> 201 nM). The CYP inhibition profiles and microsomal stability were acceptable for the <i>tert</i>-butyl and methoxyacetyl amides <b>55</b> and <b>58</b> and excellent for the ethyl and acetyl amides <b>59</b> and <b>60</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), with acetyl amide <b>60</b> having an IC<sub>50</sub> >30 μM across all CYP isoforms tested. In contrast, for the <i>iso</i>-propyl amide derivative <b>56</b>, inhibition of the CYP isoforms 2C9 and 3A4 was significant (7 and 0.4 μM, respectively), and for cyclopropyl <b>57</b>, CYP2C19 and 2C9 displayed significant inhibition (5 and 6 μM, respectively).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. pH<sub>i</sub> Potencies, hPSA Potencies, CYP450 Isoform Inhibition Potencies, Stability in Rat and Human Liver Microsomes, and PAMPA Permeability Ratings for Alkyl Amide Left-Hand Side Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0010.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0011.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p">Having identified the potent and permeable alkyl amides <b>59</b> and <b>60</b>, several core substituents were explored in an attempt to expand the structural scope of compounds for advancement. The efforts by others, leading to the discovery of cariporide, had demonstrated that the inclusion of a methyl substituent in the 6-position of the core aryl resulted a modest improvement in potency.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In our case, the inclusion of a 6-methyl substituent did not provide a similar improvement (compound <b>78</b> as compared to <b>60</b>; EC<sub>50</sub> 28 nM versus 31 nM, respectively). The inclusion of a 6-methoxy substituent was also examined (compound <b>79</b>), resulting in a decrease in potency of more than 10-fold compared to the parent compound <b>60</b> (EC<sub>50</sub> 432 nM versus 31 nM, respectively). The cariporide core substituent SAR had been examined in the context of a methylsulfone rather than a trifluoromethyl core. It was therefore hypothesized that the potency may be improved by the incorporation of such a methylsulfone in combination with the 6-methyl substituent. The replacement of the trifluoromethyl of compounds <b>59</b> and <b>60</b> with a methylsulfone (compounds <b>80</b> and <b>81</b>), however, was found to result in compounds of lower potency (EC<sub>50</sub> 31 and 31 nM for compounds <b>59</b> and <b>60</b>, respectively, versus 266 and 189 nM for <b>80</b> and <b>81</b>, respectively). However, as observed in the context of the cariporide SAR, the incorporation of the 6-methyl substituent now resulted in an approximately 3-fold potency improvement (compound <b>82</b>, EC<sub>50</sub> 88 nM and compound <b>83</b> EC<sub>50</sub> 56 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. pH<sub>i</sub> and hPSA Potencies for Core Modifications of Compounds <b>59</b> and <b>60</b> as well as Caco-2 Efflux Ratio for 2-Methyl-5-methylsulfone Core Compound <b>82</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0012.gif" alt="" id="fx9" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">pH<sub>i</sub> change IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM) hPSA</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 efflux ratio (AB/BA)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">432</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">MeSO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">266</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">MeSO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">189</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">MeSO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">MeSO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">–</td></tr></tbody></table></div></div><div class="NLM_p">During the earlier optimization efforts leading to the discovery of <b>1</b>, it was found that methylsulfone bearing cores suffered from very low oral bioavailability which was attributed to rapid efflux of the compounds (data not shown). Before undertaking further exploration of the 6-methyl methylsulfone core compounds, compound <b>82</b> was tested in the Caco-2 permeability assay and found to have a high efflux ratio of 14. The pharmacokinetic profiles of compounds <b>82</b> and <b>83</b> were evaluated in rat, and both compounds were found to suffer from very low oral bioavailability (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, 4% and 1% <i>F</i>, respectively). This problem of efflux-driven low bioavailability was found to be general for the methylsulfone-containing cores (data not shown), and therefore work on these compounds did not proceed further. The 3-trifluoromethyl-6-methyl core compound (<b>78</b>), which maintains the potency of <b>60</b>, was next examined in CYP and hERG inhibition assays. For CYPs 3A4, 2C9, and 2D6, there was no significant inhibition (IC<sub>50</sub> >30 μM), however, a modest inhibition of 2C19 did appear to be caused by the addition methyl group (IC<sub>50</sub> 22 μM). More concerning, however, was that compound <b>78</b> showed significant hERG inhibition in the PatchXpress assay (IC<sub>50</sub> 7 μM). As a result, this compound was not further pursued and efforts to explore the core SAR were abandoned.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Rat Pharmacokinetic Profiles of Methylsulfone Core Containing Compounds <b>82</b> and <b>83</b> Showing Low Bioavailability, Attributed to High Efflux</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0013.gif" alt="" id="fx10" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">clearance (%<i>Q</i><sub>H</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th><th class="colsep0 rowsep0" align="center" char=".">Vdss (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b></td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr></tbody></table></div></div><div class="NLM_p">Having identified a potent class of NHE1 inhibitors with potential for high permeability and selectivity against metabolic enzymes, we evaluated compounds from this class which had revealed acceptable CYP inhibition and both RLM and HLM stability for their clearance profiles in rat following iv administration and their propensity to inhibit the hERG channel (PatchExpress) (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). The <i>para</i>-benzonitrile compound <b>32</b> exhibited rather potent hERG inhibition with an EC<sub>50</sub> of 4 μM and was therefore eliminated from further profiling. From the remaining compounds, the ethyl and methyl amides <b>59</b> and <b>60</b> displayed low clearance (4.4 and 5.7% <i>Q</i><sub>h</sub>, respectively), while the <i>meta</i>-benzonitrile derivative <b>33</b> displayed a MRT similar to those of <b>59</b> and <b>60</b>, albeit with a substantial increase in volume of distribution (3.3 L/kg for compound <b>33</b> versus 1.0 and 0.76 L/kg for compounds <b>59</b> and <b>60</b>). Compounds <b>33</b>, <b>59</b>, and <b>60</b> were evaluated for their pharmacokinetic profiles following oral administration in both rats and dogs (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>). The bioavailabilities in rats for all three compounds were acceptable (ranging from 49% for compound <b>59</b> to 72% and 73% for compounds <b>33</b> and <b>60</b>), albeit with <b>59</b> displaying somewhat lower bioavailability compared to <b>33</b> and <b>60</b>. In dogs, <b>33</b> and <b>60</b> displayed reduced but still acceptable bioavailability (36% and 33%, respectively). Overall, the pharmacokinetic profiles in rat and dog were viewed to support the further advancement of compounds <b>33</b>, <b>59</b>, and <b>60</b>.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. hERG Inhibition and Rat i.v. Pharmacokinetics of Compounds with Acceptable in Vitro Profiles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0014.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0015.gif" alt="" id="fx12" /></img><div></div></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Full Rat and Dog Pharmacokinetic Profile of Compounds with Acceptable hERG Potencies and MRT >3 h in Rat i.v. Pharmacokinetics</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rat</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">dog</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">clearance (%<i>Q</i><sub>H</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th><th class="colsep0 rowsep0" align="center" char=".">Vdss (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">clearance (%<i>Q</i><sub>H</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th><th class="colsep0 rowsep0" align="center" char=".">Vdss (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">0.76</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr></tbody></table></div></div><div class="NLM_p">The attractive overall profiles of compounds <b>59</b> and <b>60</b> prompted the evaluation of these compounds for their selectivity against NHE2 and NHE3 using a pH<sub>i</sub> assay format (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>). Both compounds, displayed >30-fold selectivity against NHE2 and with no measurable inhibitory activity against the NHE3 isoform (up to 16 μM concentration). While both <b>59</b> and <b>60</b> were attractive compounds based on their overall profile to this point, the modestly superior CYP inhibition profile of <b>60</b> resulted in the selection of this compound for further advanced profiling in preparation for in vivo pharmacology and toxicology studies. The potential for this compound to induce CYP 3A4 expression was assessed using the PXR induction assay in which <b>60</b> showed no significant induction of CYP3A4 (6% of rifampin at 10 μM). Compound <b>60</b> was also free of time-dependent CYP3A4 inactivation up to 50 μM. Testing in several in vitro toxicology assays also supported the further advancement of compound <b>60</b>, as it was found to be free of mutagenicity potential in the Ames assay both directly and after S9 incubation up to 5000 μg/plate, free of cytotoxicity up to 100 μM, and free of phospholipidosis potential in the Nile Red assay up to 50 μM.</div><div class="NLM_p">Compound <b>60</b> was therefore examined in the Langendorff isolated perfused rat heart model<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> ex vivo to examine its ability to prevent or attenuate ischemia-reperfusion injury. Compound <b>60</b> was found to have a profound efficacy in this model, providing recovery of left ventricular developed pressure (LVDP) to levels of 100% and 36% of baseline pressure at perfusate concentrations of 100 and 10 nM, as measured 30 min postreperfusion. Furthermore, the administration of compound <b>60</b> provided a significantly beneficial effect on left-ventricular end diastolic pressure, preventing much of the increase seen postreperfusion for the vehicle control (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). These effects were particularly remarkable in light of the fact that the platelet-swelling assay using rat platelets (rPSA) had revealed an EC<sub>50</sub> for compound <b>60</b> of only 138 nM, demonstrating that compound <b>60</b> exerts profound beneficial effects at concentrations approximating its EC<sub>50</sub> value.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0017.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Left ventricular developed pressure (LVDP) and left ventricular end-diastolic pressure (LVEDP) for compound <b>60</b>. Data were analyzed using a repeated-measures ANOVA followed by a post hoc Tukey’s test, <i>N</i> = 6, for all groups. For LVDP, values indicate the percentage recovery from baseline values obtained immediately before initiating ischemia. Preischemic baseline values for LVDP (in mm Hg) were 63 ± 5, 61 ± 7, and 59 ± 5 nM for control, and 10 and 100 nM compound <b>60</b>-treated hearts, respectively. Absolute values are shown for LVEDP, which were initially adjusted to approximately 5 mmHg as indicated in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. *<i>P</i> < 0.05 from compound <b>60</b>-free group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, optimization of <b>1</b> beginning with replacement of the piperazine with a piperidine linker followed by optimization of the left-hand side amide afforded the acetyl compound <b>60</b> with high NHE1 potency, low DDI potential as measured by CYP inhibition, CYP 3A4 inactivation, and PXR mediated CYP 3A4 induction, low hERG potency with concomitant absence of effects in lengthening action potential duration, excellent pharmacokinetics in rat and dog, and remarkably potent activity in the isolated heart model of ischemia-reperfusion injury. Further pharmacological and toxicological profiling of this compound will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedures</h3><div class="NLM_p">All reactions were performed at ambient temperature where not otherwise indicated. Unless otherwise indicated, extraction and washing steps were performed a single time. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance (400 MHz unless otherwise indicated) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl<sub>3</sub>, 7.24 ppm; DMSO-<i>d</i><sub>6</sub>, 2.52 ppm; CD<sub>3</sub>OD, 3.34 ppm). Data are reported as follows: Chemical shifts, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, dq = doublet of quartets, dm = doublet of multiplets, br = broad, vbr = very broad, m = multiplet, app = apparent), coupling constants (Hz), and integration. Flash chromatography was performed using prepacked silica gel columns (Analogix Flash chromatograph RS-12 cartridges) of the indicated solvent system unless otherwise indicated. Separation was achieved with a CombiFlash SQ16X chromatographer by Isco. HPLC purification was performed on a Gilson GX280 platform fitted with a Waters SunFire Prep C-18 OBD column (20 mm × 150 mm, 5 μm), Gilson 322 binary pump, and Gilson UV/vis 155 detector using a 20 mL/min flow rate, detection at 254 nM, and the indicated gradient unless otherwise indicated. For compounds <b>24</b>–<b>29</b> and <b>52</b>–<b>54</b>, HPLC purification was performed on a Waters 2767 platform fitted with a Waters 2525 gradient module, Waters 515 binary pump, Waters 2996 DAD, and Waters Micromass ZQ mass spectrometer fitted with a SunFire Prep C18 OBD column (19 mm × 150 mm, 5 μm) and running the following gradient (expressed as a percentage of acetonitrile in water with 0.1% formic acid) at a 20 mL/min flow rate: 0–3.5 min 10%, 3.5–13.0 min 10–85%, 13.0–13.5 min 85–95%, 13.5–15.0 min isocratic 95%. All compounds described were of >95% purity unless otherwise indicated. Compounds dosed in vivo were of >98% purity. Purity was confirmed by analytical LC/MS recorded on a system consisting of a Waters ZQ mass spectrometer, an Agilent 1100 DAD, Sedex 85 ELS detector, and an Agilent 1100 HPLC system, equipped with a Zorbax SB-C18 rapid resolution cartridge (4.6 mm × 30 mm, 3.5 μm). Elution started with 95% water (0.1% formic acid)/5% acetonitrile (0.1% formic acid) and ended with 95% acetonitrile (0.1% formic acid)/5% water (0.1% formic acid) and used a linear gradient at a flow rate of 2.5 mL/min. Purity of final compounds submitted to biological testing was assessed by HPLC recorded on a system consisting of an Agilent 1100 HPLC system equipped with a Zorbax Eclipse XDB-C8 column (4.6 mm × 150 mm, 3.5 μm) with a flow rate of 1 mL/min and a column temperature of 50 °C using the following two gradient conditions for all compounds: (1) 5–70% acetonitrile/water/0.1%TFA from 0 to 18 min, 18–26 min run isocratic at 70% acetonitrile/water/0.1%TFA; (2) 3090% acetonitrile/water/0.1% TFA from 0 to 14 min, 14–16 min 90% acetonitrile/water/0.1% TFA.</div><div class="NLM_p last">The following compounds were synthesized according to available literature procedures: <i>N</i>-carbobenzyloxyguanidine;<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> 6-benzyloxy-nicotinic acid,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> pyrrole-2-carboxylic acid chloride,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> 4-fluoro-3-trifluoromethylbenzoic acid methyl ester,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> 4-bromo-3-methylsulfonyl-benzoic acid.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> All commercially available chemicals were used as received and were purchased from Sigma-Aldrich except where indicated.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Computational Methods</h3><div class="NLM_p last">Structural overlays were generated using Cresset Fieldalign (Fieldalign 3.0.0, revision 14780, copyright 2006–2010, Cresset Biomolecular Discovery Ltd., BioPark, Hertfordshire, Broadwater Road, Welwyn Garden City, Herts AL7 3AX, United Kingdom) and matching the acylguanidine functionality in each molecule. The graphics were generated using Maestro 9.1. from Schrödinger LLC, New York, New York, USA, (2010).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthetic Methods</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-{3-[(1<i>H</i>-Pyrrole-2-carbonyl)-amino]-pyrrolidin-1-yl}-3-trifluoromethyl-benzoic Acid Methyl Ester (<b>11a</b>)</h4><div class="NLM_p">To a solution of 4-fluoro-3-trifluoromethyl-benzoic acid methyl ester (<b>8</b>, 5.0 g, 22.5 mmol) in dry DMSO (50 mL) was added K<sub>2</sub>CO<sub>3</sub> (3.08 g, 23.3 mmol) and <i>tert</i>-butyl-pyrrolidin-3-yl-carbamate (<b>9a</b>) (TCI, 4.2 g, 22.5 mmol) at room temperature. The reaction mixture was heated at 95 °C overnight. The reaction mixture was diluted with water and extracted three times with ethyl acetate. The combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was removed in vacuo. The residue was purified by flash chromatography eluting 20% ethyl acetate/petroleum-ether to give the desired product <b>10a</b> as a white solid with an unknown impurity still present. The impure residue was dissolved in methanol (50 mL) and saturated methanolic HCl (50 mL) was added at 0 °C. The reaction mixture was stirred overnight at room temperature, after which time the solvent was removed in vacuo and the residue was washed with diethyl ether (100 mL) to afford the piperidine hydrochloride salt product (5 g, 68% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.26 (br s, 2H), 8.13 (d, <i>J</i> = 1.8 Hz, 1H), 7.97 (dd, <i>J</i> = 1.9 Hz, 9.0 Hz, 1H), 7.06 (d, <i>J</i> = 9.0 Hz, 1H), 3.94–3.91 (m, 1H), 3.82 (s, 3H), 3.79–3.75 (m, 1H), 3.69–3.63 (m, 1H), 3.55–3.49 (m, 2H), 2.32–2.26 (m, 1H), 2.11–2.08 (m, 1H). MS (ES+): calcd for C<sub>13</sub>H<sub>14</sub>F<sub>3</sub>NO<sub>3</sub> + H<sup>+</sup> 289.26, found 289.28.</div><div class="NLM_p last">To a partially dissolved mixture of the product from the previous step (1 g, 3.08 mmol) in dry THF (30 mL) was added HATU (1.2 g, 3.16 mmol) and pyrrole-2-carboxylic acid (0.324 g, 3.06 mmol), and the resulting mixture was stirred at room temperature for 30 min. The reaction mixture was cooled to 0 °C and diisopropylamine (1.2 mL, 15.40 mmol) was added, and the mixture was stirred overnight at room temperature. The solvent was removed in vacuo, and the residue was diluted with H<sub>2</sub>O (50 mL) and extracted three times with ethyl acetate. The combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was removed in vacuo. The residue was purified by flash chromatography eluting 10% ethyl acetate/petroleum ether to afford the desired product as a white solid contaminated with 5 wt % TMU (0.75 g, 59% yield accounting for presence of TMU). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.31 (br s, 2H), 8.31 (s, 1H), 8.01 (d, <i>J</i> = 8.8 Hz, 1H), 6.94–6.90 (m, 2H), 6.55 (s, 1H), 6.24 (d, <i>J</i> = 3.5 Hz, 1H), 6.00 (d, <i>J</i> = 7.6 Hz, 1H), 4.76 (d, <i>J</i> = 5.9 Hz, 1H), 3.90 (s, 3H), 3.79–3.75 (m, 1H), 3.71–3.66 (m, 1H), 3.54–3.39 (m, 1H), 2.40–2.35 (m, 1H), 2.10–2.04 (m, 1H). MS (ES+): calcd for C<sub>18</sub>H<sub>17</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 382.36, found 382.26.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-{3-[(1<i>H</i>-Pyrrole-2-carbonyl)-amino]-pyrrolidin-1-yl}-3-trifluoromethyl-benzoic Acid (<b>12a</b>)</h4><div class="NLM_p last">To a solution of <b>11a</b> (0.75 g, 1.97 mmol) in THF/H<sub>2</sub>O (9/1) was added LiOH (0.25 g, 5.91 mmol), and the resulting mixture was stirred overnight. The solvent was removed in vacuo, and the residue was diluted with H<sub>2</sub>O and extracted with ether. The aqueous phase was acidified with 10% aqueous citric acid, and the resulting precipitate was collected by filtration and washed with ether to give pure desired product as a white solid (0.65 g, 89%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.0–12.4 (vbr s, 1H), 11.4 (s, 1H), 8.11–8.09 (m, 2H), 7.93 (d, <i>J</i> = 8.8 Hz, 1H), 7.03 (d, <i>J</i> = 7.0 Hz, 1H), 6.86 (s, 1H), 6.82 (s, 1H), 6.08 (d, <i>J</i> = 2.3 Hz, 1H), 4.52–4.49 (m, 1H), 3.75–3.71 (m, 1H), 3.58–3.53 (m, 2H), 3.44–3.40 (m, 1H), 2.24–2.20 (m, 1H), 2.19–2.04 (m, 1H). MS (ES+): calcd for C<sub>17</sub>H<sub>15</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 368.33, found 368.26.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Procedure for Mukuyama Coupling</h4><div class="NLM_p last">To a solution of the desired acid (1 equiv) in NMP (approximately 0.2 M concentration) was added 2-chloro-1-methylpyridinium iodide (1.2 equiv), and the resulting solution was stirred for 30 min at room temperature and then at 50 °C for 30 min. The dark-orange solution was cooled to room temperature, and either BOC or CBZ protected guanidine (1.3 equiv) and DIEA (3 equiv) were added. The resulting mixture was stirred overnight, after which time the solvent was removed in vacuo. The mixture was partitioned between water and ethyl acetate, and the phases were separated. The organic phase was washed twice with water, once with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was removed in vacuo. The crude material was purified via silica gel chromatography using the indicated eluent.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1<i>H</i>-Pyrrole-2-carboxylic Acid [1-(4-(<i>N</i>-Carbobenzyloxy)-guanidinocarbonyl-2-trifluoromethyl-phenyl)-pyrrolidin-3-yl]-amide (<b>13a</b>)</h4><div class="NLM_p last">Synthesized according to the Mukuyama coupling general procedure using <b>12a</b> (50.0 mg, 0.136 mmol). The crude material was purified via silica gel chromatography using a gradient elution of 0–80% ethyl acetate/hexanes to afford the desired product (46.2 mg, 63%) as a glassy solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.5 (s, 1H), 8.37 (s, 1H), 8.12–8.06 (m, 2H), 7.42–7.35 (m, 5H), 7.02 (d, 1H, <i>J</i> = 8.9 Hz), 6.88–6.86 (m, 1H), 6.85–6.81 (m, 1H), 6.08 (app dd, <i>J</i> = 2.4 Hz, 5.9 Hz, 1H), 5.19 (s, 1H), 4.50 (app quintet, <i>J</i> = 6.0 Hz, 1H), 3.74–3.70 (m, 1H), 3.59–3.50 (m, 1H), 3.44–3.40 (m, 1H), 2.25–2.17 (m, 1H), 2.09–2.03 (m, 1H). MS (ES+): calcd for C<sub>26</sub>H<sub>24</sub>F<sub>3</sub>N<sub>6</sub>O<sub>4</sub> + H<sup>+</sup> 543.52, found 543.47.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure for the Removal of the CBZ Protecting Group</h4><div class="NLM_p last">To a solution of CBZ-guanidine compound (1 equiv) in ethanol under an argon atmosphere was added 20 wt % Pd(OH)<sub>2</sub> on carbon (3 mol %) or 10 wt % Pd on carbon (10 mol %), and the mixture was stirred under a hydrogen atmosphere for 3–16 h. The mixture was filtered through Celite, and the solvent was removed in vacuo. The resulting residues were purified by the methods indicated for the specific compounds.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1<i>H</i>-Pyrrole-2-carboxylic Acid [1-(4-Guanidinocarbonyl-2-trifluoromethyl-phenyl)-pyrrolidin-3-yl]-amide (<b>5</b>)</h4><div class="NLM_p last">The CBZ protecting group of <b>13a</b> was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (4.0 mL) for 4 h. The crude residue was dissolved in minimal 10% methanol/CH<sub>2</sub>Cl<sub>2</sub> and precipitated using ether. The resulting precipitate was collected by filtration and triturated with ether to give the desired product as a white solid (10.5 mg, 28%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.41 (s, 1H), 11.36 (s, 1H), 8.47–8.22 (br m, 4H), 8.18 (d, <i>J</i> = 2.1 Hz, 1H), 8.07 (d, <i>J</i> = 6.5 Hz, 1H), 8.05–8.00 (m, 1H), 6.81–6.77 (m, 1H), 6.77–6.71 (m, 1H), 6.04–5.98 (m, 1H), 4.52–4.40 (m, 1H), 3.76–3.66 (m, 1H), 3.64–3.47 (m, 2H), 3.45–3.37 (m, 1H), 2.27–2.10 (m, 1H), 2.10–1.96 (m, 1H). MS (ES+): calcd for C<sub>18</sub>H<sub>19</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 409.39, found 409.40.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-{3-[(1<i>H</i>-Pyrrole-2-carbonyl)-amino]-piperidin-3-yl}-3-trifluoromethyl-benzoic Acid Methyl Ester (<b>11b</b>)</h4><div class="NLM_p">Following the procedure for the first two steps of the synthesis of compound <b>11a</b> using as the starting material <b>8</b> (7 g, 31.5 mmol) and <i>tert</i>-butyl piperidin-3-yl-carbamate (<b>9b</b>) (Oakwood, 6.31 g, 31.5 mmol) afforded the desired product as a white solid (4.00 g, 41% over two steps) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.21 (d, <i>J</i> = 8.4 Hz, 1H), 8.16 (s, 1H), 7.99 (br s, 2H), 7.60 (d, <i>J</i> = 8.4 Hz, 1H), 3.88 (s, 3H), 3.24 (m, 1H), 3.02 (d, <i>J</i> = 11.8 Hz, 1H), 2.81–2.79 (m, 2H), 2.03 (m, 1H), 1.86–1.83 (m, 1H), 1.64–1.61 (m, 1H), 1.48 (m, 1H). MS (ES+): calcd for C<sub>14</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> 303.30, found 303.26.</div><div class="NLM_p last">Using the product of the previous step as starting material (1 g, 2.95 mmol) and employing the procedure for <b>11a</b> step 3 afforded the desired product as a white solid contaminated with 9 wt % tetramethylurea (TMU) (0.9 g, 71% yield accounting for presence of TMU). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.27 (s, 1H), 8.35 (d, <i>J</i> = 1.8 Hz, 1H), 8.21 (dd, <i>J</i> = 1.6 Hz, 8.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 6.92 (d, <i>J</i> = 1.1 Hz, 1H), 6.86 (d, <i>J</i> = 8.1 Hz, 1H), 6.63 (s, 1H), 6.27 (dd, <i>J</i> = 2.5 Hz, 6.2 Hz, 1H), 3.94 (s, 3H), 3.21–3.18 (m, 1H), 3.14 (d, <i>J</i> = 10.7 Hz, 1H), 3.03–3.00 (m, 1H), 2.76–2.73 (m, 1H), 2.04–1.97 (m, 2H), 1.69–1.64 (m, 2H). MS (ES+): calcd for C<sub>19</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>+ H<sup>+</sup> 396.38, found 382.26 (pdt – Me + H<sup>+</sup>).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-{3-[(1<i>H</i>-Pyrrole-2-carbonyl)-amino]-piperidin-3-yl}-3-trifluoromethyl-benzoic Acid (<b>12b</b>)</h4><div class="NLM_p last">Following the procedure for <b>12a</b> using as the starting material <b>11b</b> (0.90 g, 2.12 mmol) afforded the desired product as a white solid (0.75 g, 87%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.4 (s, 1H), 8.13 (m, 1H), 7.70 (d, <i>J</i> = 8.0 Hz, 1H), 7.53 (d, <i>J</i> = 9.0 Hz, 1H), 6.84 (s, 1H), 6.77 (s, 1H), 6.07 (d, <i>J</i> = 3.5 Hz, 1H), 3.17 (d, <i>J</i> = 4.9 Hz, 1H), 3.11–3.09 (m, 1H), 2.80–2.72 (m, 1H), 2.69–2.57 (m, 1H), 1.92–1.89 (m, 1H), 1.84–1.81 (m, 1H), 1.69–1.66 (m, 1H), 1.54–1.51 (m, 1H). MS (ES+): calcd for C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 382.36, found 382.31</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1<i>H</i>-Pyrrole-2-carboxylic Acid [1-(4-Guanidinocarbonyl-2-trifluoromethyl-phenyl)-piperidin-3-yl]-amide (<b>6</b>)</h4><div class="NLM_p last">The required protected acyl guanidine intermediate <b>13b</b> was synthesized according to the Mukuyama coupling general procedure using <b>12b</b> (100 mg, 0.262 mmol) and was used without purification in the next step. The residue was dissolved in 1,4-dioxane (2.0 mL), and 4 M HCl in 1,4-dioxane (1.5 mL) was added. The reaction was stirred for 60 h, at which time the solvent was removed in vacuo. The residue was purified by preparative HPLC eluting 0–75% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (44 mg, 40% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.44 (s, 1H), 11.38 (s, 1H), 8.18 (s, 1H), 8.13 (dd, <i>J</i> = 2.2 Hz, 8.6 Hz, 1H), 7.77 (d, <i>J</i> = 7.8 Hz, 9.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.6 Hz, 1H,), 6.85 (s, 1H), 6.78 (s, 1H), 6.08 (s, 1H), 4.04–4.02 (m, 1H), 3.34 (d, <i>J</i> = 8.6 Hz, 1H,), 3.19 (app d, <i>J</i> = 12.0 Hz, 1H,), 2.83 (t, <i>J</i> = 9.3 Hz, 1H,), 2.73 (t, <i>J</i> = 10.4 Hz, 1H,), 1.94–1.83 (m, 2H), 1.72–1.51 (m, 2H). MS (ES+): calcd for C<sub>19</sub>H<sub>21</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 423.41, found 423.44.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-{4-[(1<i>H</i>-Pyrrole-2-carbonyl)-amino]-piperidin-1-yl}-3-trifluoromethyl-benzoic Acid (<b>12c</b>)</h4><div class="NLM_p">Following the procedure for the first two steps of the synthesis of <b>11a</b> using as the starting material piperidin-4-yl-carbamic acid <i>tert</i>-butyl ester (Astatech, <b>9c</b>, 0.43 g, 2.25 mmol) and <b>8</b> (0.50 g, 2.25 mmol) afforded crude <b>10c</b> as a yellow solid. HCl gas was bubbled through a solution of crude <b>10c</b> in methanol (25 mL) at 0 °C for 5 min. The reaction mixture was then stirred overnight at room temperature. The solvent was removed in vacuo, and the residue was washed with diethyl ether (100 mL) to afford the title compound as a yellow solid (0.30 g, 44% over two steps). <sup>1</sup>H NMR (DMSO): δ 8.24 (partially obscured br s, 2H), 8.20–8.11 (m, 2H), 7.57 (d, <i>J</i> = 8.40 Hz, 1H), 3.87 (s, 3H), 3.25–3.12 (m, 3H), 2.92–2.80 (m, 2H), 2.09–1.99 (m, 2H), 1.80- 1.60 (m, 2H). MS (EI): calcd for C<sub>14</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> 303.30, found 303.10.</div><div class="NLM_p last">Following the procedure for the third step of the synthesis of <b>11a</b> using as starting material the product of the previous step (1.00 g, 2.95 mmol) afforded crude <b>11c</b> as a white solid. Crude <b>11c</b> (1.00 g, 2.52 mmol) was subjected to the same procedure as for <b>12a</b> to afford the title compound as an off-white solid (0.75 g, 67% over two steps). <sup>1</sup>H NMR (DMSO): δ 13.19 (broad, 1H), 11.39 (s, 1H), 8.15 (partially obscured d, <i>J</i> = 8.0 Hz, 1H), 8.14 (s, 1H), 7.90–7.82 (m, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 1H), 6.83 (s, 2H), 6.07 (s, 1H), 3.95 (br s, 1H), 3.22–3.12 (m, 2H), 3.10–2.85 (m, 2H), 1.95–1.82 (m, 2H), 1.80–1.60 (m, 2H). MS (EI): calcd for C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 382.34, found 382.1.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1<i>H</i>-Pyrrole-2-carboxylic Acid [1-(4-Guanidinocarbonyl-2-trifluoromethyl-phenyl)-piperidin-4-yl]-amide (<b>7</b>)</h4><div class="NLM_p last">Following the procedure for <b>13a</b> using as the starting material <b>12c</b> (23.0 mg, 0.06 mmol) afforded crude <b>13c</b> as a white solid. This crude material (0.02 g, 0.32 mmol) was treated as in the procedure for <b>6</b> to the title compound as a white solid (10.0 mg, 47% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.72–11.41 (m, 2H), 8.75–8.32 (m, 4H), 8.25 (d, <i>J</i> = 8.4 Hz, 1 H), 8.20 (s, 1H) 7.68- 758 (d, <i>J</i> = 8.92 Hz, 1H), 6.90 (s, 1H), 5.62–5.40 (m, 1H), 4.15–3.90 (m, 1H), 3.85–3.60 (m, 2H), 3.60–3.18 (obscured by water peak, m, 1H), 2.45–2/07 (m, 2H). MS (EI): calcd for C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> 410.37, found 410.36.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-Bromo-3-trifluoromethyl-benzoic Acid Methyl Ester (<b>15</b>)</h4><div class="NLM_p last">To a solution of 4-bromo-3-trifluoromethyl-benzoic acid (3B Scientific, 115 g, 428 mmol) in methanol (400 mL) was added concentrated sulfuric acid (2 mL). The mixture was sealed and heated at 80 °C overnight. The mixture was cooled to room temperature, and the solvent was removed in vacuo. The residue was treated with water, and the resulting solid was collected by filtration to afford the desired product as a colorless solid (121 g, 98%). <sup>1</sup>H NMR (CDCl3): δ 8.21 (d, <i>J</i> = 2.0 Hz, 1H), 7.90 (dd, <i>J</i> = 2.0 Hz, 8.1 Hz, 1H), 7.68 (d, <i>J</i> = 8.1 Hz, 1H), 3.82 (s, 3H). MS (EI): calcd for C<sub>9</sub>H<sub>6</sub>BrF<sub>3</sub>O<sub>2</sub> + H<sup>+</sup> 282.95, 284.95, found 283.00 and 285.00.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(4-Methoxycarbonyl-2-trifluoromethyl-phenyl)-3,6-dihydro-2<i>H-</i>pyridine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>17</b>)</h4><div class="NLM_p last">To a solution of <b>15</b> (17.3 g, 61.2 mmol) in 1,4-dioxane (250 mL) were added 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic acid <i>tert</i>-butyl ester (<b>16</b>, Digital Specialty Chemicals, 18.9 g, 61.2 mmol), 2 M aqueous potassium carbonate (61.2 mL, 122 mmol), and tetrakistriphenylphosphinepalladium(0) (Strem, 7.07 g, 6.10 mmol). The reaction vessel was sealed and heated to 140 °C for 4 h. The mixture was cooled to room temperature, and the dioxane was removed in vacuo. The resulting residue was diluted with water and ethyl acetate and filtered to remove insoluble material, and the phases were separated. The aqueous phase was extracted twice with ethyl acetate, the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was removed in vacuo. The brown residue was then passed through a short bed of silica rinsing first with 10% ethyl acetate in hexane, then 20% ethyl acetate in hexane. The material collected from the 20% ethyl acetate fraction was evaporated to afford the desired product as a light-yellow solid (19.6 g, 83%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (d, <i>J</i> = 1.5 Hz, 1H), 8.17 (dm, <i>J</i> = 7.6 Hz, 1H), 7.33 (d, <i>J</i> = 7.8 Hz, 1H), 5.64 (s, 1H), 4.06 (q, <i>J</i> = 3.0 Hz, 2H), 3.98 (s, 3H), 3.65 (t, <i>J</i> = 5.6 Hz, 2H), 2.34 (br s, 2H), 1.52 (s, 9H). MS (ES+): calcd for C<sub>19</sub>H<sub>22</sub>F<sub>3</sub>NO<sub>4</sub> – tBu + CH<sub>3</sub>CN + H<sup>+</sup> 371.11, found 371.51.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(4-Methoxycarbonyl-2-trifluoromethyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>18</b>)</h4><div class="NLM_p last">To a solution of <b>17</b> (13.6 g, 35.3 mmol) in acetic acid (180 mL) under an argon atmosphere was added platinum(IV) oxide (750 mg, 3.3 mmol), and the mixture was stirred under a hydrogen atmosphere for 60 h. The mixture was filtered through Celite, and the solvent was removed in vacuo to give the desired product as a foam (13.5 g, 99%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.16 (s, 1H), 8.14 (s, 1H), 7.82 (d, <i>J</i> = 8.8 Hz, 1H), 4.11–4.08 (m, 2H), 3.02–3.01 (m, 1H), 2.94–2.70 (m, 2H), 1.67–1.64 (m, 4H), 1.42 (s, 9H). MS (ES+): calcd for C<sub>19</sub>H<sub>25</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> – Me + H<sup>+</sup> 373.39, found 373.33.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-(4-Carboxy-2-trifluoromethyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>19</b>)</h4><div class="NLM_p last">To a solution of <b>18</b> (5.10 g, 13.2 mmol) in methanol (39 mL) and water (13 mL) was added potassium carbonate (3.64 g, 26.3 mmol), and the reaction was stirred for 16 h at room temperature. The methanol was removed in vacuo, the residue was poured into dilute aqueous hydrochloric acid, and the desired product was isolated by filtration (5.0 g, 100%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.14 (s, 1H), 8.12 (s, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 1H), 4.10 (br d, <i>J</i> = 10.7 Hz, 2H), 3.16–3.00 (m, 1H), 2.90–2.75 (m, 2H), 1.67–1.61 (m, 4H), 1.42 (s, 9H). MS (ES+): calcd for C<sub>18</sub>H<sub>22</sub>F<sub>3</sub>NO<sub>4</sub> + H<sup>+</sup> 374.38, found 374.60.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(4-Piperidin-4-yl-3-trifluoromethyl-benzoyl)-(<i>N</i>′-(carbobenzyloxy)-guanidine (<b>20a</b>)</h4><div class="NLM_p">Synthesized according to the Mukuyama coupling general procedure using <b>19</b> (2.60 g, 6.96 mmol). The crude residue was purified via flash chromatography eluting 0–80% ethyl acetate/hexanes to give the desired CBZ-guanidine as a pale-orange oil (3.06 g, 80%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.22 (br s, 1H), 9.80 (br s, 1H), 8.74 (br s, 1H), 8.41 (d, <i>J</i> = 1.6 Hz, 1H), 8.26 (dd, <i>J</i> = 1.2 Hz, 8.2 Hz, 1H), 7.74 (d, <i>J</i> = 8.2 Hz, 1H), 7.46–7.34 (m, 5H), 5.23 (s, 2H), 4.11 (br d, <i>J</i> = 10.0 Hz, 2H), 3.12–2.96 (m, 1H), 2.90–2.72 (m, 2H), 1.68–1.59 (m, 4H), 1.43 (s, 9H). MS (ES+): calcd for C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>4</sub>O<sub>5</sub> + H<sup>+</sup> 549.57, found 549.20.</div><div class="NLM_p last">To a solution of the product of the previous step (3.06 g, 5.58 mmol) in 1,4-dioxane (25 mL) was added 4 M hydrogen chloride in 1,4-dioxane (14.0 mL, 55.8 mmol), and the mixture was stirred for 16 h. The mixture was concentrated to give pure product as a white powder as the hydrochloride salt (2.70 g, 100%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.16 (br s, 1H), 9.40–9.60 (m, 2H), 9.21–9.19 (m, 1H), 8.46 (s, 1H), 8.44 (d, <i>J</i> = 8.2 Hz, 1H), 7.74 (d, <i>J</i> = 8.2 Hz, 1H), 7.47–7.36 (m, 5H), 5.30 (s, 2H), 3.38–3.35 (m, 2H), 3.23 (t, <i>J</i> = 11.8 Hz, 1H), 3.06 (app q, <i>J</i> = 11.9 Hz, 2H), 2.22–2.19 (m, 2H), 1.84–1.81 (m, 2H). MS (ES+): calcd for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 449.57, found 449.20.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Procedure for Amide Bond Coupling with CDI</h4><div class="NLM_p last">To a solution of benzoic acid derivative (1.10 equiv) in DMF was added CDI (1.10 equiv), and the mixture was stirred for 30–60 min. <b>20a</b> or <b>20b</b> was then added (1.00 equiv), followed by DIEA (3.0 equiv), and the reaction was stirred overnight at room temperature. The resulting mixture was either diluted with water or dilute HCl solution and filtered to give the desired the product or diluted with ethyl acetate and washed with water three times followed by brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting coupling products were either used crude in the next step or purified by flash chromatography as indicated.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-{4-[1-(1<i>H</i>-Pyrrole-2-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine, Hydrochloride (<b>14</b>)</h4><div class="NLM_p last">The CBZ-protected amide intermediate was obtained using the CDI coupling general procedure from pyrrole-2-carboxylic acid (75.7 mg, 0.682 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (10 mL) and <b>20a</b> (300 mg, 0.619 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd on carbon in a mixture of ethanol and ethyl acetate (10:2, 4 mL) for 16 h. The residue was purified by two serial flash chromatography purifications eluting 0–40% methanol in dichloromethane. The resulting pure residue was treated with 4N HCl in 1,4-dioxane to give the desired compound as a white solid (54 mg, 20% over two steps). <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.28–8.21 (m, 1H), 8.26–8.12 (m, 1H), 7.63 (d, <i>J</i> = 8.16 Hz, 1H), 6.90–6.80 (m, 1H), 6.66–6.58 (m, 1 H), 6.26–6.17 (m, 1H), 4.70–4.62 (m, 2H), 3.40–3.25 (m, 1H), 3.10–2.95 (m, 2H), 1.91–1.74 (m, 4H). MS (EI): calcd for C<sub>19</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>+ H<sup>+</sup> 408.40, found 408.56.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-[4-(1,2,3,6-Tetrahydro-pyridin-4-yl)-3-trifluoromethyl-benzoyl]-<i>N</i>′-(carbobenzyloxy)-guanidine (<b>20b</b>)</h4><div class="NLM_p">To a solution of <b>17</b> (2.74 g, 7.10 mmol) in methanol (40.0 mL) was added water (4.00 mL) and potassium carbonate (2.46 g, 17.8 mmol), and the reaction mixture was heated at 60 °C for 2 h. The mixture was then diluted with ethyl acetate (200 mL) and water (100 mL). The aqueous phase was brought to a pH of about 4 using 1N aqueous hydrochloric acid. The phases were separated, and the aqueous phase was extracted twice with ethyl acetate. The combined organic phase were dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was removed in vacuo to yield the desired carboxylic acid as a colorless solid (2.48 g, 94%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.33 (d, <i>J</i> = 1.3 Hz, 1H), 8.15 (dd, <i>J</i> = 1.5 Hz, 8.0 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 5.57 (s, 1H), 3.99–3.98 (m, 2H), 3.56 (t, <i>J</i> = 5.6 Hz, 2H), 2.31–2.30 (m, 2H), 1.44 (s, 9H). MS (ES+): calcd for C<sub>16</sub>H<sub>14</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> – tBu + CH<sub>3</sub>CN + H<sup>+</sup> 357.10, found 357.46.</div><div class="NLM_p">The required CBZ-protected guanidine intermediate was synthesized according to the Mukuyama coupling general procedure using the product of the previous step (2.48 g, 6.68 mmol). The crude material was purified via silica gel chromatography using a gradient elution of 0–40% ethyl acetate/hexanes to afford the desired CBZ-protected guanidine intermediate (3.37 g, 92%) as a glassy solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.47–8.40 (m, 2H), 7.47–7.38 (m, 6H), 5.63 (br s, 1H), 4.06 (s, 2H), 3.73–3.63 (m, 2H), 2.47–2.29 (m, 2H), 1.52 (s, 9H). MS (ES+): calcd for C<sub>27</sub>H<sub>30</sub>F<sub>3</sub>N<sub>4</sub>O<sub>5</sub> + H<sup>+</sup> 548.22, found 547.83.</div><div class="NLM_p last">To a solution of the product of the previous step (3.37 g, 6.20 mmol) in dichloromethane (24 mL) was added 4 N hydrogen chloride in 1,4-dioxane (25 mL, 100 mmol), and the reaction was stirred for 2 h. The mixture was diluted with ether (200 mL) and filtered to give the desired product as a colorless solid (2.80 g, 94%). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.41 (s, 1H), 8.34 (br s, 1H), 7.64 (br s, 1H), 7.56–7.38 (m, 5H), 5.77 (s, 1H), 5.37 (s, 2H), 3.85 (br s, 2H), 3.47 (br s, 2H), 2.66 (br s, 2H). MS (ES+): calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 447.43, found 447.77.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-{4-[1-(4-Trifluoromethyl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>23</b>)</h4><div class="NLM_p">The required CBZ-protected acylguanidine was obtained using the CDI coupling general procedure from 4-trifluoromethyl-benzoic acid (43.3 mg, 0.228 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20b</b> (100 mg, 0.207 mmol). The desired product was obtained following aqueous workup and flash chromatography eluting 0–60% ethyl acetate/hexanes (103 mg, 80%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.03 (br s, 1H), 8.62 (br s, 1H), 8.45 (s, 1H), 8.22 (d, <i>J</i> = 7.2 Hz, 1H), 7.71 (d, <i>J</i> = 8.0 Hz, 2H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.42–7.37 (m, 5H), 7.24–7.20 (m, 1H, partially obscured by CHCl<sub>3</sub> peak), 5.74–5.50 (m, 1H), 5.24 (s, 2H), 4.38 (s, 1H), 4.01 (s, 2H), 3.57 (s, 1H), 2.51–2.38 (m, 2H). MS (ES+): calcd for C<sub>30</sub>H<sub>27</sub>F<sub>3</sub>N<sub>4</sub>O<sub>6</sub>S + H<sup>+</sup> 619.53, found 619.46.</div><div class="NLM_p last">The product of the previous step (103 mg, 0.167 mmol) was treated according to the CBZ removal general procedure using Pd on carbon in ethanol (4.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (64.0 mg, 64%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.67 (br s, 1H), 8.79–8.43 (m, 4H), 8.22–8.20 (m, 2H), 8.05 (d, <i>J</i> = 8.2 Hz, 1H), 7.85 (d, <i>J</i> = 8.1 Hz, 2H), 7.71 (d, <i>J</i> = 8.0 Hz, 2H), 4.70 (d, <i>J</i> = 10.8 Hz, 1H), 3.60 (d, <i>J</i> = 13.6 Hz, 1H), 3.27–3.17 (m, 2H), 2.94–2.89 (m, 1H), 1.91–1.76 (m, 3H), 1.66–1.63 (m, 1H). MS (ES+): calcd for C<sub>22</sub>H<sub>20</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 487.41, found 487.74.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-{4-[1-(4-Hydroxy-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>31</b>)</h4><div class="NLM_p">The required CBZ-protected acylguanidine was obtained using the CDI coupling general procedure from 4-benzyloxy-benzoic acid (Lancaster, 52.0 mg, 0.228 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20b</b> (100 mg, 0.207 mmol). The desired product was obtained following aqueous workup and flash chromatography eluting 0–60% ethyl acetate/hexanes (78 mg, 57%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.42 (vbr s, 1H), 8.66 (br s, 1H), 8.42 (s, 1H), 8.19 (d, <i>J</i> = 8.2 Hz, 1H), 7.45–7.21 (m, 13H), 7.00 (dd, <i>J</i> = 2.0 Hz, 6.9 Hz, 2H), 6.79–5.41 (m, 1H), 5.23 (s, 2H), 5.11 (s, 2H), 4.41–3.64 (m, 4H), 2.44 (br s, 2H). MS (ES+): calcd for C<sub>36</sub>H<sub>31</sub>F<sub>3</sub>N<sub>4</sub>O<sub>5</sub> + H<sup>+</sup> 657.65, found 657.60.</div><div class="NLM_p last">The product of the previous step (78 mg, 0.118 mmol) was treated according to the CBZ removal general procedure using Pd on carbon in ethanol (3.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (39.0 mg, 60%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.71 (br s, 1H), 9.87 (br s, 1H), 8.64–8.45 (m, 4H), 8.22 (d, <i>J</i> = 1.5 Hz, 1H), 8.18 (dd, <i>J</i> = 1.7 Hz, 8.2 Hz, 1H), 8.02 (d, <i>J</i> = 8.3 Hz, 1H), 7.34 (d, <i>J</i> = 8.6 Hz, 2H), 6.82 (d, <i>J</i> = 8.6 Hz, 2H), 4.96–3.78 (vbr s 2H), 3.97 (s, 1H), 3.21–2.76 (m, 3H). MS (ES+): calcd for C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 435.41, found 435.72.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-{4-[1-(3-Methylsulfonyl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>36</b>)</h4><div class="NLM_p">The required CBZ-protected acylguanidine was obtained using the CDI coupling general procedure from 3-methylsulfonyl-benzoic acid (Acros, 36.9 mg, 0.228 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20b</b> (100 mg, 0.207 mmol). The desired product was obtained following aqueous workup and flash chromatography eluting 0–100% ethyl acetate/hexanes (110 mg, 85%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.62 (br s, 1H), 8.69–8.41 (m, 4H), 8.21–8.19 (m, 2H), 8.07–8.01 (m, 3H), 7.85 (dt, <i>J</i> = 1.2 Hz, 7.7 Hz, 1H), 7.76 (t, <i>J</i> = 7.7 Hz, 1H), 4.69 (d, <i>J</i> = 11.8 Hz, 1H), 3.63 (d, <i>J</i> = 11.7 Hz, 1H), 3.30 (s, 3H), 3.28–3.21 (m, 2H, partially obscured by singlet at 3.30), 3.07–2.93 (m, 1H), 1.99–1.76 (m, 3H), 1.73–1.64 (m, 1H). MS (ES+): calcd for C<sub>30</sub>H<sub>27</sub>F<sub>3</sub>N<sub>4</sub>O<sub>6</sub>S + H<sup>+</sup> 629.62, found 629.41.</div><div class="NLM_p last">The product of the previous step (110.0 mg, 0.175 mmol) was treated according to the CBZ removal general procedure using Pd on carbon in ethanol (3.0 mL) for 48 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (60.0 mg, 56%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.16 (br s, 1H), 9.86 (br s, 1H), 8.73 (br s, 1H), 8.46 (s, 1H), 8.28 (d, <i>J</i> = 7.2 Hz, 1H), 8.03 (d, <i>J</i> = 7.7 Hz, 1H), 7.97 (s, 1H), 7.83–7.75 (m, 2H), 7.52 (br s, 1H), 7.45–7.39 (m, 5H), 5.74–5.55 (m, 1H), 4.26 (s, 1H), 4.03 (s, 1H), 3.88 (s, 1H), 3.52 (s, 1H), 3.29 (s, 3H), 2.42–2.36 (m, 2H). MS (ES+): calcd for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup> 497.49, found 497.73.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-{4-[1-(2-Methylsulfonyl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>37</b>)</h4><div class="NLM_p">The required CBZ-protected amide intermediate was obtained using the CDI coupling general procedure from 2-methylsulfonyl-benzoic acid (Acros, 46.0 mg, 0.228 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL) and <b>20b</b> (100 mg, 0.207 mmol). The desired product was obtained following aqueous workup and was used crude in the following step.</div><div class="NLM_p last">The CBZ protecting group was removed according to the general procedure using Pd on carbon (20 mol %) in ethanol (4.0 mL) for 48 h at 40 °C. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (37.0 mg, 29% over two steps). <sup>1</sup>H NMR (CD<sub>3</sub>OD) mixture of 2 rotamers in a 3:1 ratio, shifts reported for major rotamer: δ 8.26 (d, <i>J</i> = 1.6 Hz, 1H), 8.18 (dd, <i>J</i> = 1.8 Hz, 8.3 Hz, 1H), 8.12 (dd, <i>J</i> = 1.0 Hz, 8.9 HZ, 1H), 7.84 (d, <i>J</i> = 8.4 Hz, 1H), 7.81 (dt, <i>J</i> = 1.1 Hz, 7.5 Hz, 1H), 7.71 (dt, <i>J</i> = 1.2 Hz, 7.7 Hz, 1H), 7.49 (dd, <i>J</i> = 1.1 Hz, 7.6 Hz, 1H), 4.83–4.81 (m, 1H), 3.58–3.55 (m, 1H), 3.36–3.33 (m, 1H, partially obscured by methyl singlet), 3.31 (s, 3H), 2.99 (dt, <i>J</i> = 2.6 Hz, 13.0 Hz, 1H), 2.19 (dq, <i>J</i> = 4.2 Hz, 12.4 Hz, 1H), 2.04 (dq, <i>J</i> = 3.7 Hz, 12.6 Hz, 1H, partially obscured), 2.00–1.95 (m, 1H, partially obscured), 1.81–1.77 (m, 1H), 1.58–1.55 (m, 1H). MS (ES+): calcd for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup> 497.50, found 497.38.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-{4-[1-(4-Methoxy-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>47</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 4-methoxy-benzoic acid (34.7 mg, 0.228 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL) and <b>20b</b> (100 mg, 0.207 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd on carbon in ethanol (4.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (60.0 mg, 52% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.68 (br s, 1H), 8.78–8.44 (m, 4H), 8.22 (s, 1H), 8.18 (dd, <i>J</i> = 1.6 Hz, 8.3 Hz, 1H), 8.03 (d, <i>J</i> = 8.3 Hz, 1H), 7.45 (d, <i>J</i> = 8.8 Hz, 2H), 7.00 (d, <i>J</i> = 8.8 Hz, 2H), 4.68–4.57 (m, 1H), 3.81 (s, 4H), 3.28–3.06 (m, 1H), 3.02–2.84 (m, 2H), 1.91–1.63 (m, 4H). MS (ES+): calcd for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 449.44, found 449.73.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-[4-(4-Guanidinocarbonyl-2-trifluoromethyl-phenyl)-piperidine-1-carbonyl]-<i>N</i>-methyl-benzamide (<b>48</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from <i>N</i>-methyl-terephthalamic acid (Matrix, 61.0 mg, 0.340 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (4 mL) and <b>20b</b> (150 mg, 0.311 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd on carbon (20 mol %) in ethanol (4.0 mL) for 48 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (50.0 mg, 28% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.57 (br s, 1H), 8.71–8.26 (m, 5H), 8.21–8.18 (m, 2H), 8.05 (d, <i>J</i> = 8.0 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 2H), 7.55 (d, <i>J</i> = 7.9 Hz, 2H), 4.79–4.54 (m, 1H), 3.66–3.64 (m, 1H, partially obscured by H<sub>2</sub>O peak), 2.95–2.84 (m, 2H), 2.80 (d, <i>J</i> = 4.2 Hz, 3H), 2.00–1.55 (m, 4H). MS (ES+): calcd for C<sub>23</sub>H<sub>24</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> 476.46, found 476.67.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>,<i>N</i>-Dimethyl-terephthalamic Acid</h4><div class="NLM_p last">To a solution of terephthalic acid monomethyl ester chloride (TCI, 1.00 g, 5.04 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added dimethylamine (2 M solution in methanol, 5.29 mL, 10.6 mmol) dropwise over 15 min, and the reaction was stirred for 1 h. The resulting mixture was diluted with ethyl acetate and washed with water, 1 M HCl, and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the desired amide which was used directly in the next reaction. To a solution of the crude ester in methanol (30 mL) was added water (10 mL) followed by K<sub>2</sub>CO<sub>3</sub> (1.58 g, 11.4 mmol), and the resulting mixture was heated at 50 °C for 3.5 h. The methanol was removed in vacuo, and the resulting aqueous solution was acidified with concentrated aqueous HCl and diluted with 25 mL of water. The cloudy aqueous solution was extracted twice with ethyl acetate, the combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was removed in vacuo to give the desired product as a white solid (690 mg, 71% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.16 (br s, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 2H), 7.51 (d, <i>J</i> = 8.4 Hz, 2H), 3.00 (s, 3H), 2.88 (s, 3H). MS (ES+): calcd for C<sub>10</sub>H<sub>11</sub>NO<sub>3</sub> + H<sup>+</sup> 194.20, found 194.32.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-[4-(4-Guanidinocarbonyl-2-trifluoromethyl-phenyl)-piperidine-1-carbonyl]-<i>N</i>,<i>N</i>-dimethyl-benzamide (<b>49</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from <i>N</i>,<i>N</i>-dimethyl-terephthalamic acid (65.7 mg, 0.340 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (4 mL) and <b>20b</b> (150 mg, 0.311 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd on carbon (20 mol %) in ethanol (4.0 mL) for 48 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (100 mg, 53% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.69 (br s, 1H), 8.87–8.30 (m, 4H), 8.21–8.18 (m, 2H), 8.05 (d, <i>J</i> = 8.3 Hz, 1H), 7.53 (d, <i>J</i> = 8.2 Hz, 2H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 4.69 (br s, 1H), 3.70 (br s, 1H), 3.30–3.10 (m, 2H), 3.00 (s, 3H), 2.92 (s, 3H), 2.90–2.80 (m, 1H, partially obscured by methyl peak), 1.90–1.57 (m, 4H). MS (ES+): calcd for C<sub>23</sub>H<sub>24</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> 490.49, found 490.70.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-[4-(1-Benzoyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>21</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from benzoic acid (27.7 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (3.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–100% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (68 mg, 62% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.62 (br s, 1H), 8.71–8.41 (m, 4H), 8.21 (s, 1H), 8.17 (d, <i>J</i> = 8.3 Hz, 1H), 8.05 (d, <i>J</i> = 8.3 Hz, 1H), 7.47 (s, 5H), 4.69 (br s, 1H), 3.72 (br s, 1H), 3.39–3.31 (m, 2H), 3.00–2.90 (m, 1H), 1.99–1.58 (m, 4H). MS (ES+): calcd for C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 419.42, found 419.30.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-{4-[1-(4-Fluoro-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>22</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling general procedure from 4-fluorobenzoic acid (1.85 g, 13.2 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (120 mL) and <b>20a</b> (5.82 g, 12.0 mmol). The desired product was obtained by diluting the mixture with ice-cold dilute hydrochloric acid solution followed by filtration and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd on carbon in ethanol (75 mL) for 16 h. The residue was dissolved in dioxane (100 mL) and treated with excess 4 M hydrogen chloride in 1,4-dioxane. The solvent was removed in vacuo, and the resulting residue was triturated with ether. The resulting solid was recrystallized from acetonitrile to give the desired product as a colorless solid (3.77 g, 65% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.15 (s, 1H), 8.72–8.49 (m, 4H), 8.40–8.38 (d, <i>J</i> = 8.4 Hz, 1H), 8.33 (s, 1H), 8.04 (d, <i>J</i> = 8.3 Hz, 1H), 7.57–7.53 (m, 2H), 7.32–7.27 (m, 2H), 4.70 (br s, 1H), 3.73 (br s, 1H), 3.19–3.17 (m, 2H), 2.95–2.75 (m, 1H), 1.90–1.67 (m, 4H), 1.84–1.81 (m, 2H). MS (ES+): calcd for C<sub>21</sub>H<sub>20</sub>F<sub>4</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 437.40, found 437.20.</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-{4-[1-(4-Imidazol-1-yl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>30</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 4-(1<i>H</i>-imidazol-1-yl)benzoic acid (42.7 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd on carbon in ethanol (3.0 mL) for 16 h. The residue was redissolved in methanol/CH<sub>2</sub>Cl<sub>2</sub> and treated with an excess of 1N HCl in ether. The resulting mixture was concentrated, and the resulting white solid was suspended in acetonitrile and boiled for 15 min. The resulting precipitate was collected by filtration to give the desired product as a crystalline white solid (73 mg, 64% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.56 (br s, 1H), 9.73 (s, 1H), 8.88 (br s, 2H), 8.70 (br s, 2H), 8.54 (dd, <i>J</i> = 1.3 Hz, 8.2 Hz, 1H), 8.40 (d, <i>J</i> = 1.5 Hz, 1H), 8.34 (t, <i>J</i> = 1.7 Hz, 1H), 8.07 (d, <i>J</i> = 8.4 Hz, 1H), 7.93–7.91 (m, 3H), 7.77 (d, <i>J</i> = 8.6 Hz, 2H), 4.77–4.61 (m, 1H), 3.72–3.58 (m, 1H), 3.32–3.16 (m, 2H), 2.99–2.83 (m, 1H), 2.02–1.58 (m, 4H). MS (ES+): calcd for C<sub>24</sub>H<sub>23</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 484.49, found 485.25.</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-{4-[1-(4-Cyano-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>32</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling general procedure from 4-cyanobenzoic acid (33.4 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (15 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (4.0 mL). The residue was purified via preparative HPLC using a gradient elution from 10% to 80% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (66 mg, 57% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.57 (br s, 1H), 8.70–8.30 (m, 4H), 8.25–8.18 (m, 2H), 8.05 (d, <i>J</i> = 8.3 Hz, 1H), 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 2H), 4.68 (d, <i>J</i> = 11.7 Hz, 1H), 3.57–3.54 (m, 1H), 3.26–3.23 (m, 2H), 2.91 (app t, <i>J</i> = 11.6 Hz, 1H), 1.92–1.76 (m, 3H), 1.72–1.65 (m, 1H). MS (ES+): calcd for C<sub>22</sub>H<sub>20</sub>F<sub>4</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 444.43, found 444.40.</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-{4-[1-(3-Cyano-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>33</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 3-cyanobenzoic acid (33.4 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step (115 mg, 80%). The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (4.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–80% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (71.7 mg, 62% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.60 (br s, 1H), 8.69–8.36 (m, 4H), 8.21–8.19 (m, 2H), 8.06 (d, <i>J</i> = 8.2 Hz, 1H), 7.99 (m, 1H), 7.95 (dt, <i>J</i> = 1.3 Hz, 7.7 Hz, 1H), 7.82 (dt, <i>J</i> = 1.3 Hz, 7.9 Hz, 1H), 4.68 (d, <i>J</i> = 11.3 Hz, 1H), 3.60 (d, <i>J</i> = 12.4 Hz, 1H), 3.30–3.15 (m, 2H), 2.98–2.85 (m, 1H), 1.88–1.82 (m, 3H), 1.66–1.55 (m, 1H). MS (ES+): calcd for C<sub>22</sub>H<sub>20</sub>F<sub>4</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 444.43, found 444.37.</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-{4-[1-(2-Cyano-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>34</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 2-cyanobenzoic acid (33.4 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (4.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–80% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (78 mg, 68% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.54 (br s, 1H), 8.66–8.28 (m, 4H), 8.22–8.20 (m, 2H), 8.00–7.92 (m, 2H), 7.83 (td, <i>J</i> = 1.2 Hz, 7.7 Hz, 1H), 7.72–7.65 (m, 2H), 4.72 (d, <i>J</i> = 13.1 Hz, 1H), 3.46–3.43 (m, 1H), 3.33–3.16 (m, 2H), 3.09–2.90 (m, 1H), 1.86–1.76 (m, 3H), 1.69–1.66 (m, 1H). MS (ES+): calcd for C<sub>22</sub>H<sub>20</sub>F<sub>4</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 444.43, found 444.39.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-{4-[1-(4-Methylsulfonyl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>35</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 4-methylsulfonyl-benzoic acid (136 mg, 0.681 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (8 mL) and <b>20a</b> (300 mg, 0.619 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (8.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (253 mg, 67% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.58 (br s, 1H), 8.81–8.36 (m, 4H), 8.22–8.19 (m, 2H), 8.11–8.02 (m, 3H), 7.75 (d, <i>J</i> = 8.4 Hz, 2H), 4.70 (d, <i>J</i> = 12.6 Hz, 1H), 3.58 (d, <i>J</i> = 13.0 Hz, 1H), 3.28 (s, 3H), 3.25–3.20 (m, 2H), 2.92 (app t, <i>J</i> = 11.2 Hz, 1H), 1.98–1.83 (m, 3H), 1.66–1.50 (m, 1H). MS (ES+): calcd for C<sub>22</sub>H<sub>23</sub>F<sub>4</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup> 496.50, found 497.34.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-{4-[1-(Pyridine-4-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>38</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from isonicotinic acid (28.2 mg, 0.227 mmol) in DMF (2.0 mL) and <b>20a</b> (100 mg, 0.206 mmol) using TEA as the base. The desired product was obtained by dilution with water and filtration of the resulting precipitate. The CBZ protecting group was removed according to the general procedure using Pd on carbon (15 mol %) in ethyl acetate (1.0 mL) and methanol (1.0 mL) for 16 h. The crude material was purified by column chromatography eluting 0–10% methanol/dichloromethane to give the desired product as a white solid (68 mg, 79% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.69 (dd, <i>J</i> = 1.5 Hz, 4.4 Hz, 2H), 8.36 (d, <i>J</i> = 1.6 Hz, 1H), 8.25 (d, <i>J</i> = 8.1 Hz, 1H), 8.02 (s, 2H), 7.79 (d, <i>J</i> = 8.2 Hz, 1H), 7.47 (dd, <i>J</i> = 1.6 Hz, 4.4 Hz, 2H), 6.75 (s, 2H), 4.66 (d, <i>J</i> = 13.0 Hz, 1H), 3.54 (d, <i>J</i> = 13.4 Hz, 1H), 3.26–3.07 (m, 2H), 2.95–2.79 (m, 1H), 1.89–1.73 (m, 3H), 1.63 (d, <i>J</i> = 11.9 Hz, 1H). MS (ES+): calcd for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 420.41, found 420.20.</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-{4-[1-(Pyridine-3-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>39</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from nicotinic acid (28 mg, 0.23 mmol) in DMF (2.0 mL) and <b>20a</b> (100 mg, 0.206 mmol) using TEA as the base. The desired product was obtained by dilution with water and filtration of the resulting precipitate. The CBZ protecting group was removed according to the general procedure using Pd on carbon (20 mol %) in ethyl acetate (1.0 mL) and methanol (1.0 mL) for 16 h. The crude hydrogenation was purified by flash chromatography eluting 0–10% ethanol/dichloromethane to give the desired product as a white solid (71 mg, 82% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.69 (d, <i>J</i> = 2.1 Hz, 1H), 8.66 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.36 (d, <i>J</i> = 1.5 Hz, 1H), 8.26 (d, <i>J</i> = 8.2 Hz, 1H), 7.96 (br s, 2H), 7.96–7.88 (m, 1H), 7.80 (d, <i>J</i> = 8.2 Hz, 1H), 7.50 (dd, <i>J</i> = 4.9 Hz, 7.8 Hz, 1H), 6.77 (s, 2H), 4.68 (d, <i>J</i> = 8.3 Hz, 1H), 3.64 (d, <i>J</i> = 11.3 Hz, 1H), 3.28–3.09 (m, 2H), 2.97–2.80 (m, 1H), 1.95–1.55 (m, 4H). MS (ES+): calcd for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 420.41, found 420.60.</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-{4-[1-(Pyridine-2-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>40</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from picolinic acid (28.2 mg, 0.227 mmol) in DMF (2.0 mL) and <b>20a</b> (100 mg, 0.206 mmol) using TEA as the base. The desired product was obtained by dilution with water and filtration of the resulting precipitate. The CBZ protecting group was removed according to the general procedure using Pd on carbon (15 mol %) in ethyl acetate (1.0 mL) and methanol (1.0 mL) for 16 h. The crude hydrogenation was purified by flash chromatography eluting 0–10% methanol/dichloromethane to give the desired product as a white solid (68 mg, 79% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.60 (ddd, <i>J</i> = 0.9 Hz, 1.6 Hz, 4.8 Hz, 1H), 8.36 (d, <i>J</i> = 1.6 Hz, 1H), 8.26 (d, <i>J</i> = 8.1 Hz, 1H), 7.98 (br s, 2H), 7.94 (td, <i>J</i> = 1.7 Hz, 7.7 Hz, 1H), 7.71 (d, <i>J</i> = 8.2 Hz, 1H), 7.62 (dt, <i>J</i> = 1.0 Hz, 7.8 Hz, 1H), 7.48 (ddd, <i>J</i> = 1.2 Hz, 4.8 Hz, 7.6 Hz, 1H), 6.76 (s, 2H), 4.69 (d, <i>J</i> = 13.1 Hz, 1H), 3.79 (d, <i>J</i> = 13.4 Hz, 1H), 3.24–3.09 (m, 2H), 2.89 (td, <i>J</i> = 12.8, 3.3 Hz, 1H), 1.88–1.58 (m, 4H). MS (ES+): calcd for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 420.41, found 420.59.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-[4-(4-Guanidinocarbonyl-2-trifluoromethyl-phenyl)-piperidine-1-carbonyl]-benzamide (<b>41</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from terephthalamic acid (37.5 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (6.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 20–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (35 mg, 30% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.63 (br s, 1H), 8.57–8.41 (m, 4H), 8.25–8.17 (m, 2H), 8.07–8.00 (m, 2H), 7.93 (d, <i>J</i> = 8.3 Hz, 2H), 7.54 (d, <i>J</i> = 8.3 Hz, 2H), 7.48 (s, 1H), 4.70–4.67 (m, 1H), 3.65–3.62 (m, 1H), 3.33–3.16 (partially obscured m, 2H), 2.99–2.75 (m, 1H), 1.89–1.65 (m, 4H). MS (ES+): calcd for C<sub>22</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> 462.45, found 462.70.</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-{4-[1-(6-Hydroxy-pyridine-3-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>42</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 6-benzyloxy-nicotinic acid (52 mg, 0.23 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (4 mL) and <b>20a</b> (100 mg, 0.206 mmol) using TEA as the base. The desired product was obtained by dilution with water and filtration of the resulting precipitate. The CBZ protecting group was removed according to the general procedure using Pd on carbon (20 mol %) in methanol (4.0 mL) for 48 h. The crude hydrogenation was dissolved in methanol, and Et<sub>2</sub>O was added. A white solid was formed, and it was filtered and rinsed with more Et<sub>2</sub>O. The material was recrystallized from methanol to give the desired product as a white solid (25 mg, 28% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.09 (s, 1H), 8.62 (s, 2H), 8.51 (s, 2H), 8.37 (dd, <i>J</i> = 1.5 Hz, 8.3 Hz, 1H), 8.32 (d, <i>J</i> = 1.6 Hz, 1H), 8.01 (d, <i>J</i> = 8.3 Hz, 1H), 7.63 (d, <i>J</i> = 2.3 Hz, 1H), 7.56 (dd, <i>J</i> = 2.6 Hz, 9.5 Hz, 1H), 6.36 (d, <i>J</i> = 9.5 Hz, 1H), 4.22 (s, 2H), 3.14 (s, 1H), 3.01 (d, <i>J</i> = 15.8 Hz, 2H), 1.95–1.61 (m, 4H). MS (ES+): calcd for C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> 436.41, found 436.41.</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-{4-[1-(4-Sulfamoyl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>43</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 4-sulfamoyl-benzoic acid (45.6 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (3 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (4.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 10–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (20.0 mg, 16% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.46 (br s, 1H), 8.60–8.45 (m, 6H), 7.99 (d, <i>J</i> = 8.2 Hz, 1H), 7.84 (d, <i>J</i> = 8.4 Hz, 2H), 7.61 (d, <i>J</i> = 8.4 Hz, 2H), 7.42 (s, 1H), 4.63 (d, <i>J</i> = 10.5 Hz, 1H), 3.56–3.46 (m, 1H), 3.21–3.11 (m, 2H), 2.96–2.76 (m, 1H), 1.85–1.76 (m, 3H), 1.70–1.61 (m, 1H). MS (ES+): calcd for C<sub>21</sub>H<sub>22</sub>F<sub>4</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> 498.49, found 498.61.</div></div><div id="sec4_4_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-{4-[1-(1,5-Dimethyl-1<i>H</i>-pyrazole-3-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>44</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 1,5-dimethyl-1<i>H</i>-pyrazole-3-carboxylic acid (Maybridge, 33.5 mg, 0.227 mmol) in DMF (2.0 mL) and <b>20a</b> (100 mg, 0.206 mmol) using TEA as the base. The desired product was obtained by dilution with water and filtration of the resulting precipitate. The CBZ protecting group was removed according to the general procedure using Pd on carbon (15 mol %) in ethyl acetate (2.0 mL) and methanol (1.0 mL) for 60 h. The crude hydrogenation was purified by column chromatography eluting 0–10% methanol/dichloromethane to give the desired product as a white solid (54 mg, 60% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (d, <i>J</i> = 1.6 Hz, 1H), 8.24 (d, <i>J</i> = 8.2 Hz, 1H), 8.05 (s, 2H), 7.66 (d, <i>J</i> = 8.2 Hz, 1H), 6.75 (s, 2H), 6.35 (d, <i>J</i> = 0.6 Hz, 1H), 4.86 (d, <i>J</i> = 12.6 Hz, 1H), 4.65 (d, <i>J</i> = 11.8 Hz, 1H), 3.75 (s, 3H), 3.23–3.03 (m, 2H), 2.78 (t, <i>J</i> = 12.1 Hz, 1H), 2.27 (s, 3H), 1.85–1.59 (m, 4H). MS (ES+): calcd for C<sub>20</sub>H<sub>23</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 437.44, found 437.20.</div></div><div id="sec4_4_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-{4-[1-(1-Methyl-1<i>H</i>-imidazole-2-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>45</b>)</h4><div class="NLM_p last">The required CBZ protected amide intermediate was obtained using the CDI coupling according to the general procedure from 1-methyl-1<i>H</i>-imidazole-2-carboxylic acid (Combi-Blocks, 28.6 mg, 0.227 mmol) in DMF (2.0 mL) and <b>20a</b> (100 mg, 0.206 mmol) using TEA as the base. The desired product was obtained by dilution with water and filtration of the resulting precipitate. The CBZ protecting group was removed according to the general procedure using Pd on carbon (20 mol %) in ethyl acetate (2.0 mL) for 16 h. The crude hydrogenation was purified by flash chromatography eluting 0–10% methanol/dichloromethane to give the desired product as a white solid (50 mg, 57% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO): δ 8.36 (d, <i>J</i> = 1.6 Hz, 1H), 8.25 (d, <i>J</i> = 8.2 Hz, 1H), 8.03 (s, 2H), 7.68 (d, <i>J</i> = 8.2 Hz, 1H), 7.31 (d, <i>J</i> = 0.9 Hz, 1H), 6.98 (d, <i>J</i> = 1.1 Hz, 1H), 6.76 (s, 2H), 4.77 (d, <i>J</i> = 13.3 Hz, 1H), 4.67 (d, <i>J</i> = 12.7 Hz, 1H), 3.79 (s, 3H), 3.24 – 3.10 (m, 2H), 2.86 (t, <i>J</i> = 11.6 Hz, 1H), 1.91–1.62 (m, 4H). MS (ES+): calcd for C<sub>19</sub>H<sub>21</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 423.41, found 423.55.</div></div><div id="sec4_4_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-{4-[1-(3-Methyl-3<i>H</i>-imidazole-4-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>46</b>)</h4><div class="NLM_p last">The required CBZ protected-amide intermediate was obtained using the CDI coupling according to the general procedure from 3-methyl-3<i>H</i>-imidazole-4-carboxylic acid (Maybridge, 28.6 mg, 0.227 mmol) in DMF (2.0 mL) and <b>20a</b> (100 mg, 0.206 mmol) using TEA as the base. The desired product was obtained by dilution with water and filtration of the resulting precipitate. The CBZ protecting group was removed according to the general procedure using Pd on carbon (15 mol %) in ethyl acetate (1.0 mL), methanol (1.0 mL), and dichloromethane (1.0 mL) for 16 h. The crude hydrogenation was purified by column chromatography eluting 0–10% methanol/dichloromethane to give the desired product as a white solid (68 mg, 78%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.36 (d, <i>J</i> = 1.4 Hz, 1H), 8.30 (d, <i>J</i> = 8.2 Hz, 1H), 8.26 (br s, 2H), 7.83 (d, <i>J</i> = 8.2 Hz, 1H), 7.78 (s, 1H), 7.39 (br s, 2H), 7.27 (s, 1H), 4.45 (br s, 2H), 4.11 (d, <i>J</i> = 4.2 Hz, 1H), 3.72 (s, 3H), 3.14–2.89 (m, 2H), 1.90–1.69 (m, 4H). MS (ES+): calcd for C<sub>19</sub>H<sub>21</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 423.41, found 423.76.</div></div><div id="sec4_4_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-{4-[1-(4-Methylsulfamoyl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>50</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 4-methylsulfamoyl-benzoic acid (Buttpark, 48.8 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The residue was dissolved in acetic acid (1.0 mL) and 30 wt % HBr in acetic acid (1.0 mL) was added, and the resulting mixture was stirred for 2 h and diluted with CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and then with ether. The resulting precipitate was collected by filtration and purified by preparative HPLC eluting 10–90% acetonitrile/water with 0.1% TFA to obtain the desired product as the trifluoroacetic acid salt (67.0 mg, 53.2% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.59 (br s, 1H), 8.78–8.40 (m, 4H), 8.27–8.25 (m, 2H), 8.12–8.10 (d, <i>J</i> = 8.2 Hz, 1H), 7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.76 (d, <i>J</i> = 8.4 Hz, 2H), 7.64 (q, <i>J</i> = 5.0 Hz, 1H), 3.74–3.42 (m, 1H, partially obscured by H<sub>2</sub>O peak), 3.33–3.23 (m, 2H), 3.12–2.98 (m, 1H), 2.51 (d, 3H, <i>J</i> = 5.0 Hz), 1.97–1.88 (m, 3H), 1.79–1.70 (m, 1H). MS (ES+): calcd for C<sub>22</sub>H<sub>24</sub>F3N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> 512.52, found 512.72.</div></div><div id="sec4_4_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-{4-[1-(4-Dimethylsulfamoyl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>51</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained using the CDI coupling according to the general procedure from 4-dimethylsulfamoyl-benzoic acid (Buttpark, 52.0 mg, 0.227 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL) and <b>20a</b> (100 mg, 0.206 mmol). The desired product was obtained following aqueous workup and was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon in ethanol (4.0 mL) for 16 h. The residue was purified via preparative HPLC eluting 20–90% acetonitrile/water with 0.1% trifluoroacetic acid to obtain the desired product as the trifluoroacetic acid salt (55.0 mg, 42% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.69 (br s, 1H), 8.80–8.44 (m, 4H), 8.22–8.21 (m, 2H), 8.04 (d, <i>J</i> = 8.3 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 2H), 7.73 (d, <i>J</i> = 8.4 Hz, 2H), 4.69 (d, <i>J</i> = 12.4 Hz, 1H), 3.61 (d, <i>J</i> = 12.3 Hz, 1H), 3.28–3.17 (m, 2H), 2.95–2.90 (m, 1H), 2.66 (s, 6H), 1.99–1.83 (m, 3H), 1.76–1.64 (m, 1H). MS (ES+): calcd for C<sub>23</sub>H<sub>26</sub>F<sub>4</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> 525.55, found 526.38.</div></div><div id="sec4_4_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> General Procedure for Acid Chloride Coupling</h4><div class="NLM_p last">To a suspension of <b>20a</b> (100 mg, 0.206 mmol) in dichloromethane (2.0 mL) was added triethylamine (0.072 mL, 0.52 mmol). To the resulting solution was added the required acid chloride (0.186 mmol) dropwise, and the mixture was stirred for 1 h at room temperature. The reaction was diluted with saturated NaHCO<sub>3</sub> and water and extracted three times with dichloromethane. The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed in vacuo and the products were used crude.</div></div><div id="sec4_4_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-{4-[1-(2,2-Dimethyl-propionyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>55</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate obtained according to the general procedure for acid chloride coupling using 2,2-dimethyl-propionyl chloride (0.023 mL, 0.186 mmol) to give the crude product which was subjected to the general procedure for CBZ deprotection using Pd on carbon in ethyl acetate (2.0 mL) for 2 h to afford the pure product as a white amorphous solid (68 mg, 83% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.36 (s, 1H), 8.23 (d, <i>J</i> = 8.1 Hz, 1H), 8.04 (s, 2H), 7.66 (d, <i>J</i> = 8.2 Hz, 1H), 6.76 (s, 2H), 4.46 (d, <i>J</i> = 12.9 Hz, 2H), 3.11 (t, <i>J</i> = 11.3 Hz, 1H), 2.87 (t, <i>J</i> = 11.9 Hz, 2H), 1.79–1.53 (m, 4H), 1.23 (s, 9H). MS (ES+): calcd for C<sub>19</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 399.43, found 399.69.</div></div><div id="sec4_4_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-[4-(1-Isobutyryl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>56</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate obtained according to the general procedure for acid chloride coupling using isobutyryl chloride (0.020 mL, 0.186 mmol) to give the crude product which was subjected to the general procedure for CBZ deprotection using Pd on carbon in ethyl acetate (2.0 mL) for 2 h to afford the pure product as a white solid (75 mg, 95% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.36 (d, <i>J</i> = 1.6 Hz, 1H), 8.23 (d, <i>J</i> = 9.2 Hz, 1H), 8.13 (s, 2H), 7.65 (d, <i>J</i> = 8.2 Hz, 1H), 6.76 (s, 2H), 4.60 (d, <i>J</i> = 12.8 Hz, 1H), 4.09 (d, <i>J</i> = 15.1 Hz, 1H), 3.15–3.01 (m, 2H), 2.97–2.83 (m, 1H), 2.58 (t, <i>J</i> = 11.9 Hz, 1H), 1.81–1.48 (m, 4H), 1.03 (dd, <i>J</i> = 20.3, 6.6 Hz, 6H). MS (ES+): calcd for C<sub>18</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 385.40, found 385.58.</div></div><div id="sec4_4_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-[4-(1-Cyclopropanecarbonyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>57</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate was obtained according to the general procedure for acid chloride coupling using cyclopropane carboxylic acid chloride (0.019 mL, 0.206 mmol) to give the crude product which was subjected to the general procedure for CBZ deprotection using Pd on carbon in ethyl acetate (2.0 mL) for 2 h to afford the pure product as a white solid (65 mg, 83% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (d, <i>J</i> = 1.6 Hz, 1H), 8.24 (d, <i>J</i> = 9.5 Hz, 1H), 8.02 (s, 2H), 7.67 (d, <i>J</i> = 8.2 Hz, 1H), 6.76 (s, 2H), 4.56 (d, <i>J</i> = 12.0 Hz, 1H), 4.41 (d, <i>J</i> = 13.0 Hz, 1H), 3.25–3.06 (m, 2H), 2.63 (t, <i>J</i> = 12.1 Hz, 1H), 2.01 (dt, <i>J</i> = 12.9, 6.3 Hz, 1H), 1.83–1.50 (m, 4H), 0.88 – 0.64 (m, 4H). MS (ES+): calcd for C<sub>18</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 383.29, found 383.44.</div></div><div id="sec4_4_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i>-{4-[1-(2-Methoxy-acetyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>58</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate obtained according to the general procedure for acid chloride coupling using 2-methoxyacetyl chloride (0.018 mL, 0.186 mmol) to give the crude product, which was subjected to the general procedure for CBZ deprotection using Pd on carbon in ethyl acetate (2.0 mL) for 2 h to afford the pure product as a white amorphous solid (46 mg, 58% over two steps). <sup>1</sup>H NMR (DMSO): δ 8.35 (d, <i>J</i> = 1.3 Hz, 1H), 8.24 (d, <i>J</i> = 8.2 Hz, 1H), 8.03 (s, 2H), 7.65 (d, <i>J</i> = 8.3 Hz, 1H), 6.76 (s, 2H), 4.52 (d, <i>J</i> = 13.3 Hz, 1H), 4.21–4.03 (m, 2H), 3.89 (d, <i>J</i> = 13.5 Hz, 1H), 3.31 (s, 3H), 3.14–3.01 (m, 2H), 2.64 (t, <i>J</i> = 12.1 Hz, 1H), 1.84–1.52 (m, 4H). MS (ES+): calcd for C<sub>17</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 387.38, found 387.59.</div></div><div id="sec4_4_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>N</i>-[4-(1-Propionyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>59</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate obtained according to the general procedure for acid chloride coupling using propionyl chloride (0.017 mL, 0.186 mmol) to give the crude product, which was subjected to the general procedure for CBZ deprotection using Pd on carbon in ethyl acetate (2.0 mL) for 2 h to afford the pure product as a white solid (67 mg, 88% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.36 (d, <i>J</i> = 1.5 Hz, 1H), 8.24 (d, <i>J</i> = 8.2 Hz, 1H), 8.13 (s, 2H), 7.66 (d, <i>J</i> = 8.2 Hz, 1H), 6.78 (s, 2H), 4.59 (d, <i>J</i> = 12.9 Hz, 1H), 4.00 (d, <i>J</i> = 13.4 Hz, 1H), 3.17–3.00 (m, 2H), 2.59 (t, <i>J</i> = 11.7 Hz, 1H), 2.36 (q, <i>J</i> = 7.4 Hz, 2H), 1.81–1.50 (m, 4H), 1.02 (t, <i>J</i> = 7.4 Hz, 3H). MS (ES+): calcd for C<sub>17</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 371.38, found 371.62</div></div><div id="sec4_4_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-[4-(1-Acetyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>60</b>)</h4><div class="NLM_p last">The required CBZ-protected amide intermediate obtained according to the general procedure for acid chloride coupling using acetyl chloride (0.013 mL, 0.186 mmol) to give the crude product, which was subjected to the general procedure for CBZ deprotection using Pd on carbon in ethyl acetate (2.0 mL) for 2 h to afford the pure product as a white solid (41 mg, 56% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (s, 1H), 8.24 (d, <i>J</i> = 8.1 Hz, 1H), 8.03 (s, 2H), 7.66 (d, <i>J</i> = 8.2 Hz, 1H), 6.77 (s, 2H), 4.56 (d, <i>J</i> = 13.0 Hz, 1H), 3.94 (d, <i>J</i> = 13.4 Hz, 1H), 3.20–3.01 (m, 2H), 2.58 (t, <i>J</i> = 11.6 Hz, 1H), 2.04 (s, 3H), 1.83–1.49 (m, 4H). MS (ES+): calcd for C<sub>16</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 357.35, found 357.59.</div></div><div id="sec4_4_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-(4-Methoxycarbonyl-2-trifluoromethyl-phenyl)-piperidine-1-carboxylic Acid Benzyl Ester (<b>61</b>)</h4><div class="NLM_p">To a solution of <b>19</b> (2.50 g, 6.45 mmol) in CH<sub>2</sub>Cl<sub>2</sub>/MeOH (8/2, 50 mL) was added 4N HCl in dioxane (8.07 mL, 32.3 mmol), and the resulting mixture was stirred for 16 h. The solvent was removed in vacuo to give the desired free piperidine product as a white solid as the hydrochloride salt (1.90 g, 91%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.33 (s, 1H), 8.29 (d, <i>J</i> = 8.5 Hz, 1H), 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 4.89 (s, 3H), 3.58–3.55 (m, 2H), 3.39–3.34 (partially obscured m, 1H), 3.28–3.12 (m, 2H), 2.27–1.98 (m, 4H). MS (ES+): calcd for C<sub>14</sub>H<sub>16</sub>F<sub>3</sub>NO<sub>2</sub> + H<sup>+</sup> 288.28, found 288.58.</div><div class="NLM_p last">To a solution of the product of the previous step (1.90 g, 5.86 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL) at 0 °C was added benzylchloroformate (0.94 mL, 6.61 mmol), followed by <i>N</i>,<i>N</i>-diisopropylamine (2.62 mL, 10.1 mmol), and the mixture was warmed to room temperature and stirred 16 h. The reaction mixture was then washed three times with saturated NaHCO<sub>3</sub> (30 mL each) and brine (30 mL), the organics were dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was removed in vacuo. The resulting oily residue was purified by flash chromatography eluting 0–100% ethyl acetate/hexanes to afford the desired product as a colorless oil (2.20 g, 89%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.20–8.12 (m, 2H), 7.84 (d, <i>J</i> = 8.8 Hz, 1H), 7.42–7.31 (m, 5H), 5.11 (s, 2H), 4.18 (d, <i>J</i> = 13.0 Hz, 2H), 3.89 (s, 3H), 3.09–2.82 (m, 3H), 1.86–1.69 (m, 4H). MS (ES+): calcd for C<sub>22</sub>H<sub>22</sub>F<sub>3</sub>NO<sub>4</sub> + H<sup>+</sup> 422.41, found 422.31.</div></div><div id="sec4_4_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 4-(4-(<i>N</i>-<i>tert</i>-Butoxycarbonyl)-guanidinocarbonyl-2-trifluoromethyl-phenyl)-piperidine-1-carboxylic Acid Benzyl Ester (<b>62</b>)</h4><div class="NLM_p">To a solution of <b>61</b> (2.20 g, 5.22 mmol) in methanol (40 mL) was added water (4 mL) followed by K<sub>2</sub>CO<sub>3</sub> (1.80 g, 13.1 mmol), and the reaction was heated at 60 °C for 5 h. The reaction was concentrated to a paste in vacuo, and the residue was partitioned between ethyl acetate and water and the pH of the aqueous phase was adjusted to pH 5 (pH paper) by addition of 1 N HCl. The phases were separated, and the aqueous was extracted with ethyl acetate three times. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the desired product as a white solid (1.91 g, 90%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.38 (br s, 1H), 8.21–8.11 (m, 2H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H), 7.45–7.31 (m, 5H), 5.11 (s, 2H), 4.18 (d, <i>J</i> = 13.0 Hz, 2H), 3.09–2.83 (m, 3H), 1.76–1.58 (m, 4H). MS (ES+): calcd for C<sub>21</sub>H<sub>20</sub>F<sub>3</sub>NO<sub>4</sub> + H<sup>+</sup> 408.38, found 408.20.</div><div class="NLM_p last">To a solution of the product of the previous step (2.52 g, 4.59 mmol) in <i>N</i>-methylpyrrolidinone (20 mL) was added 2-chloro-1-methylpyridinium iodide (1.42 g, 5.56 mmol), and the mixture was stirred for 75 min. To this mixture was added <i>tert</i>-butoxycarbonyl-guanidine (0.960 g, 6.03 mmol) and diisopropylamine (2.30 mL, 13.9 mmol), and the resulting mixture was stirred for 16 h. The crude mixture was partitioned between water and ethyl acetate, the phases were separated, and the organics were washed 2 times with water and then once with brine. The organics were collected, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to pale-orange oil. The crude residue was purified by flash chromatography eluting 0–60% ethyl acetate/hexanes to give the desired product as a colorless oil (2.52 g, 99%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.98 (br s, 2H), 8.43 (br s, 1H), 8.29 (s, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 1H), 7.36–7.15 (m, 5H), 5.01 (s, 2H), 4.20 (br s, 2H), 2.99 (t, <i>J</i> = 11.6 Hz, 1H), 2.90–2.74 (m, 2H), 1.73–1.39 (m, 4H). MS (ES+): calcd for C<sub>27</sub>H<sub>31</sub>F<sub>3</sub>N<sub>4</sub>O<sub>5</sub> + H<sup>+</sup> 549.55, found 549.74.</div></div><div id="sec4_4_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-(4-Piperidin-4-yl-3-trifluoromethyl-benzoyl)-<i>N</i>′-(<i>tert</i>-butoxycarbonyl)-guanidine (<b>63a</b>)</h4><div class="NLM_p last">To a solution of <b>62</b> (11.0 g, 20.1 mmol) in ethanol (200 mL) was added Pd(OH)<sub>2</sub> on carbon (10 mol %, 500 mg, 0.356 mmol), and the reaction was stirred under a hydrogen atmosphere for 36 h. The reaction was diluted with ethyl acetate (200 mL) and filtered through Celite. The solvent was removed in vacuo, the resulting foam was triturated with ether, and the resulting solid was collected by filtration to give the desired product as a white solid (6.81 g, 82%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.67 (br s, 1H), 8.62 (br s, 1H), 8.40 (d, <i>J</i> = 1.6 Hz, 1H), 8.27 (d, <i>J</i> = 8.2 Hz, 1H), 7.68 (d, <i>J</i> = 8.2 Hz, 1H), 3.03 (d, <i>J</i> = 12.1 Hz, 2H), 2.91 (t, <i>J</i> = 11.3 Hz, 1H), 2.67–2.66 (m, 2H), 1.69–1.56 (m, 4H), 1.48 (s, 9H). MS (ES+): calcd for C<sub>19</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 415.43, found 415.72.</div></div><div id="sec4_4_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-(4-Piperidin-4-yl-3-trifluoromethyl-benzoyl)-<i>N</i>′-(<i>tert</i>-butoxycarbonyl)-guanidine hydrochloride salt (<b>63b</b>)</h4><div class="NLM_p last">To a solution of <b>63a</b> (1.89 g, 4.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added 1N HCl in ether (5.0 mL). The resulting mixture was diluted with hexanes to give a cloudy white suspension from which the solvent was removed in vacuo to give the desired product as a white solid (2.05 g, 100%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.18 (br s, 1H), 9.82 (br s, 1H), 9.21–9.13 (m, 1H), 9.13–9.00 (m, 1H), 9.00–8.67 (m, 1H), 8.46 (d, <i>J</i> = 1.6 Hz, 1H), 8.37 (d, <i>J</i> = 8.2 Hz, 1H), 7.66 (d, <i>J</i> = 8.3 Hz, 1H), 3.42–3.36 (m, 2H), 3.24–3.21 (m, 1H), 3.18–3.03 (m, 2H), 2.21–2.05 (m, 2H), 1.85–1.74 (m, 2H). MS (ES+): calcd for C<sub>19</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 415.43, found 415.39</div></div><div id="sec4_4_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> General Procedure for Amide Bond Coupling with HATU</h4><div class="NLM_p last">To the benzoic acid derivative (1.10 equiv when reacting with <b>63a</b> and 2.74 equiv when reacting with <b>63b</b>) and HATU (1.10 equiv) was added DMA (1 mL), and the mixture was shaken for 15 min. A solution of <b>63a</b> or <b>63b</b> (1.00 equiv) and diisopropylamine (2 equiv) in DMA (0.5 mL) was then added, and the reaction was shaken overnight at room temperature. The crude mixtures were filtered through an SPE cartridge containing 1 g of basic alumina. The alumina plug was eluted with a 10:1 mixture of DMA:MeOH (4 × 0.5 mL), then the solutions were concentrated in vacuo, and the resulting coupling products were used crude in the next step.</div></div><div id="sec4_4_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> General Procedure for BOC Deprotection with TFA</h4><div class="NLM_p last">The crude amide from the HATU coupling was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (200 μL), and then 1–2 mL of 20% TFA in CH<sub>2</sub>Cl<sub>2</sub> was added. The resulting solution was shaken overnight at room temp. The solvent was then removed in vacuo, and the residue was purified by reverse phase mass triggered LCMS.</div></div><div id="sec4_4_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i>-{4-[1-(4-Chloro-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>24</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with 4-chlorobenzoic acid (38.2 mg, 0.244 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL) and <b>63a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after purification by preparative HPLC (60.1 mg, 60%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.53 (br s, 1H), 8.31 (s, 1H), 8.22 (d, <i>J</i> = 8.1 Hz, 1H), 8.20–8.00 (br s, 1H), 8.13 (s, 1H), 7.85 (br s, 1H), 7.51 (q, <i>J</i> = 8.6 Hz, 4H), 6.90 (s, 1H), 4.65 (br s, 1H), 3.65 (br s, 1H), 3.21–3.07 (m, 2H), 2.89 (br s, 1H), 1.87–1.58 (m, 4H). MS (ES+): calcd for C<sub>21</sub>H<sub>20</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 452.86, found 453.92.</div></div><div id="sec4_4_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-{4-[1-(3-Chloro-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>25</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with 3-chlorobenzoic acid (38.2 mg, 0.244 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL) and <b>63a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after purification by preparative HPLC (74 mg, 74%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.71 (br s, 0.5H), 11.44 (br s, 0.5H), 8.60 (s, 1H), 8.30 (s, 1H), 8.24 (d, <i>J</i> = 8.1 Hz, 1H), 8.19–8.14 (m, 1H), 7.98–7.84 (m, 2H), 7.78 (s, 1H), 7.60 (t, <i>J</i> = 7.8 Hz, 1H), 7.40 (d, <i>J</i> = 7.6 Hz, 1H), 6.91 (br s, 0.5H), 6.58 (br s, 0.5H), 4.71 (br s, 1H), 3.75 (br s, 1H), 3.23–3.13 (m, 2H), 2.90 (br s, 1H), 1.92–1.59 (m, 4H). MS (ES+): calcd for C<sub>21</sub>H<sub>20</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 453.86, found 454.13.</div></div><div id="sec4_4_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-{4-[1-(2-Chloro-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>26</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with 3-chlorobenzoic acid (38.2 mg, 0.244 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2 mL) and <b>63a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after purification by preparative HPLC (74.5 mg, 74.1%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.75 (br s, 1H), 8.49 (s, 1H), 8.35 (s, 1H), 8.26 (d, <i>J</i> = 8.0 Hz, 1H), 8.13 (s, 1H), 7.82 (d, <i>J</i> = 8.2 Hz, 1H), 7.79 (s, 1H) 7.59 (d, <i>J</i> = 8.2 Hz, 2H), 6.90 (s, 1H), 4.69 (br s, 1H), 3.74 (br s, 1H), 3.20–3.11 (m, 2H), 2.90 (br s, 1H), 1.90–1.59 (m, 4H). MS (ES+): calcd for C<sub>21</sub>H<sub>20</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 453.86, found 453.99.</div></div><div id="sec4_4_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-{4-[1-(Biphenyl-4-carbonyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>27</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with biphenyl-4-carboxylic acid (48.3 mg, 0.244 mmol)) in DMA (1 mL) and <b>63b</b> (40 mg, 0.089 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after preparative HPLC purification (12.8 mg, 27%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.73 (br s, 1H), 8.34 (s, 1H), 8.25 (d, <i>J</i> = 8.0 Hz, 1H), 8.14 (s, 1H), 8.00 (br s, 1H), 7.90–7.82 (br m, 1H), 7.76 (d, <i>J</i> = 8.2 Hz, 2H), 7.72 (d, <i>J</i> = 7.5 Hz, 2H), 7.57 (d, <i>J</i> = 8.1 Hz, 2H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 7.41 (t, <i>J</i> = 7.3 Hz, 1H), 6.90 (s, 1H), 4.70 (br s, 1H), 3.82 (br s, 1H), 3.22–3.07 (m, 2H), 3.04–2.78 (m, 1H), 1.92–1.61 (m, 4H). MS (ES+): calcd for C<sub>27</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 495.20, found 495.01.</div></div><div id="sec4_4_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i>-{4-[1-(4-Oxazol-5-yl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>28</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with 4-(1,3-oxazol-5-yl)benzoic acid (46.2 mg, 0.244 mmol) in DMA (2 mL) and <b>63a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after preparative HPLC purification (74 mg, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.80 (br s, 1H), 8.50 (s, 1H), 8.36 (d, <i>J</i> = 1.3 Hz, 1H), 8.26 (d, <i>J</i> = 8.2 Hz, 1H), 8.14 (s, 1H), 8.06 (br s, 1H), 7.87–7.75 (m, 4H), 7.58 (t, <i>J</i> = 8.0 Hz, 2H), 7.00–6.50 (br m, 2H), 4.77–4.57 (br m, 1H), 3.87–3.62 (br m, 1H), 3.65–3.06 (br m, 2H), 2.95–2.78 (br m, 1H), 1.91–1.71 (br m, 3H), 1.74–1.58 (br m, 1H). MS (ES+): calcd for C<sub>24</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> 486.17, found 486.17.</div></div><div id="sec4_4_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-{4-[1-(3-Oxazol-5-yl-benzoyl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>29</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with 3-(1,3-oxazol-5-yl)benzoic acid (46.2 mg, 0.244 mmol) in DMA (2 mL) and <b>52a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after preparative HPLC purification (70 mg, 63% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.77 (br s, 1H), 8.50 (s, 1H), 8.36 (d, <i>J</i> = 1.3 Hz, 1H), 8.26 (d, <i>J</i> = 8.2 Hz, 1H), 8.14 (s, 1H), 8.06 (br s, 1H), 7.87–7.75 (m, 4H), 7.58 (t, <i>J</i> = 8.0 Hz, 1H), 7.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.00–6.50 (br m, 3H), 4.79–4.61 (br m, 1H), 3.80–3.62 (br m, 1H), 3.40–3.10 (br m, 2H), 2.95–2.78 (br m, 1H), 1.94–1.72 (br m, 3H), 1.73–1.57 (br m, 1H). MS (ES+): calcd for C<sub>24</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> + H<sup>+</sup> 486.17, found 485.98.</div></div><div id="sec4_4_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-[4-(1-Cyclopentanecarbonyl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>52</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with cyclopentanecarboxylic acid (27.9 mg, 0.244 mmol) in DMA (2 mL) and <b>63a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after preparative HPLC purification (52 mg, 55%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.64 (br s, 1H), 8.29 (s, 1H), 8.20 (d, <i>J</i> = 8.2 Hz, 1H), 8.20–7.80 (m, 1H), 8.13 (s, 1H), 7.77 (br s, 1H), 6.91 (s, 1H), 4.60 (d, <i>J</i> = 12.1 Hz, 1H), 4.13 (d, <i>J</i> = 12.9 Hz, 1H), 3.19–3.06 (m, 2H), 3.07–2.97 (m, 1H), 2.60 (t, <i>J</i> = 12.6 Hz, 1H), 1.85–1.47 (m, 12H). MS (ES+): calcd for C<sub>20</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 411.2, found 410.84.</div></div><div id="sec4_4_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-{4-[1-(3-Methyl-butyryl)-piperidin-4-yl]-3-trifluoromethyl-benzoyl}-guanidine (<b>53</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with isovaleric acid (24.9 mg, 0.244 mmol) in DMA (2 mL) and <b>63a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after preparative HPLC purification (69 mg, 76%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.70 (br s, 1H), 8.32 (s, 1H), 8.22 (d, <i>J</i> = 8.1 Hz, 1H), 7.98 (br s, 1H), 8.13 (s, 1H), 7.73–7.65 (m, 1H), 6.91 (s, 1H), 4.61 (d, <i>J</i> = 12.6 Hz, 1H), 4.03 (d, <i>J</i> = 13.6 Hz, 5H), 3.16–3.05 (m, 2H), 2.66–2.51 (m, 1H), 2.23 (d, <i>J</i> = 6.9 Hz, 2H), 2.07–1.97 (m, 1H), 1.76–1.64 (m, 3H), 1.64–1.52 (m, 1H), 0.97–0.89 (m, 6H). MS (ES+): calcd for C<sub>19</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 399.20, found 398.92.</div></div><div id="sec4_4_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-[4-(1-Butyryl-piperidin-4-yl)-3-trifluoromethyl-benzoyl]-guanidine (<b>54</b>)</h4><div class="NLM_p last">Using the general procedure for HATU amide bond coupling with butyric acid (21.5 mg, 0.244 mmol) in DMA (2 mL) and <b>63a</b> (92 mg, 0.222 mmol) followed by the general BOC deprotection procedure afforded the title compound as the formate salt after preparative HPLC purification (59 mg, 67%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.45 (br s, 1H), 8.20 (br s, 1H), 8.26 (s, 1H), 8.18 (d, <i>J</i> = 8.3 Hz, 1H), 8.13 (s, 1H), 7.85–7.75 (m, 1H), 6.91 (s, 1H), 4.60 (d, <i>J</i> = 12.2 Hz, 1H), 4.02 (d, <i>J</i> = 13.2 Hz, 1H), 3.18–3.04 (m, 2H), 2.66–2.54 (m, 1H), 2.33 (t, <i>J</i> = 7.4 Hz, 2H), 1.78–1.63 (m, 3H), 1.65–1.50 (m, 3H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H). MS (ES+): calcd for C<sub>18</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 385.18, found 384.93</div></div><div id="sec4_4_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 4-Benzyloxy-5-iodo-2-methyl-benzoic Acid Methyl Ester (<b>66</b>)</h4><div class="NLM_p last">To a solution 4-hydroxy-5-iodo-2-methyl-benzoic acid methyl ester <b>65</b> (9.70 g, 33.2 mmol) in DMF (130 mL) was added benzyl bromide (4.46 mL, 36.5 mmol) and K<sub>2</sub>CO<sub>3</sub> (13.8 g, 99.6 mmol). The mixture was stirred at 80 °C for 2 h and was cooled to rt. The mixture was partitioned between ethyl acetate and H<sub>2</sub>O. The layers were separated, and the aqueous layer was further extracted with ethyl acetate. The combined organic phases were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. The crude material was purified via flash chromatography using a gradient elution of 0–8% ethyl acetate/hexanes to afford the desired product (8.32 g, 66%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.23 (s, 1H), 7.55–7.47 (m, 2H), 7.46–7.39 (m, 2H), 7.38–7.31 (m, 1H), 7.08 (s, 1H), 5.27 (s, 2H), 3.79 (s, 3H), 2.51 (s, 3H). MS (ES+): calcd for C<sub>16</sub>H<sub>15</sub>IO<sub>3</sub> + H<sup>+</sup> 383.19, found 383.24.</div></div><div id="sec4_4_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 4-Benzyloxy-2-methyl-5-trifluoromethyl-benzoic Acid Methyl Ester (<b>67</b>)</h4><div class="NLM_p last">To a solution of <b>66</b> (8.32 g, 21.8 mmol) in 1-methyl-2-pyrrolidone (100 mL) was added potassium trifluoroacetate (16.6 g, 108.8 mmol) and copper(I) iodide (20.7 g, 108.8 mmol). The reaction was stirred at 150 °C for 5 h and then was cooled to rt. The mixture was partitioned between ethyl acetate and saturated aqueous NH<sub>4</sub>Cl and was filtered through a pad of Celite, rinsing with ethyl acetate. The layers of the filtrate were separated, and the aqueous phase was further extracted with ethyl acetate. The combined organic phases were washed with brine and were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. The crude material was purified via flash chromatography using a gradient elution of 0–8% ethyl acetate/hexanes to afford the desired product (6.30 g, 89%) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.07 (s, 1H), 7.51–7.31 (m, 6H), 5.35 (s, 2H), 3.82 (s, 3H), 2.61 (s, 3H). MS (ES+): calcd for C<sub>17</sub>H<sub>15</sub>F<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 325.29, found 325.20.</div></div><div id="sec4_4_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 4-Hydroxy-2-methyl-5-trifluoromethyl-benzoic Acid Methyl Ester (<b>68</b>)</h4><div class="NLM_p last">To a solution of <b>67</b> (6.30 g, 19.4 mmol) in EtOH (150 mL) purged with Ar was added 10 wt % Pd/C (400 mg). The mixture was stirred under an H<sub>2</sub> atmosphere overnight. The mixture was filtered through a pad of Celite and was rinsed with EtOH. The solvent was evaporated under reduced pressure to afford the desired product (4.34 g, 95%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.39 (s, 1H), 8.00 (s, 1H), 6.93 (s, 1H), 3.79 (s, 3H), 2.52 (s, 3H). MS (ES+): calcd for C<sub>10</sub>H<sub>9</sub>F<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 235.17, found 235.20.</div></div><div id="sec4_4_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 4-(4-Methoxycarbonyl-5-methyl-2-trifluoromethyl-phenyl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic Acid <i>tert</i>-Butyl Ester) (<b>69a</b>)</h4><div class="NLM_p last">To a solution of <b>68</b> (4.34 g, 18.5 mmol) in DMF was added DIEA (3.55 mL, 20.4 mmol) followed by <i>N</i>-phenyltrifluoromethanesulfonimide. The reaction was stirred at room temperature overnight. The mixture was partitioned between ethyl acetate and saturated aqueous NaHCO<sub>3</sub>. The layers were separated, and the aqueous layer was further extracted with ethyl acetate. The combined organic phases were washed with brine and were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to afford the desired crude intermediate. The crude intermediate was divided into four equal portions and was placed into four 20 mL microwave reaction vials: To a solution of intermediate in THF (48 mL) was added <b>16</b> (Digital, 5.61 g, 18.1 mmol) and 2 M aqueous K<sub>2</sub>CO<sub>3</sub> (18.1 mL, 36.3 mmol). After the mixture was degassed, tetrakis(triphenylphosphine)palladium(0) (Strem, 3.78 g, 3.27 mmol) was added. Each vial was sealed with a Teflon lined septa cap and was irradiated in a microwave reactor at 110 °C for 30 min. After cooling to room temperature, the mixtures from all of the vials were pooled together and were partitioned between ethyl acetate and H<sub>2</sub>O. The mixture was filtered to remove the remaining undissolved solid, rinsing with ethyl acetate and water. The layers of the filtrate were separated, and the aqueous layer was extracted with ethyl acetate. The combined organic phases were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. The crude material was purified via flash chromatography using a gradient elution of 0–8% ethyl acetate/hexanes to afford the desired product (5.68 g, 78%) as a light-yellow oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.09 (s, 1H), 7.41 (s, 1H), 5.64 (s, 1H), 3.99–3.91 (m, 2H), 3.87 (s, 3H), 3.57–3.49 (m, 2H), 2.58 (s, 3H), 2.34–2.26 (m, 2H), 1.44 (s, 9H). MS (ES+): calcd for C<sub>20</sub>H<sub>24</sub>F<sub>3</sub>NO<sub>4</sub> + H<sup>+</sup> 400.40, found 422.20 (M + Na<sup>+</sup>).</div></div><div id="sec4_4_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 4-(4-Methoxycarbonyl-5-methyl-2-trifluoromethyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>84</b>)</h4><div class="NLM_p last">To a solution of <b>69</b> (5.68 g, 14.2 mmol) in EtOH (70 mL) purged with Ar was added 10 wt % Pd/C (200 mg). The mixture was stirred under an H<sub>2</sub> atmosphere. Additional catalyst was added, and the mixture continued to stir under an H<sub>2</sub> atmosphere until the reaction was complete. The mixture was filtered through a pad of Celite and was rinsed with DCM. The solvent was evaporated under reduced pressure to afford the desired product (5.15 g, 90%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.06 (s, 1H), 7.67 (s, 1H), 4.20–4.02 (m, 2H), 3.85 (s, 3H), 2.96 (br s, 1H), 2.90–2.67 (m, 2H), 2.59 (s, 3H), 1.75–1.61 (m, 4H), 1.43 (s, 9H). MS (ES+): calcd for C<sub>20</sub>H<sub>26</sub>F<sub>3</sub>NO<sub>4</sub> + H<sup>+</sup> 402.42, found 387.36 (M – CH<sub>3</sub> H<sup>+</sup>).</div></div><div id="sec4_4_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 4-(4-Carboxy-5-methyl-2-trifluoromethyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>85</b>)</h4><div class="NLM_p last">To a solution of <b>84</b> (5.15 g, 12.8 mmol) in MeOH (40 mL) and H<sub>2</sub>O (20 mL) was added LiOH monohydrate (807 mg, 19.2 mmol). The reaction was stirred at 40 °C overnight and then was cooled to rt. The MeOH was removed in vacuo, and the aqueous mixture was acidified (pH 5) with 1N aqueous HCl. The resulting solid was collected by filtration and dried in vacuo at 50 °C to afford the desired product (5.00 g, 100%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.79 (s, 1H), 7.26 (s, 1H), 4.18–4.02 (m, 2H), 2.97–2.66 (m, 3H), 2.48 (s, 3H), 1.68–1.56 (m, 4H), 1.43 (s, 9H). MS (ES+): calcd for C<sub>19</sub>H<sub>24</sub>F<sub>3</sub>NO<sub>4</sub> + H<sup>+</sup> 388.39, found 388.40</div></div><div id="sec4_4_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 4-[5-Methyl-4-(<i>N</i>-(carbobenzyloxy)-guanidinocarbonyl)-2-trifluoromethyl-phenyl]-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>86</b>)</h4><div class="NLM_p last">To a solution of <b>85</b> (5.00 g, 12.9 mmol) in 1-methyl-2-pyrrolidone (50 mL) was added 2-chloro-1-methylpyridinium iodide (3.63 g, 14.2 mmol). The mixture was stirred at room temperature for 30 min. <i>N</i>-Carbobenzyloxy-guanidine (2.99 g, 15.5 mmol) and DIEA were added to the reaction, and the mixture was allowed to stir at room temperature overnight. The mixture was partitioned between ethyl acetate and H<sub>2</sub>O, and the layers were separated. The aqueous layer was further extracted with ethyl acetate, and the combined organic phases were washed with H<sub>2</sub>O, brine, and were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. The crude material was purified via flash chromatography using a gradient elution of 10–20% ethyl acetate/hexanes to afford the desired product (5.68 g, 78%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.22 (s, 1H), 9.53 (br s, 1H), 8.79 (s, 1H), 8.05 (s, 1H), 7.53 (s, 1H), 7.44–7.29 (m, 5H), 5.16 (s, 2H), 4.22–4.01 (m, 2H), 3.02–2.65 (m, 3H), 2.52 (s, 3H), 1.73–1.60 (m, 4H), 1.42 (s, 9H). MS (ES+): calcd for C<sub>28</sub>H<sub>33</sub>F<sub>3</sub>N<sub>4</sub>O<sub>5</sub> + H<sup>+</sup> 563.58, found 563.20.</div></div><div id="sec4_4_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> <i>N</i>-(2-Methyl-4-piperidin-4-yl-5-trifluoromethyl-benzoyl)-<i>N</i>′-(carbobenzyloxy)-guanidine (<b>87</b>)</h4><div class="NLM_p last">To a solution of <b>86</b> (5.68 g, 10.1 mmol) in MeOH (20 mL) was added 4 M HCl in 1,4-dioxane (10 mL). The mixture was stirred at room temperature for 6 h. The mixture was concentrated under reduced pressure to afford the desired product (5.0 g, 100%) as the hydrochloride salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.03 (s, 1H), 9.48 (br s, 1H), 9.31–9.17 (m, 1H), 9.16–9.06 (m, 1H), 8.11 (s, 1H), 7.48 (s, 1H), 7.46–7.32 (m, 5H), 5.27 (s, 2H), 3.41–3.30 (m, 2H), 3.22–2.97 (m, 3H), 2.55 (s, 3H), 2.21–2.03 (m, 2H), 1.87–1.74 (m, 2H). MS (ES+): calcd for C<sub>23</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 463.48, found 463.20.</div></div><div id="sec4_4_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> <i>N</i>-[4-(1-Acetyl-piperidin-4-yl)-2-methyl-5-trifluoromethyl-benzoyl]-guanidine (<b>78</b>)</h4><div class="NLM_p last">To a solution of <b>87</b> (250 mg, 0.50 mmol) in DCM (2.5 mL) was added DIEA (0.26 mL, 1.50 mmol) followed by acetic anhydride (0.048 mL, 0.50 mmol). The mixture was stirred at room temperature for 45 min. The mixture was diluted with DCM and was washed with saturated aqueous NaHCO<sub>3</sub>. The aqueous layer was back-extracted with DCM, and the combined organic phases were washed with brine and were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. To a solution of the residue in DMF (1 mL) and EtOH (10 mL) purged with Ar was added 10 wt % Pd/C (50 mg). The mixture was stirred under an H<sub>2</sub> atmosphere overnight. The mixture was filtered through glass filter paper rinsing with ethyl acetate. The solvent was evaporated, and the residue was purified via preparative HPLC using a gradient elution from 10% to 75% acetonitrile/water with 0.1% TFA to obtain the desired product as the trifluoroacetate salt (85 mg, 35% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.87 (s, 1H), 8.86–8.25 (br m, 4H), 7.91 (s, 1H), 7.70 (s, 1H), 4.63–4.50 (m, 1H), 4.00–3.88 (m, 1H), 3.21–3.00 (m, 2H), 2.65–2.53 (m, 1H), 2.47 (s, 3H), 2.04 (s, 3H), 1.87–1.73 (m, 1H), 1.72–1.57 (m, 3H). MS (ES+): calcd for C<sub>17</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 371.38, found 371.20.</div></div><div id="sec4_4_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-Bromo-5-methanesulfonyl-2-methyl-benzoic Acid (<b>71</b>)</h4><div class="NLM_p last">To chlorosulfonic acid (15.0 mL, 226 mmol) cooled to 0 °C was added 4-bromo-2-methyl-benzoic acid <b>70</b> (5.00 g, 23.3 mmol) portionwise over 2 min. The reaction was allowed to warm to room temperature and was heated at 100 °C for 2 h. The reaction was cooled to room temperature and was added dropwise (very slowly) to ice (750 g). The resulting solid was collected by filtration and was dried in vacuo to afford the desired intermediate as a white solid. To a stirred solution of sodium sulfite (3.58 g, 28.4 mmol) and NaHCO<sub>3</sub> (8.52 g, 101.4 mmol) in H<sub>2</sub>O (75 mL) heated to 70 °C was added a solution of the intermediate in THF (25 mL), dropwise over 20 min. After the addition was complete, the mixture was stirred at 70 °C for 1 h and then was cooled to rt. Iodomethane (6.31 mL, 101.4 mmol) was added, and the reaction was allowed to stir at 50 °C overnight. The mixture was cooled to room temperature, and the THF was removed in vacuo. The aqueous mixture was acidified (pH 5) with 4N aqueous HCl, and the resulting precipitate was collected by filtration and dried in vacuo at 50 °C to afford the desired product (4.88 g, 72% for two steps) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.52 (s, 1H), 8.45 (s, 1H), 7.95 (s, 1H), 3.37 (s, 3H), 2.60 (s, 3H). MS (ES+): calcd for C<sub>9</sub>H<sub>9</sub>BrO<sub>4</sub>S + H<sup>+</sup> 293.14, found 293.00.</div></div><div id="sec4_4_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-Bromo-5-methanesulfonyl-2-methyl-benzoic Acid Methyl Ester (<b>72</b>)</h4><div class="NLM_p last">To a solution of <b>71</b> (4.88 g, 16.6 mmol) in MeOH (85 mL) was added acetyl chloride (12.9 mL, 166 mmol), and the mixture was stirred at 50 °C overnight. The reaction was concentrated to dryness, and the residue was partitioned between ethyl acetate and saturated aqueous NaHCO<sub>3</sub>. The layers were separated, and the aqueous layer was further extracted with ethyl acetate. The combined organic phases were washed with saturated aqueous NaHCO<sub>3</sub> and brine and were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to afford the desired product (4.47 g, 87%) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.44 (s, 1H), 7.99 (s, 1H), 3.87 (s, 3H), 3.38 (s, 3H), 2.60 (s, 3H). MS (ES+): calcd for C<sub>10</sub>H<sub>11</sub>BrO<sub>4</sub>S + H<sup>+</sup> 307.16, found 307.00.</div></div><div id="sec4_4_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-(2-Methanesulfonyl-4-methoxycarbonyl-5-methyl-phenyl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>69b</b>)</h4><div class="NLM_p last">Each reactant was divided into three equal portions and was placed into three 20 mL microwave reaction vials: To a solution of <b>72</b> (3.50 g, 11.4 mmol) in 1,4-dioxane (8.5 mL) was added 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic acid <i>tert</i>-butyl ester (Digital, 3.52 g, 11.4 mmol) and 2 M aqueous K<sub>2</sub>CO<sub>3</sub> (11.4 mL, 22.8 mmol). After the mixture was degassed, tetrakis(triphenylphosphine)palladium(0) (Strem, 1.32 g, 1.14 mmol) was added. Each vial was sealed with a Teflon lined septa cap and was irradiated in a microwave reactor at 170 °C for 30 min. After cooling, the mixtures from all of the vials were pooled together and were partitioned between ethyl acetate and water. The mixture was filtered to remove the remaining undissolved solid, rinsing with ethyl acetate and water. The layers of the filtrate were separated, and the aqueous layer was extracted with ethyl acetate. The combined organic phases were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. The crude material was purified via flash chromatography using a gradient elution of 10–40% ethyl acetate/hexanes to afford the desired product (4.8 g, 100%) as a light-yellow oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.37 (s, 1H), 7.37 (s, 1H), 5.74 (s, 1H), 4.00–3.94 (br m, 2H), 3.87 (s, 3H), 3.56–3.49 (m, 2H), 3.20 (s, 3H), 2.59 (s, 3H), 2.38–2.30 (m, 2H), 1.43 (s, 9H). MS (ES+): calcd for C<sub>20</sub>H<sub>27</sub>NO<sub>6</sub>S + H<sup>+</sup> 410.50, found 432.20 (M + Na<sup>+</sup>).</div></div><div id="sec4_4_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 4-(2-Methanesulfonyl-4-methoxycarbonyl-5-methyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>88</b>)</h4><div class="NLM_p last">To a solution of <b>69b</b> (2.70 g, 6.59 mmol) in acetic acid (40 mL) purged with Ar was added platinum(IV) oxide (750 mg). The mixture was stirred under an H<sub>2</sub> atmosphere overnight. The mixture was filtered through a pad of Celite rinsing with ethyl acetate. The solvent was evaporated under reduced pressure, and the residue was partitioned between ethyl acetate and saturated aqueous NaHCO<sub>3</sub>. The layers were separated, and the aqueous layer was further extracted with ethyl acetate. The combined organic phases were washed with brine and were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to afford the desired product (2.24 g, 83%) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.35 (s, 1H), 7.67 (s, 1H), 4.18–4.01 (br m, 2H), 3.85 (s, 3H), 3.59–3.47 (m, 1H), 3.28 (s, 3H), 2.93–2.69 (br m, 2H), 2.60 (s, 3H), 1.81–1.56 (m, 4H), 1.42 (s, 9H). MS (ES+): calcd for C<sub>20</sub>H<sub>29</sub>NO<sub>6</sub>S + H<sup>+</sup> 412.51, found 434.34 (M + Na<sup>+</sup>).</div></div><div id="sec4_4_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-(4-Carboxy-2-methanesulfonyl-5-methyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>89</b>)</h4><div class="NLM_p last">The compound was prepared according to the procedure for compound <b>85</b> using as the starting material <b>88</b> (2.24 g, 5.44 mmol) to afford the desired product (1.85 g, 86%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.23 (s, 1H), 8.36 (s, 1H), 7.62 (s, 1H), 4.19–4.01 (m, 2H), 3.58–3.46 (m, 1H), 3.27 (s, 3H), 2.95–2.69 (br m, 2H), 2.60 (s, 3H), 1.80–1.55 (m, 4H), 1.43 (s, 9H).</div></div><div id="sec4_4_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 4-{2-Methanesulfonyl-5-methyl-4-[<i>N</i>-(carbobenzyloxy)-guanidinocarbonyl]-phenyl}-piperidine-1-carboxylic Acid <i>tert-</i>Butyl Ester (<b>90</b>)</h4><div class="NLM_p last">The compound was prepared and purified via flash chromatography using a gradient elution of 25–50% ethyl acetate in hexanes according to the procedure for compound <b>7</b> using as the starting material <b>90</b> (1.85 g, 4.65 mmol) to afford the desired product (2.15 g, 81%). MS (ES+): calcd for C<sub>28</sub>H<sub>36</sub>N<sub>4</sub>O<sub>7</sub>S + H<sup>+</sup> 573.67, found 573.20.</div></div><div id="sec4_4_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 4-[5-Methanesulfonyl-2-methyl-4-piperidine-4-yl-benzoyl)-<i>N</i>-(carbobenzyloxy)-guanidine (<b>91</b>)</h4><div class="NLM_p last">The compound was prepared according to the procedure for compound <b>87</b> using as the starting material <b>90</b> (2.15 g, 3.75 mmol) to afford the desired product (1.91 g, quantitative) as the hydrochloride salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.98 (br s, 1H), 9.50 (br s, 1H), 9.30–9.08 (m, 2H), 8.76–8.51 (m, 1H), 8.27 (s, 1H), 7.54–7.31 (m, 5H), 5.26 (s, 2H), 3.78–3.62 (m, 1H), 3.39–3.30 (m, 5H), 3.10–2.93 (m, 2H), 2.55 (s, 3H), 2.16–2.01 (m, 2H), 1.97–1.85 (m, 2H). MS (ES+): calcd for C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>S + H<sup>+</sup> 473.57, found 473.20.</div></div><div id="sec4_4_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> <i>N</i>-[5-Methanesulfonyl-4-(1-propionyl-piperidin-4-yl)-2-methyl-benzoyl]-guanidine (<b>82</b>)</h4><div class="NLM_p last">To a solution of propionic acid (31 mg, 0.41 mmol) in DMF (3 mL) was added 1,1′-carbonyldiimidazole (70 mg, 0.43 mmol). The mixture was stirred at room temperature for 90 min, after which <b>91</b> (200 mg, 0.39 mmol) and DIEA (0.21 mL, 1.18 mmol) were added. The mixture was stirred at room temperature overnight. The mixture was poured over H<sub>2</sub>O, and the resulting solid was collected by filtration. To a solution of the solid in ethanol (12 mL) and DMF (2 mL) purged with Ar was added 10 wt % Pd/C (35 mg). The mixture was stirred under an H<sub>2</sub> atmosphere overnight. The mixture was filtered through glass filter paper rinsing with ethyl acetate. The solvent was evaporated, and the residue was purified via preparative HPLC using a gradient elution from 5% to 60% acetonitrile/water with 0.1% TFA to obtain the desired product as the trifluoroacetate salt (84 mg, 42% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.76 (s, 1H), 8.74–8.25 (br m, 4H), 8.10 (s, 1H), 7.71 (s, 1H), 4.64–4.53 (m, 1H), 4.05–3.94 (m, 1H), 3.71–3.59 (m, 1H), 3.31 (s, 1H), 3.18–3.06 (m, 1H), 2.68–2.54 (m, 1H), 2.48 (s, 3H), 2.36 (q, <i>J</i> = 7.3 Hz, 2H), 1.84–1.52 (m, 4H), 1.02 (t, <i>J</i> = 7.5 Hz, 3H). MS (ES+): calcd for C<sub>18</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup> 395.50, found 395.20.</div></div><div id="sec4_4_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> <i>N</i>-[4-(1-Acetyl-piperidin-4-yl)-5-methanesulfonyl-2-methyl-benzoyl]-guanidine (<b>83</b>)</h4><div class="NLM_p last">The compound was prepared and purified by preparative HPLC using a gradient elution from 1% to 50% acetonitrile/water with 0.1% TFA as the eluent according to the procedure for compound <b>78</b> using the starting material <b>92</b> (200 mg, 0.39 mmol) to give the desired intermediate which was deprotected using 10 wt % Pd/C (25 mg) to afford the desired product (50 mg, 26% over two steps) as the trifluoroacetate salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.77 (s, 1H), 8.72–8.25 (br m, 4H), 8.10 (s, 1H), 7.71 (s, 1H), 4.62–4.50 (m, 1H), 4.00–3.89 (m, 1H), 3.71–3.59 (m, 1H), 3.30 (s, 3H), 3.23–3.09 (m, 1H), 2.68–2.54 (m, 1H), 2.48 (s, 3H), 2.05 (s, 3H), 1.84–1.69 (m, 3H), 1.68–1.54 (m, 1H). MS (ES+): calcd for C<sub>17</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup> 381.47, found 381.20.</div></div><div id="sec4_4_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 4-(2-Methanesulfonyl-4-methoxycarbonyl-phenyl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>92</b>)</h4><div class="NLM_p last">The compound was prepared and purified via flash chromatography using a gradient elution of 10–40% ethyl acetate/hexanes according to the procedure for compound <b>88</b>, starting from 4-bromo-3-methanesulfonyl-benzoic acid methyl ester (3.00 g, 10.2 mmol), to afford the desired product (2.73 g, 68%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.48 (d, <i>J</i> = 1.7 Hz, 1H), 8.21 (dd, <i>J</i> = 1.9 Hz, 8.0 Hz, 1H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 5.75 (s, 1H), 4.01–3.95 (br m, 2H), 3.91 (s, 3H), 3.58–3.50 (m, 2H), 3.25 (s, 3H), 2.39–2.30 (m, 2H), 1.43 (s, 9H). MS (ES+): calcd for C<sub>19</sub>H<sub>25</sub>NO<sub>6</sub>S + H<sup>+</sup> 396.47, found 396.30.</div></div><div id="sec4_4_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 4-(2-Methanesulfonyl-4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>93</b>)</h4><div class="NLM_p last">The compound was prepared according to the procedure for compound <b>89</b>, using the starting material <b>92</b> (2.73 g, 6.90 mmol) to afford the desired product (2.00 g, 73%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.46 (d, <i>J</i> = 1.9 Hz, 1H), 8.18 (dd, <i>J</i> = 1.8 Hz, 8.2 Hz, 1H), 7.83 (d, <i>J</i> = 8.5 Hz, 1H), 4.17–4.01 (br m, 2H), 3.89 (s, 3H), 3.65–3.54 (m, 1H), 3.33 (s, 3H), 2.95–2.71 (m, 2H), 1.82–1.70 (m, 2H), 1.69–1.55 (m, 2H), 1.42 (s, 9H). MS (ES+): calcd for C<sub>19</sub>H<sub>27</sub>NO<sub>6</sub>S + H<sup>+</sup> 398.49, found 342.20 (M – tBu<sup>+</sup>).</div></div><div id="sec4_4_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 4-(4-Carboxy-2-methanesulfonyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>94</b>)</h4><div class="NLM_p last">The compound was prepared according to the procedure for compound <b>85</b> using starting material <b>93</b> (2.00 g, 5.03 mmol) to afford the desired product (1.90 g, 99%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.31 (br s, 1H), 8.45 (d, <i>J</i> = 1.8 Hz, 1H), 8.16 (dd, <i>J</i> = 1.8 Hz, 8.2 Hz, 1H), 7.80 (d, <i>J</i> = 8.3 Hz, 1H), 4.17–4.01 (br m, 2H), 3.66–3.53 (m, 1H), 3.32 (s, 3H), 2.96–2.70 (m, 2H), 1.82–1.70 (m, 2H), 1.69–1.55 (m, 2H), 1.43 (s, 9H). MS (ES+): calcd for C<sub>18</sub>H<sub>25</sub>NO<sub>6</sub>S + H<sup>+</sup> 384.46, found 384.20.</div></div><div id="sec4_4_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 4-{2-Methanesulfonyl-4-[<i>N</i>-(carbobenzyloxy)-guanidinocarbonyl]-phenyl}-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>95</b>)</h4><div class="NLM_p last">The compound was prepared and purified via flash chromatography using a gradient elution of 25–50% ethyl acetate in hexanes as the eluent according to the procedure for compound <b>86</b>, using starting material <b>94</b> (1.90 g, 4.96 mmol) to afford the desired product (2.80 g, 100%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.28 (s, 1H), 9.83 (br s, 1H), 8.75 (s, 1H), 8.63 (s, 1H), 8.30 (dd, <i>J</i> = 1.3 Hz, 8.1 Hz, 1H), 7.74 (d, <i>J</i> = 8.3 Hz, 1H), 7.48–7.26 (m, 5H), 5.22 (s, 2H), 4.22–4.01 (br m, 2H), 3.66–3.52 (m, 1H), 3.29 (s, 3H), 2.97–2.67 (m, 2H), 1.82–1.70 (m, 2H), 1.69–1.54 (m, 2H), 1.42 (s, 9H). MS (ES+): calcd for C<sub>27</sub>H<sub>34</sub>N<sub>4</sub>O<sub>7</sub>S + H<sup>+</sup> 559.65, found 559.20.</div></div><div id="sec4_4_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> <i>N</i>-(3-Methanesulfonyl-4-piperidine-4-yl-benzoyl)-<i>N</i>′-(carbobenzyloxy)-guanidine (<b>96</b>)</h4><div class="NLM_p last">The compound was prepared according to the procedure for compound <b>83</b>, using the starting material <b>95</b> (2.80 g, 5.01 mmol) and heating at 50 °C to afford the desired product (2.00 g, 81%) as the hydrochloride salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.04 (br s, 1H), 9.33–9.02 (br m, 2H), 8.64–8.59 (m, 1H), 8.49–8.41 (m, 1H), 7.72–7.66 (m, 1H), 7.47–7.34 (m, 5H), 5.27 (s, 2H), 3.79–3.63 (m, 1H), 3.52–3.31 (m, 5H), 3.12–2.96 (m, 2H), 2.18–2.00 (m, 2H), 1.97–1.85 (m, 2H). MS (ES+): calcd for C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub>S + H<sup>+</sup> 459.54, found 459.20.</div></div><div id="sec4_4_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> <i>N</i>-[3-Methanesulfonyl-4-(1-propionyl-piperidin-4-yl)-benzoyl]-guanidine (<b>80</b>)</h4><div class="NLM_p last">The compound was prepared and purified by preparative HPLC using a gradient elution from 5 to 60% acetonitrile/water with 0.1% TFA as the eluent according to the procedure for compound <b>82</b>, using the starting material <b>97</b> (200 mg, 0.40 mmol) to give the desired intermediate which was deprotected using 10 wt % palladium on carbon (50 mg) to afford the desired product (63 mg, 41% over two steps) as the trifluoroacetate salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.66 (s, 1H), 8.85–8.32 (br m, 4H), 8.45 (d, <i>J</i> = 1.9 Hz, 1H), 8.18 (dd, <i>J</i> = 1.8 Hz, 8.2 Hz, 1H), 7.93 (d, <i>J</i> = 8.2 Hz, 1H), 4.66–4.53 (m, 1H), 4.08–3.94 (m, 1H), 3.76–3.63 (m, 1H), 3.37 (s, 3H), 3.21–3.05 (m, 1H), 2.69–2.57 (m, 1H), 2.37 (q, <i>J</i> = 7.4 Hz, 2H), 1.88–1.53 (m, 4H), 1.02 (t, <i>J</i> = 7.4 Hz, 3H). MS (ES+): calcd for C<sub>17</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup> 381.47, found 381.20.</div></div><div id="sec4_4_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> <i>N</i>-[4-(1-Acetyl-piperidin-4-yl)-3-methanesulfonyl-benzoyl]-guanidine (<b>81</b>)</h4><div class="NLM_p last">The compound was prepared and purified by preparative HPLC using a gradient elution from 1% to 50% acetonitrile/water with 0.1% TFA as the eluent according to the procedure for compound <b>78</b>, using the starting material <b>97</b> (200 mg, 0.40 mmol) to give the desired intermediate which was deprotected using 10 wt % palladium on carbon (40 mg) to afford the desired product (91 mg, 47% over two steps) as the trifluoroacetate salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.62 (s, 1H), 8.79–8.29 (br m, 4H), 8.45 (d, <i>J</i> = 2.0 Hz, 1H), 8.18 (dd, <i>J</i> = 2.0 Hz, 8.2 Hz, 1H), 7.94 (d, <i>J</i> = 8.2 Hz, 1H), 4.62–4.51 (m, 1H), 4.01–3.90 (m, 1H), 3.76–3.64 (m, 1H), 3.37 (s, 3H), 3.23–3.11 (m, 1H), 2.69–2.57 (m, 1H), 2.05 (s, 3H), 1.86–1.72 (m, 3H), 1.68–1.53 (m, 1H). MS (ES+): calcd for C<sub>16</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup> 367.44, found 367.20.</div></div><div id="sec4_4_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 4-Benzyloxy-2-hydroxy-benzoic Acid Methyl Ester (<b>74</b>)</h4><div class="NLM_p last">2,4-Dihydroxy-benzoic acid methyl ester <b>73</b> (25.0 g, 148.7 mmol) was dissolved in acetone (600 mL) and treated with K<sub>2</sub>CO<sub>3</sub> (22.6 g, 163.5 mmol) and stirred at room temperature for 1 h. Benzyl bromide (19.43 mL, 163.5 mmol) was then added, and the reaction was heated to reflux for 3 h. The reaction was then cooled to room temperature and filtered. The filtrate was concentrated and triturated with water. The resulting solid was collected by filtration, resuspended in methanol, filtered, and dried under vacuum. A second crop of product was isolated by filtration of the filtrate after standing to give the desired product as a white solid (29.5 g, 77% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.76 (s, 1H), 7.72 (d, <i>J</i> = 9.5 Hz, 1H), 7.46–7.34 (m, 5H), 6.62–6.59 (m, 2H), 5.16 (s, 2H), 3.86 (s, 3H).</div></div><div id="sec4_4_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 5-Bromo-2,4-dihydroxy-benzoic Acid Methyl Ester (<b>75</b>)</h4><div class="NLM_p last">To a solution of <b>74</b> (29.04 g, 112.441 mmol) in chloroform (300 mL) at 0 °C was added a solution of bromine (6.34 mL, 123.7 mmol) in chloroform (80 mL). The resulting mixture was warmed to room temperature and stirred for 30 min, at which time it was washed with water. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The resulting solids were triturated with methanol to give the desired product as a solid (30.75 g, 81.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.73 (s, 1H), 7.91 (s, 1H), 7.48–7.33 (m, 5H), 6.82 (s, 1H), 5.27 (s, 2H), 3.86 (s, 3H).</div></div><div id="sec4_4_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 4-Benzyloxy-5-bromo-2-methoxy-benzoic Acid Methyl Ester (<b>76</b>)</h4><div class="NLM_p last">To a solution of <b>75</b> (10.0 g, 26.7 mmol) in THF (250 mL) at 0 °C was added potassium <i>tert</i>-butoxide solution (1 M in THF, 35.6 mL, 35.6 mmol), and the mixture was stirred for 30 min. At this time, methyl iodide (2.40 mL, 38.6 mmol) was added and the reaction stirred 72 h at room temperature. The reaction mixture was concentrated and the residue taken up in water and neutralized by slow addition of 1N HCl. The resulting precipitate was collected by filtration and washed with water until the solids were white. The resulting solid was dissolved in ethyl acetate and washed with water, 1 M NaOH, and brine. The organic phase was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The resulting residue was triturated with hexanes, and the solids were collected by filtration to give the desired product as a solid (8.10 g, 77.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.88 (s, 1H), 7.52–7.34 (m, 5H), 6.94 (s, 1H), 5.34 (s, 2H), 3.86 (s, 3H), 3.74 (s, 3H).</div></div><div id="sec4_4_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 4-Benzyloxy-2-methoxy-5-trifluoromethyl-benzoic Acid Methyl Ester (<b>77</b>)</h4><div class="NLM_p last"><b>76</b> (7.50 g, 21.4 mmol), CuI (24.4 g, 128 mmol), and potassium trifluoroacetate (19.5 g, 128 mmol) were combined in a round-bottom flask, and the vessel was evacuated and backfilled with argon three times. To the mixture was then added NMP (150 mL), and the reaction was heated at 150 °C overnight. The reaction was cooled to room temperature and poured into water (1.2 L), and the resulting precipitate was collected by filtration. The filter cake was then rinsed with ethyl acetate (750 mL) into a separate filtration flask, and the filtrate was dried over MgSO<sub>4</sub>, filtered, and concentrated to afford a paste. The paste was treated with water, and the resulting solid was collected by filtration to give the desired product as a brown solid (6.14 g, 84.5%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.95 (s, 1H), 7.48–7.34 (m, 5H), 7.02 (s, 1H), 5.40 (s, 2H), 3.93 (s, 3H), 3.76 (s, 3H).</div></div><div id="sec4_4_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 4-Hydroxy-2-methoxy-5-trifluoromethyl-benzoic Acid Methyl Ester (<b>97</b>)</h4><div class="NLM_p last">Synthesized according to the procedure for phenol <b>68</b> to give the desired product as a brown solid (3.36 g, 74.4%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 11.42 (s, 1H), 7.88 (s, 1H), 6.67 (s, 1H), 3.82 (s, 3H), 3.74 (s, 3H).</div></div><div id="sec4_4_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> 4-(4-Carboxy-5-methoxy-2-trifluoromethyl-phenyl)-3,6-dihydro-2<i>H</i>-pyridine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>69c</b>)</h4><div class="NLM_p last">To a solution of <b>97</b> (3.36 g, 13.4 mmol) and DIEA (2.57 mL, 14.8 mmol) in DMF (75.0 mL) was added <i>N</i>-phenyltrifluoromethanesulfonimide (5.04 g, 14.1 mmol), and the resulting mixture was stirred overnight. The reaction was then poured into a stirred saturated solution of NaHCO<sub>3</sub> in water. The mixture was then extracted with ethyl acetate (3×), and the combined extracts were washed with water (4×), saturated aqueous NaHCO<sub>3</sub>, and brine. The organic phase was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the desired intermediate as a brown oil. A solution of this intermediate in 1,4-dioxane (56.0 mL) was added to a mixture of Pd(Ph<sub>3</sub>P)<sub>4</sub> (1.58 g, 1.37 mmol), <b>16</b> (4.22 g, 13.6 mmol), and K<sub>2</sub>CO<sub>3</sub> (3.53 g, 27.3 mmol) in a pressure flask. To this mixture was then added water (14.0 mL), and the flask was sealed and heated at 140 °C overnight. The reaction was cooled to room temperature, poured over ice, and extracted with ethyl acetate. The extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford a brown oil, which was purified via flash chromatography using a gradient elution of 0–100% ethyl acetate/hexanes to afford the desired product as a solid (3.60 g, 66.7% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.02 (s, 1H), 7.92 (s, 1H), 7.09 (s, 1H), 5.63 (bs, 1H), 3.94 (bs, 1H), 3.89 (s, 3H), 3.52 (t, <i>J</i> = 5.4 Hz, 2H), 2.32 (bs, 2H), 1.42 (s, 9H).</div></div><div id="sec4_4_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 4-(4-Carboxy-5-methoxy-2-trifluoromethyl-phenyl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>99</b>)</h4><div class="NLM_p last">Synthesized according to the procedure for <b>85</b> to give the desired product as a solid (3.10 g, 85.7%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.93 (bs, 1H), 7.89 (s, 1H), 7.24, (s, 1H), 4.11 (bd, <i>J</i> = 12.8 Hz, 2H), 3.92, (s, 3H), 2.97–2.91 (m, 1H), 2.78 (bs, 2H), 1.82–1.72 (m, 2H), 1.648 (bd, <i>J</i> = 11.8 Hz, 2H), 1.42 (s, 9H).</div></div><div id="sec4_4_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> 4-[5-Methoxy-4-(<i>N</i>-(carbobenzyloxy)-guanidinocarbonyl)-2-trifluoromethyl-phenyl]-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>100</b>)</h4><div class="NLM_p last">Synthesized according to the procedure for <b>86</b> to give the desired product which was used crude without purification (4.08 g, 91.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.00 (bs, 1H), 8.92 (bs, 1H), 8.72 (bs, 1H), 8.07 (s, 1H), 7.38–7.30 (m, 6H), 5.08 (s, 2H), 4.12–4.05 (m, 5H), 2.99–2.93 (m, 1H), 2.79 (bs, 2H), 1.85–1.77 (m, 2H), 1.66 (bd, <i>J</i> = 12.4, 2H), 1.42 (s, 9H).</div></div><div id="sec4_4_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> <i>N</i>-(2-Methoxy-4-piperidin-4-yl-5-trifluoromethyl-benzoyl)-<i>N</i>′-(carbobenzyloxy)-guanidine (<b>101</b>)</h4><div class="NLM_p last">Synthesized according to the procedure for <b>87</b> to give the desired product hydrochloride salt as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.24 (bs, 1H), 9.67 (bs, 1H), 9.37 (bs, 1H), 8.98–8.91 (m, 2H), 8.14 (s, 1H), 7.44–7.36 (m, 6H), 5.22 (s, 2H), 4.10 (s, 3H), 3.40–3.35 (m, 2H), 3.25–3.19 (m, 1H), 3.13–3.04 (m, 2H), 2.28–2.19 (m, 2H), 1.84 (bd, <i>J</i> = 12.6 Hz, 2H). MS (ES+): calcd for C<sub>23</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> + H<sup>+</sup> 479.48, found 479.74.</div></div><div id="sec4_4_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> <i>N</i>-[4-(1-Acetyl-piperidin-4-yl)-2-methoxy-5-trifluoromethyl-benzoyl]-guanidine (<b>102</b>)</h4><div class="NLM_p last">The CBZ-protected amide intermediate was obtained using the CDI coupling general procedure from acetic acid (12.2 μL, 0.214 mmol) and <b>101</b> (100 mg, 0.165 mmol). The intermediate obtained was used crude in the following step. The CBZ protecting group was removed according to the general procedure using Pd(OH)<sub>2</sub> on carbon (20 wt % Pd, 50% water wet, 10.0 mg, 0.007 mmol). The residue was purified via preparative HPLC using a gradient elution from 10% to 100% acetonitrile/water with 0.1% TFA to obtain the desired product (26.0 mg, 32% over two steps) as the trifluoroacetate salt. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.82 (s, 1H), 8.6–8.35 (br m, 4H), 8.02 (s, 1H), 7.40 (s, 1H), 4.59 (d, <i>J</i> = 14.0 Hz, 1H), 4.05 (br s, 3H), 3.96 (br d, <i>J</i> = 12.9, 1H), 3.17–3.04 (br m, 2H), 2.61–2.55 (m, 1H), 2.05 (br s, 2H), 1.94–1.85 (br m, 1H), 1.77–1.64 (br m, 2H). MS (ES+): calcd for C<sub>17</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> + H<sup>+</sup> 387.38, found 387.20.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> Biological Assays</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Evaluation of NHE1 Inhibition (pH<sub>i</sub>)</h4><div class="NLM_p last">HT-29 cells (purchased from American Type Culture Collection (ATCC), Manassas, VA) resuspended in DMEM supplemented with 10% FBS, 1% NEAA, and 1% Penn–Strep were seeded at 10000 cells/well in collagen-coated 384-well plates, which were then incubated for 24 h at 37C. The next day, the medium was removed and the cells were dye (Invitrogen’s BCECF) loaded for 30′ at 37C, washed three times with an acid loading buffer (10 mM NH<sub>4</sub>Cl, 1.8 mM CaCl<sub>2</sub>, 90 mM choline Cl, 5 mM glucose, 15 mM Hepes, 5 mM KCl, 1 mM MgCl<sub>2</sub>, adjusted to pH 7.5 with KOH), and further incubated at RT for 30 min. At the end of the incubation, the buffer was removed and 5 μL of fresh acid loading buffer was added to each well to prevent the desiccation of the cells. The plate was placed in a Hamamatsu FDSS6000 instrument, and candidate compounds were added to the cells in buffer lacking the NH<sub>4</sub>Cl. The plates were read, and the compound IC<sub>50</sub>s were calculated as measurements of the 50% inhibition of the intracellular pH recovery.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Evaluation of NHE2 and -3 Inhibition (pH<sub>i</sub>)</h4><div class="NLM_p last">PS120 cells stably transfected with NHE-2 or 3 were resuspended in DMEM supplemented with 10% FBS, 1% NEAA, and 1% Penn–Strep are seeded at 10000 cells/well in collagen-coated 384-well plates which were then incubated for 24 h at 37 °C under 5% CO<sub>2</sub>. The next day, the medium were removed and the cells were dye (Invitrogen’s BCECF) loaded for 30 min at 37 °C, washed three times with an acid loading buffer (10 mM NH<sub>4</sub>Cl, 1.8 mM CaCl<sub>2</sub>, 90 mM choline Cl, 5 mM glucose, 15 mM Hepes, 5 mM KCl, 1 mM MgCl<sub>2</sub>, adjusted to pH 7.5 with KOH), and further incubated at RT for 30 min. At the end of the incubation, the buffer was removed and 5 μL of fresh acid loading buffer was added to each well to prevent the desiccation of the cells. The plate was placed in a Hamamatsu FDSS6000 instrument, and candidate compounds were added to the cells in buffer lacking the NH<sub>4</sub>Cl. The plates were read, and the compound IC<sub>50</sub>s were calculated as measurements of the 50% inhibition of the intracellular pH recovery.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> Evaluation of Functional Potency in Human Platelets (hPSA)</h4><div class="NLM_p last">Human blood was collected into 10 mL K<sub>2</sub> EDTA tubes (BD, no. 366643) at room temperature and centrifuged at 150<i>g</i> for 10 min at room temperature, and platelet rich plasma (PRP) that comprised the upper two-thirds of the plasma layer was used for the assessment of platelet swelling. The remaining plasma was further centrifuged at 1400<i>g</i> to obtain platelet poor plasma (PPP). First, 22 μL test compounds (10×) and vehicle controls were added to 96-well plates to which 28 μL/well PRP was then added. Then 172 μL/well of propionate medium (PM) (sodium propionate 140 mM, HEPES 20 mM, glucose 10 mM, KCL 5 mM, MgCl<sub>2</sub> 1 mM and CaCl<sub>2</sub> 1 mM; pH 6.7) was placed into 96-well plates to initiate platelet swelling. Platelet swelling was measured as a decrease in optical density at 680 mM measured over 6 s over 5 min using a microplate reader (Molecular Devices VMAX). Slope values were calculated, and POC was calculated using the changes in slope from control values.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> Inhibition of Cytochrome P-450s 2C19, 2C9, 2D6, and 3A4</h4><div class="NLM_p">Global lot human liver microsomes (HLM, Gentest) were used in all CYP IC<sub>50</sub> assessments with drug probes. CYP selective probe substrates (see Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>) and HLM were mixed with 0–12.5 μM test compound, followed by 2 mM NADPH, and incubated at 37 °C for a defined time period depending on the probe reactions. Reaction was quenched with acetonitrile containing an internal standard (IS). The levels of respective metabolites generated in the CYP-selective probe reactions were quantified against the IS using LC/MS/MS. The IC<sub>50</sub> values were generated by fitting data using the GraFit 5 program.</div><div class="NLM_table-wrap" id="tbl11">Table 11<div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CYP isoform</th><th class="colsep0 rowsep0" align="center">probe substrate</th><th class="colsep0 rowsep0" align="center" char=".">incubation time (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="left">7-ethoxy-3-cyanocoumarin</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="left">7-methoxy-4-(trifluoromethyl)-coumarin</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="left">3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylamino)ethyl]-7-methoxy-4-methylcoumarin</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4</td><td class="colsep0 rowsep0" align="left">7-benzyloxy-4-(trifluoromethyl)-coumarin</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr></tbody></table></div></div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> Assessment of Stability in HLM and RLM</h4><div class="NLM_p last">Stability of the test compounds was assessed in commercially obtained human and rat liver microsomes (BD Sciences). Incubations in duplicate consisted of 1 μM test compound, 1 mg/mL microsomal protein, 2.5 mM NADPH, and 50 mM potassium phosphate buffer, pH 7.4. The compound was preincubated at 37 °C in the assay buffer for 5 min, and then reaction was initiated with NADPH addition. Aliquots were removed at eight time points up to 60 min, reaction quenched with acetonitrile, and analyzed by LC/MS/MS for depletion of parent compound relative to initial concentration.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> Assessment of Membrane Permeability Using the PAMPA Assay<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h4><div class="NLM_p last">The parallel artificial membrane permeability assay (PAMPA) was carried out using a PAMPA Evolution permeability analyzer form pION, Inc., A “sandwich” was formed using 96-well microtiter plate and a 96-well filter plate. The pH values of the buffer solutions in donor wells were adjusted to 5.0, 6.2, and 7.4 with 0.5 M NaOH, the upper acceptor plate was filled with a buffer solution ASB-7.4 (pION Inc.), and the filters (pore size 0.45, thickness 125 μm) were coated with 4 μL of lipid (pION Inc.). The stock solution of the test compound was dissolved in DMSO at 10 mM concentration, of which the donor solution of 41.7 μM was prepared in diluted buffer solution. The PAMPA sandwich was incubated for 4 h without stirring. The concentration of the test compound was measured in duplicate for the reference, donor, and acceptor plates with a UV plate reader. The effective permeability of the test compound was calculated using the PAMPA Evolution permeability analyzer software. Result reporting (sum of Pe at 3 pHs): Low permeability: <2 × 10<sup>–6</sup> cm/s. High permeability: ≥2 × 10<sup>–6</sup> cm/s.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> Determination of hERG Pharmacology Using the PatchXpress Platform</h4><div class="NLM_p last">The hERG pharmacology of test agents was assessed on the PatchXpress automated electrophysiology platform (Molecular Devices, CA) as previously described<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with some minor modifications. A HEK cell line stably expressing hERG potassium channels was loaded onto PatchXpress at a final concentration of 1 × 10<sup>6</sup> cells/mL. Voltage-dependent hERG currents were recorded from single cells using the whole-cell configuration of the patch clamp technique. Peak hERG tail current was monitored during application of successive drug concentrations until a new steady state was achieved. Multiple test article concentrations were applied cumulatively in ascending order without washout between applications. Data points were collected at a frequency of 0.1 Hz. Drugs were applied once a stable baseline had been recorded for 5 min. For PatchXpress experiments, 0.1% DMSO (v/v) in extracellular solution was added as a negative control before drug application. The steady-state hERG current amplitude before and after test article application was used to calculate the percentage of current inhibited at each concentration and to derive an IC<sub>50</sub> value. Valid whole-cell recordings met the following criteria: Membrane resistance (Rm) ≥ 200 MW, access resistance (Ra) ≤ 8 MW (after series resistance compensation), peak hERG tail current ≥200 pA, and leak current ≤25% peak current.</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> Assessment of Membrane Permeability and Transport Using Caco-2 Cells</h4><div class="NLM_p last">Caco-2 cells (American Type Culture Collection, Rockville, MD) from passage number 36 were grown for 21 days in 12-transwell plates, and cells with TEER value greater than 350 Ω·cm<sup>2</sup> were used to determine compound permeability and efflux ratio. Incubations with 10 μM compound were conducted on Tecan Genesis 150. Aliquots of the compound from apical (A–B) and basolateral (B–A) sides were transferred at various time points up to 150 min for analysis by LC/MS/MS. Apparent permeability coefficient (cm/s) was determined using the following relationship:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/jm-2012-00601d_m001.gif" alt="" /></img></span>where <i>P</i><sub>app</sub> is apparent permeability coefficient (cm/s), <i>C</i> is concentration in receiver compartment (μmol/cm<sup>3</sup>), <i>A</i> is filter area (cm<sup>2</sup>), <i>t</i> is time (s), <i>S</i> is concentration in donor compartment (μmol/cm<sup>3</sup>), and <i>V</i> is volume in receiver compartment (cm<sup>3</sup>).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> Evaluation of Rat Pharmacokinetics</h4><div class="NLM_p last">With approval from Institutional Animal Care and Use Committee, jugular and femoral vein precannulated male Sprague–Dawley rats (Charles River Laboratories) were used to assess the pharmacokinetic profile of compounds. The compound was dissolved in 20% hydroxypropyl β-cyclodextrin (HPBCD) at 1 mg/mL for intravenous (iv) dosing and suspended in 0.015% Tween 80 + 0.5% aqueous methylcellulose for oral (PO) dosing to overnight fasted rats (<i>N</i> = 3 per group) at 1 and 5 mg/kg, respectively. Serial blood samples were collected up to 24 h in K<sub>2</sub>EDTA tubes for plasma collection. Plasma samples were frozen at −20 °C until analysis. The samples were processed by protein precipitation with acetonitrile, and supernatants were analyzed by LC/MS/MS. The instrumentation consisted of Hewlett-Packard series 1200 pump, Leap CTC PAL autosampler, and Applied Biosystems API4000 mass spectrometer, operating in MRM mode.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> Evaluation of Dog Pharmacokinetics</h4><div class="NLM_p last">Single dose iv and po PK studies were performed in male Beagle dog (<i>N</i> = 3 per group) using the dosing vehicles as described for rat PK studies. After 1 mg/kg iv or 5 mg/kg po doses to overnight fasted animals, blood sampling was done up to 72 h post dose, followed by plasma sample analysis as described for rat PK.</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> Assessment of CYP 3A4 Induction</h4><div class="NLM_p last">DPX cells (stably transformed with human PXR and a reporter gene vector containing the enhancer regions of CYP3A4) were used for assessment of potential PXR activation and CYP3A4 induction by the test compound at concentrations of 0.1, 1, and 10 μM. Rifampicin, mifepristone, and androstanol were used as positive controls for strong, moderate, and weak CYP3A4 induction. The induction potentials at each of the concentrations were read as percent of induction at 10 μM of the positive controls.</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> Assessment of CYP3A4 Inactivation</h4><div class="NLM_p last">Time- and concentration-dependent inhibition of CYP3A4 by test compound was tested in hLM and was characterized by determining residual enzyme activity using midazolam as the probe substrate. Preincubations were done (37 °C) from 0 to 20 min with 0.1 mg/mL hLM, at 5 concentrations of test compound ranging from 0 to 50 μM with NADPH generating system. Secondary incubation with midazolam was performed at 37 °C for 8 min, followed by analysis of midazolam metabolites.</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> AMES Mutagenicity Evaluation.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></h4><div class="NLM_p last">The mutagenic potential was assessed using <i>Salmonella typhimurium</i> strains TA1535, TA1537, TA98, and TA100 and <i>Escherichia coli</i> WP2 uvrA (pKM101) in a standard plate incorporation format. Compounds were dissolved in DMSO and added to bacterial cultures at concentrations up to 5000 μg/plate in the presence or absence of an Aroclor 1254-induced rat liver S9 metabolic activating system. Each dose level, vehicle, and positive control was plated in triplicate.</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> Cytotoxicity Potential Determination</h4><div class="NLM_p last">The cytotoxicity potential of the compound was assessed using HeLa cells in a 96-well format. Cells were seeded in 96-well plates overnight. Compounds were dissolved in DMSO and added to cell plates at concentrations up to 100 μM in triplicates. After a 24 h dosing period, plates were stained with Cytotoxicity 1 HitKit and imaged on Thermo Scientific Cellomics ArrayScan VTI. Nuclear morphology and size,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> membrane permeability status,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> lysosome mass/pH changes,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and cell density changes<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> were assessed against vehicle control to generate a cytotoxicity index for each compound.</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> Phospholipidosis Potential Determination</h4><div class="NLM_p last">Phospholipidosis was measured in a Nile Red flow cytometry assay<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> using U937 cells. Cells were treated with compound at concentrations up to 500 μM. After 48 h incubation, the cells were fixed and labeled with Nile Red and propidium iodine dyes. Nile Red fluorescence intensity was assessed against vehicle control, and values were corrected to cell viability.</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> Ex Vivo Ischemia-Reperfusion Study</h4><div class="NLM_p last">Experiments were performed on isolated hearts obtained from male Sprague–Dawley rats weighing 275–300 g (Charles River, St. Constant, Quebec, Canada). The animals were maintained in the Health Sciences Animal Care Facility of the University of Western Ontario in accordance with the guidelines of the Canadian Council on Animal Care (Ottawa, Ontario, Canada). For heart perfusion, the rats were euthanized by decapitation and the hearts were immediately removed, placed in cold Krebs–Henseleit buffer (see composition below) to inhibit any further contractions, and then mounted by the aorta on a stainless steel cannula and arranged for retrograde perfusion at a flow rate of 10 mL/min according to the Langendorff method. Flow was maintained at a constant rate with the use of a peristaltic pump. The perfusion fluid was Krebs–Henseleit buffer composed of the following (in mmol/L): 120 NaCl, 4.63 KCl, 1.17 KH<sub>2</sub>PO<sub>4</sub>, 1.25 CaCl<sub>2</sub>, 1.2 MgCl<sub>2</sub>, 20 NaHCO<sub>3</sub>, and 8 glucose. The buffer was initially equilibrated and then continuously gassed with a 95% O<sub>2</sub>–5% CO<sub>2</sub> mixture. The pH of the buffer was 7.4, and temperature was maintained at 37 °C by enclosing the entire system in a series of water-jacketed coils. Coronary pressure was measured via a side arm of the perfusion cannula, which was connected to a pressure transducer (model P23 XL, Spectramed). A latex water-filled balloon fixed to a pressure transducer was inserted through the mitral valve into the left ventricle (LV) for the determination of LV developed pressure (LVDP). LV end-diastolic pressure (LVEDP) was adjusted to 5 mmHg before the start of the experiment by adjusting the volume in the intraventricular balloon with the aid of a micrometer syringe. Hearts were electrically paced at a rate of 5 Hz throughout the entire perfusion period. All determinations of ventricular performance were obtained online with a Biopac (Goleta, CA) data analysis system. After a 30 min equilibration period, zero flow ischemia was induced by shutting of the peristalitic pump for 45 min after which flow was rapidly reintroduced for a further 30 min. When studied, <b>60</b> was administered 10 min before initiating ischemia and then throughout the ischemia and reperfusion period. Data were analyzed using a repeated measures ANOVA followed by Tukey’s posthoc test. <i>N</i> = 6 for all groups. *<i>P</i> < 0.05 from <b>60</b>-free group.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm300601d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Huber</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#513b3e393f7f392433342311333e343923383f3634237c383f36343d3934383c7f323e3c"><span class="__cf_email__" data-cfemail="4f2520272161273a2d2a3d0f2d202a273d2621282a3d622621282a23272a2622612c2022">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Bentzien</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen J. Boyer</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Burke</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stéphane De Lombaert</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Eickmeier</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry,
Boehringer Ingelheim Pharma GmbH & Co KG, 88397 Biberach an der
Riss, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Guo</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James V. Haist</span> - <span class="hlFld-Affiliation affiliation">Department
of Physiology &
Pharmacology, University of Western Ontario, Medical Sciences Building,
London, Ontario N6A 5C1,Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugene R. Hickey</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Kaplita</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Support, Boehringer
Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Morris Karmazyn</span> - <span class="hlFld-Affiliation affiliation">Department
of Physiology &
Pharmacology, University of Western Ontario, Medical Sciences Building,
London, Ontario N6A 5C1,Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raymond Kemper</span> - <span class="hlFld-Affiliation affiliation">Non-Clinical Drug Safety, Boehringer
Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles A. Kennedy</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Kirrane</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey B. Madwed</span> - <span class="hlFld-Affiliation affiliation">Cardiometabolic-Disease Research, Boehringer
Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Mainolfi</span> - <span class="hlFld-Affiliation affiliation">Cardiometabolic-Disease Research, Boehringer
Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nelamangara Nagaraja</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Support, Boehringer
Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fariba Soleymanzadeh</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Swinamer</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne B. Eldrup</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877,
United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i142" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i142"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i143" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i143"> Abbreviations Used</h2><tr><td class="NLM_term">APD</td><td class="NLM_def"><p class="first last">action potential duration</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyl diimidazole</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go channel</p></td></tr><tr><td class="NLM_term">hLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">hPSA</td><td class="NLM_def"><p class="first last">human platelet swelling assay</p></td></tr><tr><td class="NLM_term">KOtBu</td><td class="NLM_def"><p class="first last">potassium <i>tert</i>-butoxide</p></td></tr><tr><td class="NLM_term">LV</td><td class="NLM_def"><p class="first last">left ventrical</p></td></tr><tr><td class="NLM_term">LVDP</td><td class="NLM_def"><p class="first last">left ventricular developed pressure</p></td></tr><tr><td class="NLM_term">LVEDP</td><td class="NLM_def"><p class="first last">left ventricular end-diastolic pressure</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean residence time</p></td></tr><tr><td class="NLM_term">NCX</td><td class="NLM_def"><p class="first last">sodium calcium exchanger</p></td></tr><tr><td class="NLM_term">NHE</td><td class="NLM_def"><p class="first last">sodium hydrogen exchanger</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl morpholine</p></td></tr><tr><td class="NLM_term">rLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">Pd/C</td><td class="NLM_def"><p class="first last">palladium on carbon</p></td></tr><tr><td class="NLM_term">pHi</td><td class="NLM_def"><p class="first last">pH internal</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">Vdss</td><td class="NLM_def"><p class="first last">volume of distribution at steady-state</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i144">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Karmazyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumoto, K.</span><span> </span><span class="NLM_article-title">The myocardial Na<sup>+</sup>–H<sup>+</sup> exchanger: Structure, regulation, and its role in heart disease</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=777-786&issue=9&author=M.+Karmazynauthor=X.+T.+Ganauthor=R.+A.+Humphreysauthor=H.+Yoshidaauthor=K.+Kusumoto&title=The+myocardial+Na%2B%E2%80%93H%2B+exchanger%3A+Structure%2C+regulation%2C+and+its+role+in+heart+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarmazyn%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DX.%2BT.%26aulast%3DHumphreys%26aufirst%3DR.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DKusumoto%26aufirst%3DK.%26atitle%3DThe%2520myocardial%2520Na%252B%25E2%2580%2593H%252B%2520exchanger%253A%2520Structure%252C%2520regulation%252C%2520and%2520its%2520role%2520in%2520heart%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D1999%26volume%3D85%26issue%3D9%26spage%3D777%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Orlowski, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandasamy, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shull, G. E.</span><span> </span><span class="NLM_article-title">Molecular cloning of putative members of the Na/H exchanger gene family: cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=9331-9339&author=J+Orlowskiauthor=R.+A.+Kandasamyauthor=G.+E.+Shull&title=Molecular+cloning+of+putative+members+of+the+Na%2FH+exchanger+gene+family%3A+cDNA+cloning%2C+deduced+amino+acid+sequence%2C+and+mRNA+tissue+expression+of+the+rat+Na%2FH+exchanger+NHE-1+and+two+structurally+related+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrlowski%26aufirst%3DJ%26aulast%3DKandasamy%26aufirst%3DR.%2BA.%26aulast%3DShull%26aufirst%3DG.%2BE.%26atitle%3DMolecular%2520cloning%2520of%2520putative%2520members%2520of%2520the%2520Na%252FH%2520exchanger%2520gene%2520family%253A%2520cDNA%2520cloning%252C%2520deduced%2520amino%2520acid%2520sequence%252C%2520and%2520mRNA%2520tissue%2520expression%2520of%2520the%2520rat%2520Na%252FH%2520exchanger%2520NHE-1%2520and%2520two%2520structurally%2520related%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D9331%26epage%3D9339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fliegel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, J. R. B.</span><span> </span><span class="NLM_article-title">Molecular biology of the cardiac sodium/hydrogen exchanger</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1995&pages=155-159&issue=2&author=L.+Fliegelauthor=J.+R.+B.+Dyck&title=Molecular+biology+of+the+cardiac+sodium%2Fhydrogen+exchanger"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFliegel%26aufirst%3DL.%26aulast%3DDyck%26aufirst%3DJ.%2BR.%2BB.%26atitle%3DMolecular%2520biology%2520of%2520the%2520cardiac%2520sodium%252Fhydrogen%2520exchanger%26jtitle%3DCardiovasc.%2520Res.%26date%3D1995%26volume%3D29%26issue%3D2%26spage%3D155%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, J. R.</span><span> </span><span class="NLM_article-title">Role of intracellular Na<sup>+</sup> in Ca2<sup>+</sup> overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H–Na and Na–Ca exchange</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1989&pages=1045-1056&author=M.+Taniauthor=J.+R.+Neely&title=Role+of+intracellular+Na%2B+in+Ca2%2B+overload+and+depressed+recovery+of+ventricular+function+of+reperfused+ischemic+rat+hearts.+Possible+involvement+of+H%E2%80%93Na+and+Na%E2%80%93Ca+exchange"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTani%26aufirst%3DM.%26aulast%3DNeely%26aufirst%3DJ.%2BR.%26atitle%3DRole%2520of%2520intracellular%2520Na%252B%2520in%2520Ca2%252B%2520overload%2520and%2520depressed%2520recovery%2520of%2520ventricular%2520function%2520of%2520reperfused%2520ischemic%2520rat%2520hearts.%2520Possible%2520involvement%2520of%2520H%25E2%2580%2593Na%2520and%2520Na%25E2%2580%2593Ca%2520exchange%26jtitle%3DCirc.%2520Res.%26date%3D1989%26volume%3D65%26spage%3D1045%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Haigney, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakatta, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, H. S.</span><span> </span><span class="NLM_article-title">Dependence of hypoxic cellular calcium loading on Na<sup>+</sup>–Ca<sup>2+</sup> exchange</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=547-557&author=M.+C.+Haigneyauthor=H.+Miyataauthor=E.+G.+Lakattaauthor=M.+D.+Sternauthor=H.+S.+Silverman&title=Dependence+of+hypoxic+cellular+calcium+loading+on+Na%2B%E2%80%93Ca2%2B+exchange"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaigney%26aufirst%3DM.%2BC.%26aulast%3DMiyata%26aufirst%3DH.%26aulast%3DLakatta%26aufirst%3DE.%2BG.%26aulast%3DStern%26aufirst%3DM.%2BD.%26aulast%3DSilverman%26aufirst%3DH.%2BS.%26atitle%3DDependence%2520of%2520hypoxic%2520cellular%2520calcium%2520loading%2520on%2520Na%252B%25E2%2580%2593Ca2%252B%2520exchange%26jtitle%3DCirc.%2520Res.%26date%3D1992%26volume%3D71%26spage%3D547%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Allen, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.-H.</span><span> </span><span class="NLM_article-title">Role of the cardiac Na<sup>+</sup>/H<sup>+</sup> exchanger during ischemia and reperfusion</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">934</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=934-941&issue=4&author=D.+G.+Allenauthor=X.-H.+Xiao&title=Role+of+the+cardiac+Na%2B%2FH%2B+exchanger+during+ischemia+and+reperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DD.%2BG.%26aulast%3DXiao%26aufirst%3DX.-H.%26atitle%3DRole%2520of%2520the%2520cardiac%2520Na%252B%252FH%252B%2520exchanger%2520during%2520ischemia%2520and%2520reperfusion%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D57%26issue%3D4%26spage%3D934%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">[Na<sup>+</sup>]<sub>i</sub> and the driving force of the Na<sup>+</sup>/Ca<sup>2+</sup>-exchanger in heart failure</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=986-995&author=A.+Baartscheerauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=%5BNa%2B%5Di+and+the+driving+force+of+the+Na%2B%2FCa2%2B-exchanger+in+heart+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3D%255BNa%252B%255Di%2520and%2520the%2520driving%2520force%2520of%2520the%2520Na%252B%252FCa2%252B-exchanger%2520in%2520heart%2520failure%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D57%26spage%3D986%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borren, M. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">Increased Na<sup>+</sup>/H<sup>+</sup>-exchange activity is the cause of increased [Na<sup>+</sup>]<sub>i</sub> in heart failure and underlies disturbed calcium handling</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=1015-1024&issue=4&author=A.+Baartscheerauthor=M.+M.+C.+Borrenauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=Increased+Na%2B%2FH%2B-exchange+activity+is+the+cause+of+increased+%5BNa%2B%5Di+in+heart+failure+and+underlies+disturbed+calcium+handling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DBorren%26aufirst%3DM.%2BM.%2BC.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3DIncreased%2520Na%252B%252FH%252B-exchange%2520activity%2520is%2520the%2520cause%2520of%2520increased%2520%255BNa%252B%255Di%2520in%2520heart%2520failure%2520and%2520underlies%2520disturbed%2520calcium%2520handling%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D57%26issue%3D4%26spage%3D1015%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Avkiran, M.</span><span> </span><span class="NLM_article-title">Rational basis for use of sodium–hydrogen exchange inhibitors in myocardial ischemia</span> <span class="citation_source-journal">Am. J. Cardiol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">10G</span><span class="NLM_x">–</span> <span class="NLM_lpage">18G</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=10G-18G&issue=10&author=M.+Avkiran&title=Rational+basis+for+use+of+sodium%E2%80%93hydrogen+exchange+inhibitors+in+myocardial+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvkiran%26aufirst%3DM.%26atitle%3DRational%2520basis%2520for%2520use%2520of%2520sodium%25E2%2580%2593hydrogen%2520exchange%2520inhibitors%2520in%2520myocardial%2520ischemia%26jtitle%3DAm.%2520J.%2520Cardiol%26date%3D1999%26volume%3D83%26issue%3D10%26spage%3D10G%26epage%3D18G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Avkiran, M.</span><span> </span><span class="NLM_article-title">Protection of the myocardium during ischemia and reperfusion: Na<sup>+</sup>/H<sup>+</sup> exchange inhibition versus ischemic preconditioning</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2469</span><span class="NLM_x">–</span> <span class="NLM_lpage">2472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1999&pages=2469-2472&author=M.+Avkiran&title=Protection+of+the+myocardium+during+ischemia+and+reperfusion%3A+Na%2B%2FH%2B+exchange+inhibition+versus+ischemic+preconditioning"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvkiran%26aufirst%3DM.%26atitle%3DProtection%2520of%2520the%2520myocardium%2520during%2520ischemia%2520and%2520reperfusion%253A%2520Na%252B%252FH%252B%2520exchange%2520inhibition%2520versus%2520ischemic%2520preconditioning%26jtitle%3DCirculation%26date%3D1999%26volume%3D100%26spage%3D2469%26epage%3D2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Avkiran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marber, M. S.</span><span> </span><span class="NLM_article-title">Na<sup>+</sup>/H<sup>+</sup> exchange inhibitors for cardioprotective therapy: progress, problems and prospects</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0735-1097%2802%2901693-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11869836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVGltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=747-753&author=M.+Avkiranauthor=M.+S.+Marber&title=Na%2B%2FH%2B+exchange+inhibitors+for+cardioprotective+therapy%3A+progress%2C+problems+and+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Na+/H+ exchange inhibitors for cardioprotective therapy: Progress, problems, and prospects</span></div><div class="casAuthors">Avkiran, Metin; Marber, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-753</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Extensive pre-clin. work indicates that inhibition of the sarcolemmal Na+/H+ exchanger (NHE) affords significant protection to myocardium subjected to ischemia and reperfusion, predominantly through reduced intracellular accumulation of Na+ and consequently Ca2+.  In contrast, recent clin. studies with the NHE inhibitors cariporide and eniporide in patients with evolving myocardial infarction (MI) and those at risk of MI have provided mixed and somewhat contradictory data.  The exptl. evidence suggests that the key mechanism through which NHE inhibitors afford protection consists in slowing the progression of myocardial injury during ischemia and thereby enhancing myocardial salvage by reperfusion.  It follows from this that, to obtain max. cardioprotective benefit, (1) the NHE inhibitor must be present in jeopardized myocardium, at a concn. sufficient to inhibit NHE activity, before (or as soon as possible after) the onset of ischemia, and (2) ischemia must be terminated by timely reperfusion.  Thus, in the GUARDIAN trial, the cardioprotective efficacy of cariporide was limited to the subset of high-risk patients who underwent coronary artery bypass graft surgery, in whom both prerequisites could be readily fulfilled.  In contrast, no cardioprotective benefit was obsd. in the ESCAMI trial, in which eniporide was administered late as an adjunct to reperfusion therapy in patients with evolving MI.  Ongoing clin. studies will det. whether NHE inhibition will find therapeutic application in the setting of cardiac surgery, while pre-clin. investigations continue to test the potential of NHE inhibitors in the treatment of other cardiovascular diseases such as heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWcVgAPjBM7Vg90H21EOLACvtfcHk0lgHf2FyAipMeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVGltb0%253D&md5=fb18063cf713069d0c5547f079032789</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0735-1097%2802%2901693-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0735-1097%252802%252901693-5%26sid%3Dliteratum%253Aachs%26aulast%3DAvkiran%26aufirst%3DM.%26aulast%3DMarber%26aufirst%3DM.%2BS.%26atitle%3DNa%252B%252FH%252B%2520exchange%2520inhibitors%2520for%2520cardioprotective%2520therapy%253A%2520progress%252C%2520problems%2520and%2520prospects%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2002%26volume%3D39%26spage%3D747%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Engelhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klambt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of Na<sup>+</sup>–H<sup>+</sup> exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=814-819&author=S.+Engelhardtauthor=L.+Heinauthor=U.+Kellerauthor=K.+Klambtauthor=M.+J.+Lohse&title=Inhibition+of+Na%2B%E2%80%93H%2B+exchange+prevents+hypertrophy%2C+fibrosis%2C+and+heart+failure+in+beta%281%29-adrenergic+receptor+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DS.%26aulast%3DHein%26aufirst%3DL.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DKlambt%26aufirst%3DK.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520Na%252B%25E2%2580%2593H%252B%2520exchange%2520prevents%2520hypertrophy%252C%2520fibrosis%252C%2520and%2520heart%2520failure%2520in%2520beta%25281%2529-adrenergic%2520receptor%2520transgenic%2520mice%26jtitle%3DCirc.%2520Res.%26date%3D2001%26volume%3D19%26spage%3D814%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gumina, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buerger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eickmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daemmgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span> </span><span class="NLM_article-title">Inhibition of the Na<sup>–</sup>/H<sup>–</sup> exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2519</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1999&pages=2519-2526&author=R.+J.+Guminaauthor=E.+Buergerauthor=C.+Eickmeierauthor=J.+Mooreauthor=J.+Daemmgenauthor=G.+J.+Gross&title=Inhibition+of+the+Na%E2%80%93%2FH%E2%80%93+exchanger+confers+greater+cardioprotection+against+90+minutes+of+myocardial+ischemia+than+ischemic+preconditioning+in+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGumina%26aufirst%3DR.%2BJ.%26aulast%3DBuerger%26aufirst%3DE.%26aulast%3DEickmeier%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DDaemmgen%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520Na%25E2%2580%2593%252FH%25E2%2580%2593%2520exchanger%2520confers%2520greater%2520cardioprotection%2520against%252090%2520minutes%2520of%2520myocardial%2520ischemia%2520than%2520ischemic%2520preconditioning%2520in%2520dogs%26jtitle%3DCirculation%26date%3D1999%26volume%3D100%26spage%3D2519%26epage%3D2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Camillión de Hurtado, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portiansky, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebolledo, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cingolani, H. E.</span><span> </span><span class="NLM_article-title">Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na<sup>+</sup>/H<sup>+</sup>-exchanger</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=862-868&issue=4&author=M.+C.+Camilli%C3%B3n+de+Hurtadoauthor=E.+L.+Portianskyauthor=N.+G.+Perezauthor=O.+R.+Rebolledoauthor=H.+E.+Cingolani&title=Regression+of+cardiomyocyte+hypertrophy+in+SHR+following+chronic+inhibition+of+the+Na%2B%2FH%2B-exchanger"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamilli%25C3%25B3n%2Bde%2BHurtado%26aufirst%3DM.%2BC.%26aulast%3DPortiansky%26aufirst%3DE.%2BL.%26aulast%3DPerez%26aufirst%3DN.%2BG.%26aulast%3DRebolledo%26aufirst%3DO.%2BR.%26aulast%3DCingolani%26aufirst%3DH.%2BE.%26atitle%3DRegression%2520of%2520cardiomyocyte%2520hypertrophy%2520in%2520SHR%2520following%2520chronic%2520inhibition%2520of%2520the%2520Na%252B%252FH%252B-exchanger%26jtitle%3DCardiovasc.%2520Res.%26date%3D2002%26volume%3D53%26issue%3D4%26spage%3D862%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Can, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmazyn, M.</span><span> </span><span class="NLM_article-title">Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">H381</span><span class="NLM_x">–</span> <span class="NLM_lpage">H387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=H381-H387&issue=1&author=L.+Chenauthor=C.+X.+Chenauthor=X.+T.+Canauthor=N.+Beierauthor=W.+Scholzauthor=M.+Karmazyn&title=Inhibition+and+reversal+of+myocardial+infarction-induced+hypertrophy+and+heart+failure+by+NHE-1+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%2BX.%26aulast%3DCan%26aufirst%3DX.%2BT.%26aulast%3DBeier%26aufirst%3DN.%26aulast%3DScholz%26aufirst%3DW.%26aulast%3DKarmazyn%26aufirst%3DM.%26atitle%3DInhibition%2520and%2520reversal%2520of%2520myocardial%2520infarction-induced%2520hypertrophy%2520and%2520heart%2520failure%2520by%2520NHE-1%2520inhibition%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2004%26volume%3D286%26issue%3D1%26spage%3DH381%26epage%3DH387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">Chronic inhibition of Na<sup>+</sup>/H<sup>+</sup>-exchanger attenuates cardiac hypertrophy and prevents cellular remodelling in heart failure</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=83-92&issue=1&author=A.+Baartscheerauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=Chronic+inhibition+of+Na%2B%2FH%2B-exchanger+attenuates+cardiac+hypertrophy+and+prevents+cellular+remodelling+in+heart+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3DChronic%2520inhibition%2520of%2520Na%252B%252FH%252B-exchanger%2520attenuates%2520cardiac%2520hypertrophy%2520and%2520prevents%2520cellular%2520remodelling%2520in%2520heart%2520failure%26jtitle%3DCardiovasc.%2520Res.%26date%3D2005%26volume%3D65%26issue%3D1%26spage%3D83%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chahine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bkaily, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Khoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, W..</span><span> </span><span class="NLM_article-title">NHE-1-dependent intracellular sodium overload in hypertrophic hereditary cardiomyopathy: prevention by NHE-1 inhibitor</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2Fj.yjmcc.2005.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=15808834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivF2ju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=571-582&issue=4&author=M.+Chahineauthor=G.+Bkailyauthor=M.+Naderauthor=J.+Al-Khouryauthor=D.+Jacquesauthor=N.+Beierauthor=W..+Scholz&title=NHE-1-dependent+intracellular+sodium+overload+in+hypertrophic+hereditary+cardiomyopathy%3A+prevention+by+NHE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">NHE-1-dependent intracellular sodium overload in hypertrophic hereditary cardiomyopathy and prevention by NHE-1 inhibitor</span></div><div class="casAuthors">Chahine, Mirna; Bkaily, Ghassan; Nader, Moni; Al-Khoury, Johny; Jacques, Danielle; Beier, Norbert; Scholz, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">571-582</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was to verify whether myocardial intracellular Na+ overload may take place in the hereditary cardiomyopathic hamster (CMH), as a result of an increased activity of the Na+-H+ exchanger isoform-1 (NHE-1).  Our results showed that simultaneous intracellular Na+ and Ca2+ overloads as well as an increase of NHE-1 protein level took place during the development of necrosis and hypertrophy in the CMH.  Treatment of 30-day-old CMHs during the development of necrosis and in the absence of hypertrophy with the specific NHE-1 inhibitor EMD87580 (EMD) for 50 days significantly prevented the increase of NHE-1 protein level and intracellular Na+ and Ca2+ overloads as well as necrosis.  Treatment of CMHs during the development of hypertrophy with EMD for 198 days prevented the development of both necrosis and hypertrophy.  In conclusion, our results suggest that NHE-1 overexpression as well as Na+ and Ca2+ overloads do take place during the development of necrosis and hypertrophy in hereditary CMHs.  Moreover, our results suggest that the blockade of NHE-1 by EMD87580 prevents these diseases by preventing the increase of Na+ influx through the NHE-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmpQ7ZAz-FrVg90H21EOLACvtfcHk0lhZAN9OwDtiWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivF2ju78%253D&md5=a064d1a21c6c2270468586fc42521fd8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2005.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2005.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DChahine%26aufirst%3DM.%26aulast%3DBkaily%26aufirst%3DG.%26aulast%3DNader%26aufirst%3DM.%26aulast%3DAl-Khoury%26aufirst%3DJ.%26aulast%3DJacques%26aufirst%3DD.%26aulast%3DBeier%26aufirst%3DN.%26aulast%3DScholz%26aufirst%3DW..%26atitle%3DNHE-1-dependent%2520intracellular%2520sodium%2520overload%2520in%2520hypertrophic%2520hereditary%2520cardiomyopathy%253A%2520prevention%2520by%2520NHE-1%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2005%26volume%3D38%26issue%3D4%26spage%3D571%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Baartscheer, A.</span><span> </span><span class="NLM_article-title">Chronic inhibition of the Na<sup>+</sup>/H<sup>+</sup>-exchanger in the heart</span> <span class="citation_source-journal">Curr. Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.2174%2F157016106775203117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=16472174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=23-29&issue=1&author=A.+Baartscheer&title=Chronic+inhibition+of+the+Na%2B%2FH%2B-exchanger+in+the+heart"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic inhibition of Na+/H+-exchanger in the heart</span></div><div class="casAuthors">Baartscheer, Antonius</div><div class="citationInfo"><span class="NLM_cas:title">Current Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">CVPUAY</span>;
        ISSN:<span class="NLM_cas:issn">1570-1611</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The incidence and prevalence of heart failure (HF) has increased over the last decades.  The main reasons for this increase are the ageing population and an increase in survival rate after myocardial infarction and other cardiovascular diseases.  Although, pharmacotherapy has significantly improved survival, the prognosis of HF is still rather poor.  Total mortality is high and approx. half of the deaths are sudden and unexpected.  Angiotensin-converting-enzyme (ACE)-inhibitors generally given with diuretic and digoxin are the std. treatment for patients with HF.  Despite the established benefits of ACE-inhibitors there is a need for new pharmacol. tools for the treatment of HF.  Recent exptl. evidence has shown that activity of the Na+/H+-exchanger in the heart (NHE-1) is increased in HF.  Because NHE-1 exchanges intracellular H+ for extracellular Na+ in a one by one stoichiometry, the intracellular ionic changes resulting from increased activity, will be a increased pHi and intracellular sodium ([Na+]i).  Activation of NHE-1 results only in a small increase in pHi, under physiol. conditions where bicarbonate-dependent mechanisms are active.  However, a considerable increase in [Na+]i was always present.  The elevation of [Na+]i might be responsible for the increase of intracellular calcium ([Ca2+]i) levels mediated by the Na+/Ca2+-exchanger (NCX).  Increases in [Na+]i, pHi and [Ca2+]i, features of cardiac myocytes isolated from failing hearts, are recognized as a cell growth signal And thus may play a role in the hypertrophic response, cellular remodeling and finally the development of HF.  Acute application of cariporide, an inhibitor of NHE-1, on failing myocytes not only normalized [Na+]i but also cytoplasmic and sarcoplasmic reticulum calcium handling and the propensity to develop delayed after depolarizations (DAD's).  In several animal models of HF it has been shown the chronic inhibition of NHE-1 attenuates the development of hypertrophy and whole heart remodeling.  Recently, in a vol. and pressure overload model of HF in rabbits it has been demonstrated that chronic treatment also prevents the development of HF and cellular ionic and electrophysiol. remodeling.  Therefore, chronic treatment with an inhibitor of NHE-1 might prove beneficial in patients at risk of developing HF, esp. when given at an early stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTF9ZhIacbbVg90H21EOLACvtfcHk0lhZAN9OwDtiWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGhtw%253D%253D&md5=aafde0cf7aaeddf12da1e9a12ca14a73</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F157016106775203117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016106775203117%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26atitle%3DChronic%2520inhibition%2520of%2520the%2520Na%252B%252FH%252B-exchanger%2520in%2520the%2520heart%26jtitle%3DCurr.%2520Vasc.%2520Pharmacol.%26date%3D2006%26volume%3D4%26issue%3D1%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardziyenka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Borren, M. M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkerk, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">Chronic inhibition of the Na<sup>+</sup>/H<sup>+</sup> exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1038%2Fbjp.2008.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=18493245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1266-1275&issue=6&author=A.+Baartscheerauthor=M.+Hardziyenkaauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=M.+M.+G.+J.+van+Borrenauthor=A.+O.+Verkerkauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=Chronic+inhibition+of+the+Na%2B%2FH%2B+exchanger+causes+regression+of+hypertrophy%2C+heart+failure%2C+and+ionic+and+electrophysiological+remodelling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic inhibition of the Na+/H+-exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling</span></div><div class="casAuthors">Baartscheer, A.; Hardziyenka, M.; Schumacher, C. A.; Belterman, C. N. W.; van Borren, M. M. G. J.; Verkerk, A. O.; Coronel, R.; Fiolet, J. W. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1266-1275</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Increased activity of the Na+/H+-exchanger (NHE-1) in heart failure underlies raised [Na+]i causing disturbances of calcium handling.  Inhibition of NHE-1, initiated at the onset of pressure/vol. overload, prevents development of hypertrophy, heart failure and remodelling.  We hypothesized that chronic inhibition of NHE-1, initiated at a later stage, would induce regression of hypertrophy, heart failure, and ionic and electrophysiol. remodelling.  Exptl. approach: Development of heart failure in rabbits was monitored electrocardiog. and echocardiog., after one or three months.  Cardiac myocytes were also isolated.  One group of animals were treated with cariporide (inhibitor of NHE-1) in the diet after one month.  Cytoplasmic calcium, sodium and action potentials were measured with fluorescent markers and sarcoplasmic reticulum calcium content by rapid cooling.  Calcium after-transients were elicited after rapid pacing.  Sodium channel current (INa) was measured using patch-clamp techniques.  Key results: Hypertrophy and heart failure developed after one month and progressed during the next two months.  After one month, dietary treatment with cariporide was initiated.  Two months of treatment reduced hypertrophy and heart failure, duration of action potential QT-interval and QRS, and restored sodium and calcium handling and the incidence of calcium after-transients.  In cardiac myocytes, parameters of INa were not changed by cariporide.  Conclusion and implications: In rabbit hearts with hypertrophy and signs of heart failure one month after induction of pressure/vol. overload, two months of dietary treatment with the NHE-1 inhibitor cariporide caused regression of hypertrophy, heart failure and ionic and electrophysiol. remodelling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKUQOxvIBuRrVg90H21EOLACvtfcHk0li4Qhb618VGVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCjtLw%253D&md5=1a6d78ffa2adc9db4f63a1f54a702f5d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.189%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DHardziyenka%26aufirst%3DM.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3Dvan%2BBorren%26aufirst%3DM.%2BM.%2BG.%2BJ.%26aulast%3DVerkerk%26aufirst%3DA.%2BO.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3DChronic%2520inhibition%2520of%2520the%2520Na%252B%252FH%252B%2520exchanger%2520causes%2520regression%2520of%2520hypertrophy%252C%2520heart%2520failure%252C%2520and%2520ionic%2520and%2520electrophysiological%2520remodelling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26issue%3D6%26spage%3D1266%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mraiche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmazyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fliegel, L.</span><span> </span><span class="NLM_article-title">Activated NHE1 is required to induce early cardiac hypertrophy in mice</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1007%2Fs00395-011-0161-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=21359875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2011&pages=603-616&author=F.+Mraicheauthor=T.+Okaauthor=X.+T.+Ganauthor=M.+Karmazynauthor=L.+Fliegel&title=Activated+NHE1+is+required+to+induce+early+cardiac+hypertrophy+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activated NHE1 is required to induce early cardiac hypertrophy in mice</span></div><div class="casAuthors">Mraiche, Fatima; Oka, Tatsujiro; Gan, Xiaohong T.; Karmazyn, Morris; Fliegel, Larry</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-616</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The Na+/H+ exchanger isoform 1 (NHE1) has been implicated as being causal in cardiac hypertrophy and the protein level and activity are elevated in the diseased myocardium.  However, it is unclear whether mere elevation of the protein is sufficient for cardiac pathol., or whether activation of the protein is required.  In this study, we examd. the comparative effects of elevation of wild type and activated NHE1.  Two mouse transgenic models that expressed either a wild type NHE1 protein or an activated NHE1 protein were characterized.  Expression of activated NHE1 caused significant increases in heart wt. to body wt., apoptosis, cross-sectional area, interstitial fibrosis and decreased cardiac performance.  Expression of wild type NHE1 caused a much milder pathol.  When we examd. 2 or 10-wk-old mouse hearts, there was neither elevation of calcineurin levels nor increased phosphorylation of ERK or p38 in either NHE1 transgenic mouse line.  Expression of activated NHE1 in intact mice caused an increased sensitivity to phenylephrine-induced hypertrophy.  Our results show that expression of activated NHE1 promotes cardiac hypertrophy to a much greater degree than elevated levels of wild type NHE1 alone.  In addn., expression of activated NHE1 promotes greater sensitivity to neurohormonal stimulation.  The results suggest that activation of NHE1 is a key component that accentuates NHE1-induced myocardial pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra0p9akEQtbbVg90H21EOLACvtfcHk0li4Qhb618VGVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVaitr4%253D&md5=bea6accf5067d82005259f0adaf017c5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00395-011-0161-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-011-0161-4%26sid%3Dliteratum%253Aachs%26aulast%3DMraiche%26aufirst%3DF.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DGan%26aufirst%3DX.%2BT.%26aulast%3DKarmazyn%26aufirst%3DM.%26aulast%3DFliegel%26aufirst%3DL.%26atitle%3DActivated%2520NHE1%2520is%2520required%2520to%2520induce%2520early%2520cardiac%2520hypertrophy%2520in%2520mice%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2011%26volume%3D106%26spage%3D603%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Touret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanneur, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godart, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dammgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Counillon, L.</span><span> </span><span class="NLM_article-title">Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x"> (</span><span class="NLM_issue">2–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0014-2999%2802%2902824-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=12524140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVer" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2003&pages=151-158&issue=2%E2%80%933&author=N.+Touretauthor=V.+Tanneurauthor=H.+Godartauthor=R.+Seidlerauthor=N.+Takiauthor=E.+Burgerauthor=J.+Dammgenauthor=L.+Counillon&title=Characterization+of+sabiporide%2C+a+new+specific+NHE-1+inhibitor+exhibiting+slow+dissociation+kinetics+and+cardioprotective+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects</span></div><div class="casAuthors">Touret, Nicolas; Tanneur, Valerie; Godart, Helene; Seidler, Randolph; Taki, Naoyuki; Burger, Erich; Dammgen, Jurgen; Counillon, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Sabiporide, a new benzoguanidine, was characterized on fibroblasts stably expressing the Na+/H+ exchanger isoforms NHE-1, NHE-2 and NHE-3. 2.  22Na+ uptake expts. show that this compd. possesses a Ki of 5 ± 1.2 x 10-8 M for NHE-1, and discriminates efficiently between the NHE-1, -2 and -3 isoforms (K for NHE-2: 3 ± 0.9 x 10-6 M, and K >1 mM for NHE-3).  Similar Ki values are obtained on rat cardiomyocytes and human platelets expressing NHE-1 (Ki's of 7 ± 1 × 10-9 and 2.7 ± 0.4 × 10-8 M resp.).  Interestingly, when compared with amiloride and cariporide, sabiporide inhibition persists even after this mol. had been rinsed out (half time of 7 h for sabiporide, and of 1 and 2.5 min for amiloride and cariporide, resp.), the decay of all these mols. exhibiting a complex multiexponential behavior.  Thus, sabiporide, which possesses remarkable cardioprotective properties, is a specific NHE-1 inhibitor possessing unique binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2_rkDHJTJcrVg90H21EOLACvtfcHk0li4Qhb618VGVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVer&md5=9f3eb7cc5d0996fca429174f2b3e4a18</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902824-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902824-8%26sid%3Dliteratum%253Aachs%26aulast%3DTouret%26aufirst%3DN.%26aulast%3DTanneur%26aufirst%3DV.%26aulast%3DGodart%26aufirst%3DH.%26aulast%3DSeidler%26aufirst%3DR.%26aulast%3DTaki%26aufirst%3DN.%26aulast%3DBurger%26aufirst%3DE.%26aulast%3DDammgen%26aufirst%3DJ.%26aulast%3DCounillon%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520sabiporide%252C%2520a%2520new%2520specific%2520NHE-1%2520inhibitor%2520exhibiting%2520slow%2520dissociation%2520kinetics%2520and%2520cardioprotective%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D459%26issue%3D2%25E2%2580%25933%26spage%3D151%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Knight, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacAndrew, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellery, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marala, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, R.t.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, W. R.</span><span> </span><span class="NLM_article-title">A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11259552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2001&pages=254-259&issue=1&author=D.+R.+Knightauthor=A.+H.+Smithauthor=D.+M.+Flynnauthor=J.+T.+MacAndrewauthor=S.+S.+Elleryauthor=J.+X.+Kongauthor=R.+B.+Maralaauthor=R.t.+Westerauthor=A.+Guzman-Perezauthor=R.+J.+Hillauthor=W.+P.+Mageeauthor=W.+R.+Tracey&title=A+novel+sodium-hydrogen+exchanger+isoform-1+inhibitor%2C+zoniporide%2C+reduces+ischemic+myocardial+injury+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo</span></div><div class="casAuthors">Knight, Delvin R.; Smith, Andrew H.; Flynn, David M.; Macandrew, Joseph T.; Ellery, Suzanne S.; Kong, Jimmy X.; Marala, Ravi B.; Wester, Ronald T.; Guzman-Perez, Angel; Hill, Roger J.; Magee, William P.; Tracey, W. Ross</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">254-259</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The cardioprotective efficacy of zoniporide (CP-597,396), a novel, potent, and selective inhibitor of the sodium-hydrogen exchanger isoform 1 (NHE-1), was evaluated both in vitro and in vivo using rabbit models of myocardial ischemia-reperfusion injury.  In these models, myocardial injury was elicited with 30 min of regional ischemia and 120 min of reperfusion.  Zoniporide elicited a concn.-dependent redn. in infarct size (EC50 of 0.25 nM) in the isolated heart (Langendorff) and reduced infarct size by 83% (50 nM).  This compd. was 2.5- to 20-fold more potent than either eniporide or cariporide (EC50 of 0.69 and 5.11 nM, resp.), and reduced infarct size to a greater extent than eniporide (58% redn. in infarct size).  In open-chest, anesthetized rabbits, zoniporide also elicited a dose-dependent redn. in infarct size (ED50 of 0.45 mg/kg/h) and inhibited NHE-1-mediated platelet swelling (max. inhibition 93%).  Furthermore, zoniporide did not cause any in vivo hemodynamic (mean arterial pressure, heart rate, rate pressure product) changes.  Zoniporide represents a novel class of potent NHE-1 inhibitors with potential utility for providing clin. cardioprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2jLqF30VgvbVg90H21EOLACvtfcHk0lipsKd36LydOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVSrsbk%253D&md5=2cdde108aa2640c1617a21e4e2ac3b2a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DD.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BH.%26aulast%3DFlynn%26aufirst%3DD.%2BM.%26aulast%3DMacAndrew%26aufirst%3DJ.%2BT.%26aulast%3DEllery%26aufirst%3DS.%2BS.%26aulast%3DKong%26aufirst%3DJ.%2BX.%26aulast%3DMarala%26aufirst%3DR.%2BB.%26aulast%3DWester%26aufirst%3DR.t.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DMagee%26aufirst%3DW.%2BP.%26aulast%3DTracey%26aufirst%3DW.%2BR.%26atitle%3DA%2520novel%2520sodium-hydrogen%2520exchanger%2520isoform-1%2520inhibitor%252C%2520zoniporide%252C%2520reduces%2520ischemic%2520myocardial%2520injury%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D297%26issue%3D1%26spage%3D254%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scholz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albus, U.</span><span> </span><span class="NLM_article-title">Development of the Na<sup>+</sup>/H<sup>+</sup> exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial</span> <span class="citation_source-journal">J. Thromb. Thrombolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1023%2FA%3A1008998716063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=10481216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFOrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=61-69&issue=1&author=W.+Scholzauthor=A.+Jesselauthor=U.+Albus&title=Development+of+the+Na%2B%2FH%2B+exchange+inhibitor+cariporide+as+a+cardioprotective+drug%3A+from+the+laboratory+to+the+GUARDIAN+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial</span></div><div class="casAuthors">Scholz, Wolfgang; Jessel, Andreas; Albus, Udo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 27 refs. on the development of cariporide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpe6RKfrF3wrVg90H21EOLACvtfcHk0lipsKd36LydOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFOrsL8%253D&md5=21a44f58482116bf0ec25928a0fac0d7</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008998716063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008998716063%26sid%3Dliteratum%253Aachs%26aulast%3DScholz%26aufirst%3DW.%26aulast%3DJessel%26aufirst%3DA.%26aulast%3DAlbus%26aufirst%3DU.%26atitle%3DDevelopment%2520of%2520the%2520Na%252B%252FH%252B%2520exchange%2520inhibitor%2520cariporide%2520as%2520a%2520cardioprotective%2520drug%253A%2520from%2520the%2520laboratory%2520to%2520the%2520GUARDIAN%2520trial%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D1999%26volume%3D8%26issue%3D1%26spage%3D61%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karmazyn, M.</span><span> </span><span class="NLM_article-title">Pharmacology and clinical assessment of cariporide for the treatment of coronary artery diseases</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1099</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1099-1108&issue=5&author=M.+Karmazyn&title=Pharmacology+and+clinical+assessment+of+cariporide+for+the+treatment+of+coronary+artery+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarmazyn%26aufirst%3DM.%26atitle%3DPharmacology%2520and%2520clinical%2520assessment%2520of%2520cariporide%2520for%2520the%2520treatment%2520of%2520coronary%2520artery%2520diseases%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26issue%3D5%26spage%3D1099%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yeshmina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marban, E.</span><span> </span><span class="NLM_article-title">Cariporide (HOE642), a selective Na<sup>+</sup>–H<sup>+</sup> exchange inhibitor, inhibits the mitochondrial death pathway</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">2275</span><span class="NLM_x">–</span> <span class="NLM_lpage">2281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2003&pages=2275-2281&author=T.+Yeshminaauthor=M.+Akaoauthor=S.+P.+Jonesauthor=E.+Marban&title=Cariporide+%28HOE642%29%2C+a+selective+Na%2B%E2%80%93H%2B+exchange+inhibitor%2C+inhibits+the+mitochondrial+death+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYeshmina%26aufirst%3DT.%26aulast%3DAkao%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BP.%26aulast%3DMarban%26aufirst%3DE.%26atitle%3DCariporide%2520%2528HOE642%2529%252C%2520a%2520selective%2520Na%252B%25E2%2580%2593H%252B%2520exchange%2520inhibitor%252C%2520inhibits%2520the%2520mitochondrial%2520death%2520pathway%26jtitle%3DCirculation%26date%3D2003%26volume%3D108%26spage%3D2275%26epage%3D2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zeymer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryapranata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monassier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opolski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmanis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linssen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebbe, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machnig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhaus, K. L.</span><span> </span><span class="NLM_article-title">The Na<sup>+</sup>/H<sup>+</sup> exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1644</span><span class="NLM_x">–</span> <span class="NLM_lpage">1650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0735-1097%2801%2901608-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11704395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVyhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1644-1650&author=U.+Zeymerauthor=H.+Suryapranataauthor=J.+P.+Monassierauthor=G.+Opolskiauthor=J.+Daviesauthor=G.+Rasmanisauthor=G.+Linssenauthor=U.+Tebbeauthor=R.+Schroderauthor=R.+Tiemannauthor=T.+Machnigauthor=K.+L.+Neuhaus&title=The+Na%2B%2FH%2B+exchange+inhibitor+eniporide+as+an+adjunct+to+early+reperfusion+therapy+for+acute+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial</span></div><div class="casAuthors">Zeymer, Uwe; Suryapranata, Harry; Monassier, Jean Pierre; Opolski, Grzegorz; Davies, John; Rasmanis, Gundars; Linssen, Gerard; Tebbe, Ulrich; Schroder, Rolf; Tiemann, Rolf; Machnig, Thomas; Neuhaus, Karl-Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1644-1650</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We conducted an international, prospective, randomized, double-blind, placebo-controlled phase 2 trial in patients undergoing thrombolytic therapy or primary angioplasty for acute ST-elevation myocardial infarction (MI) to investigate the effect of eniporide on infarct size and clin. outcome.  Exptl. studies suggest that the activity of the Na+/H+ exchange (NHE) plays an important role in the unfavorable sequels of myocardial ischemia and reperfusion.  Eniporide specifically inhibits the NHE-1 isoform and has been shown to limit infarct size in exptl. models.  The primary efficacy end point was the infarct size measured by the cumulative release of alpha-hydroxybutyrate dehydrogenase (alpha-HDBH) (area under the curve [AUC] 0 to 72 h).  In stage 1, 50, 100, 150 or 200 mg eniporide given as a 10-min infusion before start of reperfusion therapy were compared with placebo in 430 patients, and in stage 2, 100 and 150 mg eniporide were compared with placebo in 959 patients.  In stage 1, the administration of 100 mg and 150 mg eniporide resulted in smaller infarct sizes (mean alpha-HBDH AUC in U/mL × h, placebo: 44.2, 100 mg eniporide: 40.2, 150 mg eniporide: 33.9), esp. in the angioplasty group.  In contrast, in stage 2 there was no difference in the enzymic infarct size between the three groups (placebo: 41.2, 100 mg eniporide: 43.0, 150 mg eniporide: 41.5).  Overall there was no effect of eniporide on clin. outcome (death, cardiogenic shock, heart failure, life-threatening arrhythmias).  However, there was a significant redn. of the incidence of heart failure in patients reperfused late (>4 h).  In this large study administration of the NHE-1 inhibitor eniporide, before reperfusion therapy in patients with acute ST elevation MI, did not limit infarct size or improve clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhuAOlR56VaLVg90H21EOLACvtfcHk0lipsKd36LydOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVyhtbk%253D&md5=a53736cb6dd567f09dd30726b1cf335e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0735-1097%2801%2901608-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0735-1097%252801%252901608-4%26sid%3Dliteratum%253Aachs%26aulast%3DZeymer%26aufirst%3DU.%26aulast%3DSuryapranata%26aufirst%3DH.%26aulast%3DMonassier%26aufirst%3DJ.%2BP.%26aulast%3DOpolski%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DRasmanis%26aufirst%3DG.%26aulast%3DLinssen%26aufirst%3DG.%26aulast%3DTebbe%26aufirst%3DU.%26aulast%3DSchroder%26aufirst%3DR.%26aulast%3DTiemann%26aufirst%3DR.%26aulast%3DMachnig%26aufirst%3DT.%26aulast%3DNeuhaus%26aufirst%3DK.%2BL.%26atitle%3DThe%2520Na%252B%252FH%252B%2520exchange%2520inhibitor%2520eniporide%2520as%2520an%2520adjunct%2520to%2520early%2520reperfusion%2520therapy%2520for%2520acute%2520myocardial%2520infarction%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2001%26volume%3D38%26spage%3D1644%26epage%3D1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gumina, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buerger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eickmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daemmgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span> </span><span class="NLM_article-title">Na<sup>+</sup>/H<sup>+</sup> exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2000&pages=1563-1570&issue=4&author=R.+J.+Guminaauthor=J.+Auchampachauthor=R.+Wangauthor=E.+Buergerauthor=C.+Eickmeierauthor=J.+Mooreauthor=J.+Daemmgenauthor=G.+J.+Gross&title=Na%2B%2FH%2B+exchange+inhibition-induced+cardioprotection+in+dogs%3A+effects+on+neutrophils+versus+cardiomyocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGumina%26aufirst%3DR.%2BJ.%26aulast%3DAuchampach%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DBuerger%26aufirst%3DE.%26aulast%3DEickmeier%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DDaemmgen%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26atitle%3DNa%252B%252FH%252B%2520exchange%2520inhibition-induced%2520cardioprotection%2520in%2520dogs%253A%2520effects%2520on%2520neutrophils%2520versus%2520cardiomyocytes%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2000%26volume%3D279%26issue%3D4%26spage%3D1563%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation reactions of five-membered aromatic heterocyclic rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&issue=3&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+reactions+of+five-membered+aromatic+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0lgbpqjJkZgXtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520reactions%2520of%2520five-membered%2520aromatic%2520heterocyclic%2520rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26issue%3D3%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lgbpqjJkZgXtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mukaiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saigo, K.</span><span> </span><span class="NLM_article-title">A convenient method for the synthesis of carboxylic esters</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&pages=1045-1048&author=T.+Mukaiyamaauthor=M.+Usuiauthor=E.+Shimadaauthor=K.+Saigo&title=A+convenient+method+for+the+synthesis+of+carboxylic+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukaiyama%26aufirst%3DT.%26aulast%3DUsui%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DE.%26aulast%3DSaigo%26aufirst%3DK.%26atitle%3DA%2520convenient%2520method%2520for%2520the%2520synthesis%2520of%2520carboxylic%2520esters%26jtitle%3DChem.%2520Lett.%26date%3D1975%26spage%3D1045%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Saigo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, T.</span><span> </span><span class="NLM_article-title">New method for the preparation of carboxylic esters</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1977&pages=1863-1866&author=K.+Saigoauthor=M.+Usuiauthor=K.+Kikuchiauthor=E.+Shimadaauthor=T.+Mukaiyama&title=New+method+for+the+preparation+of+carboxylic+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaigo%26aufirst%3DK.%26aulast%3DUsui%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DE.%26aulast%3DMukaiyama%26aufirst%3DT.%26atitle%3DNew%2520method%2520for%2520the%2520preparation%2520of%2520carboxylic%2520esters%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1977%26volume%3D50%26spage%3D1863%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saigo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama., T.</span><span> </span><span class="NLM_article-title">A facile synthesis of carboxamides by using 1-methyl-2-halo pyridinium iodides as coupling reagents</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&pages=1163-1166&author=E.+Baldauthor=K.+Saigoauthor=T.+Mukaiyama.&title=A+facile+synthesis+of+carboxamides+by+using+1-methyl-2-halo+pyridinium+iodides+as+coupling+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBald%26aufirst%3DE.%26aulast%3DSaigo%26aufirst%3DK.%26aulast%3DMukaiyama.%26aufirst%3DT.%26atitle%3DA%2520facile%2520synthesis%2520of%2520carboxamides%2520by%2520using%25201-methyl-2-halo%2520pyridinium%2520iodides%2520as%2520coupling%2520reagents%26jtitle%3DChem.%2520Lett.%26date%3D1975%26spage%3D1163%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Baumgarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gericke, R.</span><span> </span><span class="NLM_article-title">(2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na<sup>+</sup>/H<sup>+</sup> antiporter Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2017</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960768n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2017-2034&author=M.+Baumgarthauthor=N.+Beierauthor=R.+Gericke&title=%282-Methyl-5-%28methylsulfonyl%29benzoyl%29guanidine+Na%2B%2FH%2B+antiporter+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm960768n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960768n%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgarth%26aufirst%3DM.%26aulast%3DBeier%26aufirst%3DN.%26aulast%3DGericke%26aufirst%3DR.%26atitle%3D%25282-Methyl-5-%2528methylsulfonyl%2529benzoyl%2529guanidine%2520Na%252B%252FH%252B%2520antiporter%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2017%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahmad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarco, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorso, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span> </span><span class="NLM_article-title">Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3302</span><span class="NLM_x">–</span> <span class="NLM_lpage">3310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010100v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3302-3310&author=S.+Ahmadauthor=L.+M.+Doweykoauthor=S.+Dugarauthor=N.+Grazierauthor=K.+Nguauthor=S.+C.+Wuauthor=K.+J.+Yostauthor=B.-C.+Chenauthor=J.+Z.+Gougoutasauthor=J.+D.+DiMarcoauthor=S.-J.+Lanauthor=B.+J.+Gavinauthor=A.+J.+Chenauthor=C.+R.+Dorsoauthor=R.+Serafinoauthor=M.+Kirbyauthor=K.+S.+Atwal&title=Arylcyclopropanecarboxyl+guanidines+as+novel%2C+potent%2C+and+selective+inhibitors+of+the+sodium+hydrogen+exchanger+isoform-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fjm010100v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010100v%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DL.%2BM.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DGrazier%26aufirst%3DN.%26aulast%3DNgu%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DS.%2BC.%26aulast%3DYost%26aufirst%3DK.%2BJ.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DLan%26aufirst%3DS.-J.%26aulast%3DGavin%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DA.%2BJ.%26aulast%3DDorso%26aufirst%3DC.%2BR.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DArylcyclopropanecarboxyl%2520guanidines%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitors%2520of%2520the%2520sodium%2520hydrogen%2520exchanger%2520isoform-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3302%26epage%3D3310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ahmad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen., B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective, and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=177-180&author=S.+Ahmadauthor=K.+Nguauthor=D.+W.+Combsauthor=S.+C.+Wuauthor=S.+D.+Weinsteinauthor=W.+Liuauthor=B.-C.+Chen.author=G.+Chandrasenaauthor=C.+Dorsoauthor=M.+Kirbyauthor=K.+S.+Atwal&title=Aminoimidazoles+as+bioisosteres+of+acylguanidines%3A+novel%2C+potent%2C+selective%2C+and+orally+bioavailable+inhibitors+of+the+sodium+hydrogen+exchanger+isoform-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DNgu%26aufirst%3DK.%26aulast%3DCombs%26aufirst%3DD.%2BW.%26aulast%3DWu%26aufirst%3DS.%2BC.%26aulast%3DWeinstein%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen.%26aufirst%3DB.-C.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DDorso%26aufirst%3DC.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DAminoimidazoles%2520as%2520bioisosteres%2520of%2520acylguanidines%253A%2520novel%252C%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520sodium%2520hydrogen%2520exchanger%2520isoform-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D177%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorso, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1<i>H</i>-imidazol-4-yl)piperidin-1-yl)pyrimidine analogues as potent, highly selective, and orally bioavailable NHE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4796</span><span class="NLM_x">–</span> <span class="NLM_lpage">4799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4796-4799&author=K.+S.+Atwalauthor=S.+V.+O%E2%80%99Neilauthor=S.+Ahmadauthor=L.+Doweykoauthor=M.+Kirbyauthor=C.+R.+Dorsoauthor=G.+Chandrasenaauthor=B.-C.+Chenauthor=R.+Zhaoauthor=R.+Zahler&title=Synthesis+and+biological+activity+of+5-aryl-4-%284-%285-methyl-1H-imidazol-4-yl%29piperidin-1-yl%29pyrimidine+analogues+as+potent%2C+highly+selective%2C+and+orally+bioavailable+NHE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DDorso%26aufirst%3DC.%2BR.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DZahler%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%25205-aryl-4-%25284-%25285-methyl-1H-imidazol-4-yl%2529piperidin-1-yl%2529pyrimidine%2520analogues%2520as%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520bioavailable%2520NHE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4796%26epage%3D4799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, B. S.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-heteroaryl-2-amino-5-methylimidazole analogs as NHE-1 inhibitors</span> <span class="citation_source-journal">Bull. Korean Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2621</span><span class="NLM_x">–</span> <span class="NLM_lpage">2624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.5012%2Fbkcs.2009.30.11.2621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFylt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2621-2624&issue=11&author=S.+Leeauthor=K.+Yangauthor=B.+H.+Leeauthor=B.+S.+Yoon&title=Synthesis+and+biological+evaluation+of+4-heteroaryl-2-amino-5-methylimidazole+analogs+as+NHE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of 4-heteroaryl-2-amino-5-methylimidazole analogs as NHE-1 inhibitors</span></div><div class="casAuthors">Lee, Sunkyung; Yi, Kyu Yang; Lee, Byung Ho; Yoon, Boo Soon</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2621-2625</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">To identify a non-acylguanidine NHE-1 inhibitor, an acylguanidne group was replaced with an imidazole group in the potent sodium hydrogen exchanger type 1 (NHE-1) inhibitors with furan or benzothiophene core template, found from the authors' previous studies.  4-(2-Furyl)- and 4-(benzothienyl)-2-amino-5-methylimidazoles were synthesized and evaluated biol.  All these imidazoles presented potent NHE-1 inhibitory activity similar to the corresponding acylguanidines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJCqDe1fz7xbVg90H21EOLACvtfcHk0liSgcSS3sVFWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFylt7fE&md5=79fd3cbea24a5d0a71b8c83e8b61ba68</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2009.30.11.2621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2009.30.11.2621%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DYoon%26aufirst%3DB.%2BS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-heteroaryl-2-amino-5-methylimidazole%2520analogs%2520as%2520NHE-1%2520inhibitors%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2009%26volume%3D30%26issue%3D11%26spage%3D2621%26epage%3D2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span> </span><span class="NLM_article-title">Calculating partition coefficient by atom-additive method</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=47-66&author=R.+Wangauthor=Y.+Gaoauthor=L.+Lai&title=Calculating+partition+coefficient+by+atom-additive+method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DCalculating%2520partition%2520coefficient%2520by%2520atom-additive%2520method%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D19%26spage%3D47%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trigg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manners, C. N.</span><span> </span><span class="NLM_article-title">Development of a generalized, quantitative physicochemical model of CYP3A4 inhibition for use in early drug discovery</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=652-655&issue=5&author=R.+J.+Rileyauthor=A.+J.+Parkerauthor=S.+Triggauthor=C.+N.+Manners&title=Development+of+a+generalized%2C+quantitative+physicochemical+model+of+CYP3A4+inhibition+for+use+in+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BJ.%26aulast%3DTrigg%26aufirst%3DS.%26aulast%3DManners%26aufirst%3DC.%2BN.%26atitle%3DDevelopment%2520of%2520a%2520generalized%252C%2520quantitative%2520physicochemical%2520model%2520of%2520CYP3A4%2520inhibition%2520for%2520use%2520in%2520early%2520drug%2520discovery%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26issue%3D5%26spage%3D652%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Langendorff, O.</span><span> </span><span class="NLM_article-title">Geschichtliche Betrachtungen zur Methodedes überlebenden Warmblüterherzens. Muench</span> <span class="citation_source-journal">Med. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1903</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1903&pages=508-509&author=O.+Langendorff&title=Geschichtliche+Betrachtungen+zur+Methodedes+%C3%BCberlebenden+Warmbl%C3%BCterherzens.+Muench"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLangendorff%26aufirst%3DO.%26atitle%3DGeschichtliche%2520Betrachtungen%2520zur%2520Methodedes%2520%25C3%25BCberlebenden%2520Warmbl%25C3%25BCterherzens.%2520Muench%26jtitle%3DMed.%2520Wochenschr.%26date%3D1903%26volume%3D50%26spage%3D508%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zimmer, H.-G.</span><span> </span><span class="NLM_article-title">The isolated perfused heart and its pioneers</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11390791" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=203-210&author=H.-G.+Zimmer&title=The+isolated+perfused+heart+and+its+pioneers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DH.-G.%26atitle%3DThe%2520isolated%2520perfused%2520heart%2520and%2520its%2520pioneers%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1998%26volume%3D13%26spage%3D203%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Schmuck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickert, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merschky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudaczek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machon, U. A</span><span> </span><span class="NLM_article-title">Facile and Efficient Multi-Gram Synthesis of <i>N</i>-Protected 5-(Guanidinocarbonyl)-1<i>H</i>-pyrrole-2-carboxylic Acids</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=324-329&author=C.+Schmuckauthor=V.+Bickertauthor=M.+Merschkyauthor=L.+Geigerauthor=D.+Rupprechtauthor=J.+Dudaczekauthor=P.+Wichauthor=T.+Rehmauthor=U.+A+Machon&title=Facile+and+Efficient+Multi-Gram+Synthesis+of+N-Protected+5-%28Guanidinocarbonyl%29-1H-pyrrole-2-carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmuck%26aufirst%3DC.%26aulast%3DBickert%26aufirst%3DV.%26aulast%3DMerschky%26aufirst%3DM.%26aulast%3DGeiger%26aufirst%3DL.%26aulast%3DRupprecht%26aufirst%3DD.%26aulast%3DDudaczek%26aufirst%3DJ.%26aulast%3DWich%26aufirst%3DP.%26aulast%3DRehm%26aufirst%3DT.%26aulast%3DMachon%26aufirst%3DU.%2BA%26atitle%3DFacile%2520and%2520Efficient%2520Multi-Gram%2520Synthesis%2520of%2520N-Protected%25205-%2528Guanidinocarbonyl%2529-1H-pyrrole-2-carboxylic%2520Acids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26spage%3D324%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pérez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimeno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Fuente, M. R.</span><span> </span><span class="NLM_article-title">New H-bonded complexes and their supramolecular liquid-crystalline organizations</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=826-833&author=A.+P%C3%A9rezauthor=N.+Gimenoauthor=F.+Veraauthor=M.+B.+Rosauthor=J.+L.+Serranoauthor=M.+R.+De+la+Fuente&title=New+H-bonded+complexes+and+their+supramolecular+liquid-crystalline+organizations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DA.%26aulast%3DGimeno%26aufirst%3DN.%26aulast%3DVera%26aufirst%3DF.%26aulast%3DRos%26aufirst%3DM.%2BB.%26aulast%3DSerrano%26aufirst%3DJ.%2BL.%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DM.%2BR.%26atitle%3DNew%2520H-bonded%2520complexes%2520and%2520their%2520supramolecular%2520liquid-crystalline%2520organizations%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26spage%3D826%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span> </span><span class="NLM_article-title">Installation of the pyrrolyl-2-carboxyl pharmacophore by CouN1 and CouN7 in the late biosynthetic steps of the aminocoumarin antibiotics clorobiocin and coumermycin A1</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">8568</span><span class="NLM_x">–</span> <span class="NLM_lpage">8578</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi060784e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=8568-8578&author=S.+Garneau-Tsodikovaauthor=A.+Staponauthor=D.+Kahneauthor=C.+T.+Walsh&title=Installation+of+the+pyrrolyl-2-carboxyl+pharmacophore+by+CouN1+and+CouN7+in+the+late+biosynthetic+steps+of+the+aminocoumarin+antibiotics+clorobiocin+and+coumermycin+A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi060784e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060784e%26sid%3Dliteratum%253Aachs%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26aulast%3DStapon%26aufirst%3DA.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DInstallation%2520of%2520the%2520pyrrolyl-2-carboxyl%2520pharmacophore%2520by%2520CouN1%2520and%2520CouN7%2520in%2520the%2520late%2520biosynthetic%2520steps%2520of%2520the%2520aminocoumarin%2520antibiotics%2520clorobiocin%2520and%2520coumermycin%2520A1%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D8568%26epage%3D8578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kleeman, H.-W</span>; <span> </span><span class="NLM_article-title">Substituted benzoylguanidines, method for production and use thereof as medicament or diagnostic and medicament comprising the same</span>. World Patent Application WO 2006/050830,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.-W+Kleeman&title=Substituted+benzoylguanidines%2C+method+for+production+and+use+thereof+as+medicament+or+diagnostic+and+medicament+comprising+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKleeman%26aufirst%3DH.-W%26atitle%3DSubstituted%2520benzoylguanidines%252C%2520method%2520for%2520production%2520and%2520use%2520thereof%2520as%2520medicament%2520or%2520diagnostic%2520and%2520medicament%2520comprising%2520the%2520same%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&issue=7&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0ljndDm-mEsnVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D7%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wohnsland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span> </span><span class="NLM_article-title">High-throughput permeability pH profile and high-throughput alkane/water log <i>P</i> with artificial membranes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&issue=6&author=F.+Wohnslandauthor=B.+Faller&title=High-throughput+permeability+pH+profile+and+high-throughput+alkane%2Fwater+log+P+with+artificial+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh-throughput%2520permeability%2520pH%2520profile%2520and%2520high-throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D6%26spage%3D923%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, H.</span><span> </span><span class="NLM_article-title">Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2Fj.vascn.2005.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=15936217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVClsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=123-135&issue=1&author=L.+Guoauthor=H.+Guthrie&title=Automated+electrophysiology+in+the+preclinical+evaluation+of+drugs+for+potential+QT+prolongation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation</span></div><div class="casAuthors">Guo, Liang; Guthrie, Heather</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction. The human ether-a-go-go-related gene (hERG) potassium channel plays a major role in the elec. conductances involved in human heart repolarization.  Drugs that decrease hERG K+ currents are at risk to produce a prolongation of the cardiac action potential, resulting in an increase of the QT interval.  Drug-induced QT prolongation or acquired long QT (aLQT) can lead to a fatal arrhythmia known as Torsade de Pointes (TdP).  Electrophysiol. methods are the best approach to evaluate potential drug candidates for hERG current inhibition.  Here we identify limitations with the PatchXpress 7000A automated electrophysiol. instrument and describe hERG protocol optimizations necessary for reliable preclin. assessment.  Methods. The PatchXpress 7000A automated electrophysiol. system was used to evaluate a group of drugs with known hERG activity under voltage clamp conditions.  We used a recombinant cell line expressing hERG, and assessed the inhibition of hERG K+ currents at different drug concns.  These data were used to det. hERG IC50 values and compare assay parameters under different recording conditions.  Results. We found that due to limitations with the PatchXpress 7000A instrument, repeated compd. addns. were crit. for achieving steady state drug concns. that generated data comparable to std. patch clamp methods, particularly when similar voltage pulse protocols were implemented.  Some discrepancies were obsd. between the PatchXpress 7000A and std. patch clamp techniques including shifts in IC50 values for very hydrophobic compds.  Most hERG IC50 values were within 3-fold of std. patch clamp IC50 values.  Discussion. Automation of electrophysiol. technologies has greatly improved the throughput of assessing lead drug candidates for hERG liability.  To maintain hERG data quality comparable to std. patch clamp techniques, the PatchXpress 7000A instrument limitations should be recognized and protocols optimized accordingly to ensure accuracy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkk2yRVCS66bVg90H21EOLACvtfcHk0ljndDm-mEsnVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVClsLc%253D&md5=c0695ae1fe20822f0fab15ec040540ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2005.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2005.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DGuthrie%26aufirst%3DH.%26atitle%3DAutomated%2520electrophysiology%2520in%2520the%2520preclinical%2520evaluation%2520of%2520drugs%2520for%2520potential%2520QT%2520prolongation%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2005%26volume%3D52%26issue%3D1%26spage%3D123%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ames, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durston, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. D.</span><span> </span><span class="NLM_article-title">Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2281</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=2281-2285&issue=8&author=B.+N.+Amesauthor=W.+E.+Durstonauthor=E.+Yamasakiauthor=F.+D.+Lee&title=Detection+of+carcinogens+as+mutagens%3A+bacterial+tester+strains+with+R+factor+plasmids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DDurston%26aufirst%3DW.%2BE.%26aulast%3DYamasaki%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DF.%2BD.%26atitle%3DDetection%2520of%2520carcinogens%2520as%2520mutagens%253A%2520bacterial%2520tester%2520strains%2520with%2520R%2520factor%2520plasmids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1973%26volume%3D70%26issue%3D8%26spage%3D2281%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunouchi, M.</span><span> </span><span class="NLM_article-title">Alternative methods for mechanistic studies in toxicology.: screening of hepatotoxicity of pesticides using freshly isolated and primary cultured hepatocytes and non-liver-derived cells, SIRC cells</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102–103</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0378-4274%2898%2900250-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=10022315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1egsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102%E2%80%93103&publication_year=1998&pages=569-573&author=Y.+Ohnoauthor=A.+Miyajimaauthor=M.+Sunouchi&title=Alternative+methods+for+mechanistic+studies+in+toxicology.%3A+screening+of+hepatotoxicity+of+pesticides+using+freshly+isolated+and+primary+cultured+hepatocytes+and+non-liver-derived+cells%2C+SIRC+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative methods for mechanistic studies in toxicology. Screening of hepatotoxicity of pesticides using freshly isolated and primary cultured hepatocytes and non-liver-derived cells, SIRC cells</span></div><div class="casAuthors">Ohno, Y.; Miyajima, A.; Sunouchi, M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102-103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">569-573</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">We constructed a screening battery for the evaluation of hepatotoxicity using freshly isolated and primary cultured rat hepatocytes (abbreviated to FIH and PCH, resp.) and rabbit eye derived cell line, SIRC cells.  Effects on cell viability and drug metabolizing enzyme activities were examd. by several pesticides and compared to those of in vivo.  Among the pesticides studied, prometryn and ametryn showed cytotoxicity on PCH at lower concn. than on SIRC cells.  Cytotoxicities of these chems. on FIH were inhibited by metyrapone.  They also increased rat serum AST in vivo.  On the other hand, cytotoxicities of IBP, elsan, alanycarb, benfuracarb, and swep in PCH were obsd. at similar concn. to those in SIRC cells.  Linuron, nitrofen, and chlomethoxyfen increased ethoxycoumarin O-deethylation activities by almost similar concn. to those of benzo(a)pyrene.  Linuron also induced ethoxycoumarin O-deethylation activity in vivo.  These findings indicated that a battery of in vitro tests consisting of FIH, PCH and SIRC cells was useful to screen the hepatotoxicity of pesticides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUakAdWQ7WNbVg90H21EOLACvtfcHk0ljndDm-mEsnVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1egsrg%253D&md5=8a38399a47ee1b4a255c7e9ae7b672fa</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0378-4274%2898%2900250-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4274%252898%252900250-1%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DY.%26aulast%3DMiyajima%26aufirst%3DA.%26aulast%3DSunouchi%26aufirst%3DM.%26atitle%3DAlternative%2520methods%2520for%2520mechanistic%2520studies%2520in%2520toxicology.%253A%2520screening%2520of%2520hepatotoxicity%2520of%2520pesticides%2520using%2520freshly%2520isolated%2520and%2520primary%2520cultured%2520hepatocytes%2520and%2520non-liver-derived%2520cells%252C%2520SIRC%2520cells%26jtitle%3DToxicol.%2520Lett.%26date%3D1998%26volume%3D102%25E2%2580%2593103%26spage%3D569%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stryd, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. L.</span><span> </span><span class="NLM_article-title">Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">82–83</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2F0378-4274%2895%2903547-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=8597037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK28Xht1Wku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82%E2%80%9383&publication_year=1995&pages=107-115&author=R.+G.+Ulrichauthor=J.+A.+Baconauthor=C.+T.+Cramerauthor=G.+W.+Pengauthor=D.+K.+Petrellaauthor=R.+P.+Strydauthor=E.+L.+Sun&title=Cultured+hepatocytes+as+investigational+models+for+hepatic+toxicity%3A+practical+applications+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development</span></div><div class="casAuthors">Ulrich, Roger G.; Bacon, James A.; Cramer, Clay T.; Peng, Geoffrey W.; Petrella, Diane K.; Stryd, Ronald P.; Sun, Elena L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">82/83</span>
        (<span class="NLM_cas:issue">1-6</span>),
    <span class="NLM_cas:pages">107-15</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 28 refs.  Drugs can fail at any phase during discovery, preclin. or clin. development due to unacceptable levels of toxicity, and liver is commonly the principle target organ.  Investigational toxicol. methods, using appropriate models and hypotheses, can often resolve problems, identify toxic chem. substituents and salvage therapeutic discovery programs.  While in vivo models are used to investigate hepatic drug effects in the context of toxicokinetics and systemic influences, cell culture models provide in vitro systems for investigating specific mechanisms in a precisely controlled environment.  Using primary hepatocytes isolated from lab. animals, we have explored several drug-induced hepatic disorders that surfaced during different phases of drug discovery and development.  Addnl., the use of human hepatocytes has allowed us to address concerns for human exposure, examine human relevance of animal data, and provide perspective on problems encountered in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRPAL4iwK6urVg90H21EOLACvtfcHk0liSI0iWDwI37g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1Wku7s%253D&md5=6d18fa490e602fef2e9fa596ecf8930c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2895%2903547-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252895%252903547-8%26sid%3Dliteratum%253Aachs%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DBacon%26aufirst%3DJ.%2BA.%26aulast%3DCramer%26aufirst%3DC.%2BT.%26aulast%3DPeng%26aufirst%3DG.%2BW.%26aulast%3DPetrella%26aufirst%3DD.%2BK.%26aulast%3DStryd%26aufirst%3DR.%2BP.%26aulast%3DSun%26aufirst%3DE.%2BL.%26atitle%3DCultured%2520hepatocytes%2520as%2520investigational%2520models%2520for%2520hepatic%2520toxicity%253A%2520practical%2520applications%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DToxicol.%2520Lett.%26date%3D1995%26volume%3D82%25E2%2580%259383%26spage%3D107%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Horakova, K.</span><span> </span><span class="NLM_article-title">The use of cell culture systems for the assessment of general cellular toxicity and to detect the nature and location of free radical damage</span> <span class="citation_source-journal">Gen. Physiol. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=10703721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVGquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=63-69&author=K.+Horakova&title=The+use+of+cell+culture+systems+for+the+assessment+of+general+cellular+toxicity+and+to+detect+the+nature+and+location+of+free+radical+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The use of cell culture systems for the assessment of general cellular toxicity and to detect the nature and location of free radical damage</span></div><div class="casAuthors">Horakova, K.</div><div class="citationInfo"><span class="NLM_cas:title">General Physiology and Biophysics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">Focus Issue</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">GPBIE2</span>;
        ISSN:<span class="NLM_cas:issn">0231-5882</span>.
    
            (<span class="NLM_cas:orgname">Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  In the process of developing compds. to counteract the damaging effects of free radicals in biol. systems it is important to det. the type and the intracellular location of specific toxic events.  For that purpose cultured cells are used, because a properly designed cell culture system allows to assess specific damage at the cellular and subcellular level and can contribute to an evaluation of the biochem. of free radical damage.  A wide range of changes in cellular activities resulting from oxidative injury in vitro have been demonstrated.  Data from many labs. indicate that cell culture system coupled with appropriate anal. techniques can be used to explore cellular and biochem. details of damage induced by free radicals.  The type of reactive oxygen species used to generate the radicals, the rate of radical prodn., and the location of action of the toxic species must be taken into account to understand the biochem. of the system.  An effort is made to analyze the considerable progress made in the development of appropriate in vitro models and end-points for use in testing and characterizing the nature and location of free radical cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqiseKNI_BWLVg90H21EOLACvtfcHk0liSI0iWDwI37g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVGquro%253D&md5=2af177469402c08a6fd2ab46aca6f0dc</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorakova%26aufirst%3DK.%26atitle%3DThe%2520use%2520of%2520cell%2520culture%2520systems%2520for%2520the%2520assessment%2520of%2520general%2520cellular%2520toxicity%2520and%2520to%2520detect%2520the%2520nature%2520and%2520location%2520of%2520free%2520radical%2520damage%26jtitle%3DGen.%2520Physiol.%2520Biophys.%26date%3D1999%26volume%3D18%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Klaassen, C. D.</span> <span class="citation_source-book">The Basic Science of Poisons</span>,; <span class="NLM_edition">3rd</span> ed.; <span class="NLM_contrib-group">Klaassen, C. D.; Amdur, M. O.; ; Doull, J.</span>, Eds.; <span class="NLM_publisher-name">MacMillan Publishing Co.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">16</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=16&author=C.+D.+Klaassenauthor=C.+D.+Klaassen&author=M.+O.+Amdur&author=J.+Doull&title=The+Basic+Science+of+Poisons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26btitle%3DThe%2520Basic%2520Science%2520of%2520Poisons%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26pub%3DMacMillan%2520Publishing%2520Co%26date%3D1986%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Casartelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristofori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivellente, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Negro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masotto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfante, V</span><span> </span><span class="NLM_article-title">A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1023%2FA%3A1024778329320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=12945744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVKls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=161-176&issue=3&author=A.+Casartelliauthor=M.+Bonatoauthor=P.+Cristoforiauthor=F.+Crivellenteauthor=G.+Dal+Negroauthor=I.+Masottoauthor=C.+Mutinelliauthor=K.+Valkoauthor=V+Bonfante&title=A+cell-based+approach+for+the+early+assessment+of+the+phospholipidogenic+potential+in+pharmaceutical+research+and+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development</span></div><div class="casAuthors">Casartelli, A.; Bonato, M.; Cristofori, P.; Crivellente, F.; Dal Negro, G.; Masotto, I.; Mutinelli, C.; Valko, K.; Bonfante, V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-176</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Phospholipidosis is a term commonly used to indicate a phospholipid storage disorder; in affected cells, phospholipids accumulate in lysosomes that acquire a multilamellar morphol. appearance.  Cationic amphiphilic drugs (CADs) are suggested to induce phospholipidosis by direct interaction of xenobiotics with intracellular phospholipids or by the action of xenobiotics on the synthesis and metab. of phospholipids.  To date, electron microscopy (EM) represents the most reliable and the preferred method for the demonstration of phospholipidotic cell damage.  Nevertheless, EM has a low throughput, it is expensive, and it is not suitable for screening purposes.  We discuss here the assessment of the phospholipidogenic potential of drugs using a cell culture-based model.  In this test, intracellular phospholipids of treated U-937 cells (a human monocyte-derived cell line) were measured using the fluorescent probe Nile red.  Eleven CADs reported to induce phospholipidosis in vivo and eight non-phospholipidogenic drugs were tested.  Results obtained with the U-937 model confirmed the phospholipidogenic potential of drugs tested as described in the literature.  Results have also been correlated with data obtained with a phys.-chem. model (chromatog. hydrophobicity index measurement).  Good correlation was obtained, confirming that the phys.-chem. properties of CADs play a crucial role in the development of phospholipidosis.  This work demonstrates that the U-937 model is a rapid and sensitive method for the detn. of phospholipidosis-mediated cell damage.  The specificity and the predictive potency obsd. make this method suitable for screening purposes in pharmaceutical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKIl4wT9QifrVg90H21EOLACvtfcHk0liSI0iWDwI37g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVKls7s%253D&md5=e24933960174cb4390dbd6832c973c60</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1023%2FA%3A1024778329320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1024778329320%26sid%3Dliteratum%253Aachs%26aulast%3DCasartelli%26aufirst%3DA.%26aulast%3DBonato%26aufirst%3DM.%26aulast%3DCristofori%26aufirst%3DP.%26aulast%3DCrivellente%26aufirst%3DF.%26aulast%3DDal%2BNegro%26aufirst%3DG.%26aulast%3DMasotto%26aufirst%3DI.%26aulast%3DMutinelli%26aufirst%3DC.%26aulast%3DValko%26aufirst%3DK.%26aulast%3DBonfante%26aufirst%3DV%26atitle%3DA%2520cell-based%2520approach%2520for%2520the%2520early%2520assessment%2520of%2520the%2520phospholipidogenic%2520potential%2520in%2520pharmaceutical%2520research%2520and%2520drug%2520development%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2003%26volume%3D19%26issue%3D3%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Perico, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivellente, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faustinelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristofori, P</span><span> </span><span class="NLM_article-title">Flow cytometry, with double staining with Nile red and anti-CD3 antibody, to detect phospholipidosis in peripheral blood lymphocytes of rats treated with amiodarone</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1007%2Fs10565-008-9114-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=19105033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKhtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=587-598&issue=6&author=M.+E.+Pericoauthor=F.+Crivellenteauthor=I.+Faustinelliauthor=A.+Suozziauthor=P+Cristofori&title=Flow+cytometry%2C+with+double+staining+with+Nile+red+and+anti-CD3+antibody%2C+to+detect+phospholipidosis+in+peripheral+blood+lymphocytes+of+rats+treated+with+amiodarone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Flow cytometry, with double staining with Nile red and anti-CD3 antibody, to detect phospholipidosis in peripheral blood lymphocytes of rats treated with amiodarone</span></div><div class="casAuthors">Perico, Maria Elisa; Crivellente, Federica; Faustinelli, Ivo; Suozzi, Anna; Cristofori, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-598</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A flow cytometry method, to monitor peripheral lymphocytes phospholipidosis, has been set up using a single staining with Nile red and double staining with Nile red and anti-CD3 monoclonal antibody.  Blood has been collected from rats treated with amiodarone (phospholipidogenic antiarrhythmic drug).  By flow cytometer, it is possible to detect phospholipids, using Nile red, a probe for intracellular lipids staining, changing its fluorescence on the stained lipid basis.  CD3 antigen has been selected to focus on T cells, to evaluate whether these cells are the target of phospholipidosis amiodarone-dependent.  In the study A, Sprague-Dawley rats were treated with three different doses (75, 150, and 300 mg kg-1 day-1) of amiodarone or vehicle alone, for 14 days, followed by 14 days of recovery: Data obtained show that by flow cytometry, with Nile red alone, it is possible to detect a dose- and time-related response of phospholipidosis-pos. lymphocytes; a partial recovery is also assessed.  In the study B, Sprague-Dawley rats were treated with a single dose (300 mg kg-1 day-1) of amiodarone, for 14 days: Data obtained show that animals treated with amiodarone have a significant increase of phospholipidosis-pos. lymphocytes (p = 0.008), in particular of CD3+ cells (p = 0.0056).  Transmission electron microscopy anal. confirmed data obtained by flow cytometry.  This work shows that flow cytometry with Nile red could be a good tool to monitor ex vivo phospholipidosis in lymphocyte cells of animals treated with amiodarone: The phospholipidogenic effect is more evident focusing on CD3+ T lymphocytes, thus suggesting that these cells are probably the target of phospholipidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopzwXCRewGw7Vg90H21EOLACvtfcHk0lj0gDkqUa4ppw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKhtLnJ&md5=b9bedd86bc14a457ba17b0fec2a0d08a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs10565-008-9114-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10565-008-9114-6%26sid%3Dliteratum%253Aachs%26aulast%3DPerico%26aufirst%3DM.%2BE.%26aulast%3DCrivellente%26aufirst%3DF.%26aulast%3DFaustinelli%26aufirst%3DI.%26aulast%3DSuozzi%26aufirst%3DA.%26aulast%3DCristofori%26aufirst%3DP%26atitle%3DFlow%2520cytometry%252C%2520with%2520double%2520staining%2520with%2520Nile%2520red%2520and%2520anti-CD3%2520antibody%252C%2520to%2520detect%2520phospholipidosis%2520in%2520peripheral%2520blood%2520lymphocytes%2520of%2520rats%2520treated%2520with%2520amiodarone%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2009%26volume%3D25%26issue%3D6%26spage%3D587%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e','cit3f'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b','cit23c'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c','cit25d'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wesley Wei Wang, Leandro Gallo, Appaso Jadhav, Richard Hawkins, <span class="NLM_string-name hlFld-ContribAuthor">Christopher G. Parker</span>. </span><span class="cited-content_cbyCitation_article-title">The Druggability of Solute Carriers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 3834-3867. <a href="https://doi.org/10.1021/acs.jmedchem.9b01237" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01237%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDruggability%252Bof%252BSolute%252BCarriers%26aulast%3DWang%26aufirst%3DWesley%2BWei%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D30072019%26date%3D19122019%26date%3D27112019%26volume%3D63%26issue%3D8%26spage%3D3834%26epage%3D3867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjun  Tang</span>, <span class="hlFld-ContribAuthor ">Nitinchandra D.  Patel</span>, <span class="hlFld-ContribAuthor ">Xudong  Wei</span>, <span class="hlFld-ContribAuthor ">Denis  Byrne</span>, <span class="hlFld-ContribAuthor ">Ashish  Chitroda</span>, <span class="hlFld-ContribAuthor ">Bikshandarkoil  Narayanan</span>, <span class="hlFld-ContribAuthor ">Alexander  Sienkiewicz</span>, <span class="hlFld-ContribAuthor ">Laurence J.  Nummy</span>, <span class="hlFld-ContribAuthor ">Max  Sarvestani</span>, <span class="hlFld-ContribAuthor ">Shengli  Ma</span>, <span class="hlFld-ContribAuthor ">Nelu  Grinberg</span>, <span class="hlFld-ContribAuthor ">Heewon  Lee</span>, <span class="hlFld-ContribAuthor ">Soojin  Kim</span>, <span class="hlFld-ContribAuthor ">Zhibin  Li</span>, <span class="hlFld-ContribAuthor ">Earl  Spinelli</span>, <span class="hlFld-ContribAuthor ">Bing-Shiou  Yang</span>, <span class="hlFld-ContribAuthor ">Nathan  Yee</span>, and <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Sodium–Hydrogen Exchange Type 1 Inhibitor: An Efficient Cu-Catalyzed Conjugated Addition of a Grignard Reagent to an Acetyl Pyridinium Salt. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2013,</strong> <em>17 </em>
                                    (3)
                                     , 382-389. <a href="https://doi.org/10.1021/op300331b" title="DOI URL">https://doi.org/10.1021/op300331b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op300331b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop300331b%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252Ba%252BSodium%2525E2%252580%252593Hydrogen%252BExchange%252BType%252B1%252BInhibitor%25253A%252BAn%252BEfficient%252BCu-Catalyzed%252BConjugated%252BAddition%252Bof%252Ba%252BGrignard%252BReagent%252Bto%252Ban%252BAcetyl%252BPyridinium%252BSalt%26aulast%3DTang%26aufirst%3DWenjun%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D14112012%26date%3D07022013%26date%3D15032013%26date%3D18012013%26volume%3D17%26issue%3D3%26spage%3D382%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Hug</span>, <span class="hlFld-ContribAuthor ">Stefan  Bernhard</span>, <span class="hlFld-ContribAuthor ">Alexander Elias Paul  Stratmann</span>, <span class="hlFld-ContribAuthor ">Maike  Erber</span>, <span class="hlFld-ContribAuthor ">Lisa  Wohlgemuth</span>, <span class="hlFld-ContribAuthor ">Christiane Leonie  Knapp</span>, <span class="hlFld-ContribAuthor ">Jonas Martin  Bauer</span>, <span class="hlFld-ContribAuthor ">Laura  Vidoni</span>, <span class="hlFld-ContribAuthor ">Michael  Fauler</span>, <span class="hlFld-ContribAuthor ">Karl Josef  Föhr</span>, <span class="hlFld-ContribAuthor ">Peter  Radermacher</span>, <span class="hlFld-ContribAuthor ">Andrea  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Markus  Huber-Lang</span>, <span class="hlFld-ContribAuthor ">David Alexander Christian  Messerer</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of Neutrophil Granulocytes by Platelet-Activating Factor Is Impaired During Experimental Sepsis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fimmu.2021.642867" title="DOI URL">https://doi.org/10.3389/fimmu.2021.642867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2021.642867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2021.642867%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DActivation%252Bof%252BNeutrophil%252BGranulocytes%252Bby%252BPlatelet-Activating%252BFactor%252BIs%252BImpaired%252BDuring%252BExperimental%252BSepsis%26aulast%3DHug%26aufirst%3DStefan%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin J.  Buckley</span>, <span class="hlFld-ContribAuthor ">Ashna  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashraf  Aboelela</span>, <span class="hlFld-ContribAuthor ">Richard S.  Bujaroski</span>, <span class="hlFld-ContribAuthor ">Xiuju  Li</span>, <span class="hlFld-ContribAuthor ">Hiwa  Majed</span>, <span class="hlFld-ContribAuthor ">Larry  Fliegel</span>, <span class="hlFld-ContribAuthor ">Marie  Ranson</span>, <span class="hlFld-ContribAuthor ">Michael J.  Kelso</span>. </span><span class="cited-content_cbyCitation_article-title">Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (6)
                                     , 2999. <a href="https://doi.org/10.3390/ijms22062999" title="DOI URL">https://doi.org/10.3390/ijms22062999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22062999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22062999%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DScreening%252Bof%252B5-%252Band%252B6-Substituted%252BAmiloride%252BLibraries%252BIdentifies%252BDual-uPA%25252FNHE1%252BActive%252Band%252BSingle%252BTarget-Selective%252BInhibitors%26aulast%3DBuckley%26aufirst%3DBenjamin%2BJ.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D6%26spage%3D2999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanshu  Zhao</span>, <span class="hlFld-ContribAuthor ">Rachel  Nepomuceno</span>, <span class="hlFld-ContribAuthor ">Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Lesley M  Foley</span>, <span class="hlFld-ContribAuthor ">Shaoxia  Wang</span>, <span class="hlFld-ContribAuthor ">Gulnaz  Begum</span>, <span class="hlFld-ContribAuthor ">Wen  Zhu</span>, <span class="hlFld-ContribAuthor ">Victoria M  Pigott</span>, <span class="hlFld-ContribAuthor ">Lindsay M  Falgoust</span>, <span class="hlFld-ContribAuthor ">Kristopher T  Kahle</span>, <span class="hlFld-ContribAuthor ">Sung-Sen  Yang</span>, <span class="hlFld-ContribAuthor ">Shih-Hua  Lin</span>, <span class="hlFld-ContribAuthor ">Seth L  Alper</span>, <span class="hlFld-ContribAuthor ">T Kevin  Hitchens</span>, <span class="hlFld-ContribAuthor ">Shaoshan  Hu</span>, <span class="hlFld-ContribAuthor ">Zhongling  Zhang</span>, <span class="hlFld-ContribAuthor ">Dandan  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Deletion of the WNK3-SPAK kinase complex in mice improves radiographic and clinical outcomes in malignant cerebral edema after ischemic stroke. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cerebral Blood Flow & Metabolism</span><span> <strong>2017,</strong> <em>37 </em>
                                    (2)
                                     , 550-563. <a href="https://doi.org/10.1177/0271678X16631561" title="DOI URL">https://doi.org/10.1177/0271678X16631561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0271678X16631561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0271678X16631561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cerebral%2520Blood%2520Flow%2520%2526%2520Metabolism%26atitle%3DDeletion%252Bof%252Bthe%252BWNK3-SPAK%252Bkinase%252Bcomplex%252Bin%252Bmice%252Bimproves%252Bradiographic%252Band%252Bclinical%252Boutcomes%252Bin%252Bmalignant%252Bcerebral%252Bedema%252Bafter%252Bischemic%252Bstroke%26aulast%3DZhao%26aufirst%3DHanshu%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D2%26spage%3D550%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jurgen  Dinges</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Harris</span>, <span class="hlFld-ContribAuthor ">Grier A.  Wallace</span>, <span class="hlFld-ContribAuthor ">Maria A.  Argiriadi</span>, <span class="hlFld-ContribAuthor ">Kara L.  Queeney</span>, <span class="hlFld-ContribAuthor ">Denise C.  Perron</span>, <span class="hlFld-ContribAuthor ">Eric  Dominguez</span>, <span class="hlFld-ContribAuthor ">Tegest  Kebede</span>, <span class="hlFld-ContribAuthor ">Kelly E.  Desino</span>, <span class="hlFld-ContribAuthor ">Hetal  Patel</span>, <span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>. </span><span class="cited-content_cbyCitation_article-title">Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (9)
                                     , 2297-2302. <a href="https://doi.org/10.1016/j.bmcl.2016.03.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHit-to-lead%252Bevaluation%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bsphingosine%252B1-phosphate%252Blyase%252Binhibitors%26aulast%3DDinges%26aufirst%3DJurgen%26date%3D2016%26volume%3D26%26issue%3D9%26spage%3D2297%26epage%3D2302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">He Benny  Chang</span>, <span class="hlFld-ContribAuthor ">Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Rachel  Nepomuceno</span>, <span class="hlFld-ContribAuthor ">Shaoshan  Hu</span>, <span class="hlFld-ContribAuthor ">Dandan  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Na+/H+ exchanger in the regulation of platelet activation and paradoxical effects of cariporide. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurology</span><span> <strong>2015,</strong> <em>272 </em>, 11-16. <a href="https://doi.org/10.1016/j.expneurol.2014.12.023" title="DOI URL">https://doi.org/10.1016/j.expneurol.2014.12.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.expneurol.2014.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.expneurol.2014.12.023%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurology%26atitle%3DNa%25252B%25252FH%25252B%252Bexchanger%252Bin%252Bthe%252Bregulation%252Bof%252Bplatelet%252Bactivation%252Band%252Bparadoxical%252Beffects%252Bof%252Bcariporide%26aulast%3DChang%26aufirst%3DHe%2BBenny%26date%3D2015%26volume%3D272%26spage%3D11%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iman A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Fatima  Mraiche</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Osteopontin, the Silent Partner of Na
              +
              /H
              +
              Exchanger Isoform 1 in Cardiac Remodeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2015,</strong> <em>230 </em>
                                    (9)
                                     , 2006-2018. <a href="https://doi.org/10.1002/jcp.24958" title="DOI URL">https://doi.org/10.1002/jcp.24958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.24958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.24958%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DTargeting%252BOsteopontin%25252C%252Bthe%252BSilent%252BPartner%252Bof%252BNa%252B%25252B%252B%25252FH%252B%25252B%252BExchanger%252BIsoform%252B1%252Bin%252BCardiac%252BRemodeling%26aulast%3DMohamed%26aufirst%3DIman%2BA.%26date%3D2015%26date%3D2015%26volume%3D230%26issue%3D9%26spage%3D2006%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maiy  Jaballah</span>, <span class="hlFld-ContribAuthor ">Iman A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Bayan  Alemrayat</span>, <span class="hlFld-ContribAuthor ">Fatima  Al-Sulaiti</span>, <span class="hlFld-ContribAuthor ">Mohamed  Mlih</span>, <span class="hlFld-ContribAuthor ">Fatima  Mraiche</span>, . </span><span class="cited-content_cbyCitation_article-title">Na+/H+ Exchanger Isoform 1 Induced Cardiomyocyte Hypertrophy Involves Activation of p90 Ribosomal S6 Kinase. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , e0122230. <a href="https://doi.org/10.1371/journal.pone.0122230" title="DOI URL">https://doi.org/10.1371/journal.pone.0122230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0122230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0122230%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNa%25252B%25252FH%25252B%252BExchanger%252BIsoform%252B1%252BInduced%252BCardiomyocyte%252BHypertrophy%252BInvolves%252BActivation%252Bof%252Bp90%252BRibosomal%252BS6%252BKinase%26aulast%3DJaballah%26aufirst%3DMaiy%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3De0122230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elise L.  Kessler</span>, <span class="hlFld-ContribAuthor ">Mohamed  Boulaksil</span>, <span class="hlFld-ContribAuthor ">Harold V. M.  van Rijen</span>, <span class="hlFld-ContribAuthor ">Marc A.  Vos</span>, <span class="hlFld-ContribAuthor ">Toon A. B.  van Veen</span>. </span><span class="cited-content_cbyCitation_article-title">Passive ventricular remodeling in cardiac disease: focus on heterogeneity. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2014,</strong> <em>5 </em><a href="https://doi.org/10.3389/fphys.2014.00482" title="DOI URL">https://doi.org/10.3389/fphys.2014.00482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2014.00482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2014.00482%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DPassive%252Bventricular%252Bremodeling%252Bin%252Bcardiac%252Bdisease%25253A%252Bfocus%252Bon%252Bheterogeneity%26aulast%3DKessler%26aufirst%3DElise%2BL.%26date%3D2014%26date%3D2014%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Kilić</span>, <span class="hlFld-ContribAuthor ">Cathy X.  Huang</span>, <span class="hlFld-ContribAuthor ">Venkatesh  Rajapurohitam</span>, <span class="hlFld-ContribAuthor ">Jeffrey B.  Madwed</span>, <span class="hlFld-ContribAuthor ">Morris  Karmazyn</span>. </span><span class="cited-content_cbyCitation_article-title">Early and Transient Sodium-Hydrogen Exchanger Isoform 1 Inhibition Attenuates Subsequent Cardiac Hypertrophy and Heart Failure Following Coronary Artery Ligation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2014,</strong> <em>351 </em>
                                    (3)
                                     , 492-499. <a href="https://doi.org/10.1124/jpet.114.217091" title="DOI URL">https://doi.org/10.1124/jpet.114.217091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.114.217091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.114.217091%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DEarly%252Band%252BTransient%252BSodium-Hydrogen%252BExchanger%252BIsoform%252B1%252BInhibition%252BAttenuates%252BSubsequent%252BCardiac%252BHypertrophy%252Band%252BHeart%252BFailure%252BFollowing%252BCoronary%252BArtery%252BLigation%26aulast%3DKili%25C4%2587%26aufirst%3DAna%26date%3D2014%26date%3D2014%26volume%3D351%26issue%3D3%26spage%3D492%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Serra</span>, <span class="hlFld-ContribAuthor ">Alessandra A.  Cominetti</span>, <span class="hlFld-ContribAuthor ">Veronica  Lissoni</span>. </span><span class="cited-content_cbyCitation_article-title">Use of (
              S
              )-
              trans
              -γ-Monocyclofarnesol as a Useful Chiral Building Block for the Stereoselective Synthesis of Diterpenic Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Communications</span><span> <strong>2014,</strong> <em>9 </em>
                                    (3)
                                     , 1934578X1400900. <a href="https://doi.org/10.1177/1934578X1400900312" title="DOI URL">https://doi.org/10.1177/1934578X1400900312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1934578X1400900312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1934578X1400900312%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Communications%26atitle%3DUse%252Bof%252B%252528%252BS%252B%252529-%252Btrans%252B-%2525CE%2525B3-Monocyclofarnesol%252Bas%252Ba%252BUseful%252BChiral%252BBuilding%252BBlock%252Bfor%252Bthe%252BStereoselective%252BSynthesis%252Bof%252BDiterpenic%252BNatural%252BProducts%26aulast%3DSerra%26aufirst%3DStefano%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D3%26spage%3D1934578X1400900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoko  Shimada-Shimizu</span>, <span class="hlFld-ContribAuthor ">Takashi  Hisamitsu</span>, <span class="hlFld-ContribAuthor ">Tomoe Y.  Nakamura</span>, <span class="hlFld-ContribAuthor ">Noriaki  Hirayama</span>, <span class="hlFld-ContribAuthor ">Shigeo  Wakabayashi</span>. </span><span class="cited-content_cbyCitation_article-title">Na
              +
              /H
              +
              Exchanger 1 Is Regulated via Its Lipid-Interacting Domain, Which Functions as a Molecular Switch: A Pharmacological Approach Using Indolocarbazole Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2014,</strong> <em>85 </em>
                                    (1)
                                     , 18-28. <a href="https://doi.org/10.1124/mol.113.089268" title="DOI URL">https://doi.org/10.1124/mol.113.089268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.113.089268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.113.089268%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DNa%252B%25252B%252B%25252FH%252B%25252B%252BExchanger%252B1%252BIs%252BRegulated%252Bvia%252BIts%252BLipid-Interacting%252BDomain%25252C%252BWhich%252BFunctions%252Bas%252Ba%252BMolecular%252BSwitch%25253A%252BA%252BPharmacological%252BApproach%252BUsing%252BIndolocarbazole%252BCompounds%26aulast%3DShimada-Shimizu%26aufirst%3DNaoko%26date%3D2014%26date%3D2013%26volume%3D85%26issue%3D1%26spage%3D18%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikram  Prasad</span>, <span class="hlFld-ContribAuthor ">John N.  Lorenz</span>, <span class="hlFld-ContribAuthor ">Marian L.  Miller</span>, <span class="hlFld-ContribAuthor ">Kanimozhi  Vairamani</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Nieman</span>, <span class="hlFld-ContribAuthor ">Yigang  Wang</span>, <span class="hlFld-ContribAuthor ">Gary E.  Shull</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular and Cellular Cardiology</span><span> <strong>2013,</strong> <em>65 </em>, 33-42. <a href="https://doi.org/10.1016/j.yjmcc.2013.09.013" title="DOI URL">https://doi.org/10.1016/j.yjmcc.2013.09.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yjmcc.2013.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yjmcc.2013.09.013%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520and%2520Cellular%2520Cardiology%26atitle%3DLoss%252Bof%252BNHE1%252Bactivity%252Bleads%252Bto%252Breduced%252Boxidative%252Bstress%252Bin%252Bheart%252Band%252Bmitigates%252Bhigh-fat%252Bdiet-induced%252Bmyocardial%252Bstress%26aulast%3DPrasad%26aufirst%3DVikram%26date%3D2013%26volume%3D65%26spage%3D33%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morris  Karmazyn</span>. </span><span class="cited-content_cbyCitation_article-title">NHE-1: Still a viable therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular and Cellular Cardiology</span><span> <strong>2013,</strong> <em>61 </em>, 77-82. <a href="https://doi.org/10.1016/j.yjmcc.2013.02.006" title="DOI URL">https://doi.org/10.1016/j.yjmcc.2013.02.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yjmcc.2013.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yjmcc.2013.02.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520and%2520Cellular%2520Cardiology%26atitle%3DNHE-1%25253A%252BStill%252Ba%252Bviable%252Btherapeutic%252Btarget%26aulast%3DKarmazyn%26aufirst%3DMorris%26date%3D2013%26volume%3D61%26spage%3D77%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0020.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Clinically investigated NHE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0021.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) diisopropylethylamine (DIEA), DMSO, 90 °C; (ii) NaOH, MeOH, reflux, 2.5 h; (iii) 1-methyl-2-chloropyridinium iodide, 1-methyl pyrrolidinone (NMP), 90 min, then CBZ-guanidine, DIEA, 16 h; (iv) HCl, dioxane, methanol, 4.5 h; (v) 1<i>H</i>-pyrrole-2-carboxylic acid chloride, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 16 h; (vi) Pd/C, 1 atm H<sub>2</sub>, EtOH, 16 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0022.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, 140 °C, 4 h; (ii) PtO<sub>2</sub>, 1 atm H<sub>2</sub>, acetic acid, 60 h; (iii) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (10/1), 60 °C, 2 h; (iv) 1-methyl-2-chloropyridinium iodide, NMP, 90 min, then CBZ-guanidine, DIEA, 16 h; (v) HCl, 1,4-dioxane, CH<sub>2</sub>Cl<sub>2</sub>, 2 h; (vi) 2-pyrrole-carboxylic acid, CDI, DMF, 90 min, then <b>20a</b>, DIEA, 16 h; (vii) Pd/C, 1 atm H<sub>2</sub>, EtOH, 4–16 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0023.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (10/1), 60 °C, 2 h; (ii) 1-methyl-2-chloropyridinium iodide, NMP, 90 min, then CBZ-guanidine, DIEA, 16 h; (iii) HCl, 1,4-dioxane, CH<sub>2</sub>Cl<sub>2</sub>, 2 h; (iv) RCO<sub>2</sub>H, CDI, DMF, 90 min, then <b>20b</b>, DIEA, 16 h; (v) Pd/C, 1 atm H<sub>2</sub>, EtOH, 4–48 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0024.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HCl, 1,4-dioxane, 18 h, then 50 °C, 6 h; (ii) benzyl chloroformate, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 16 h; (iii) K<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (3/1), 16 h; (iv) 1-methyl-2-chloropyridinium iodide, NMP, 90 min, then BOC-guanidine, DIEA, 16 h; (v) Pd(OH)<sub>2</sub>/C, 1 atm H<sub>2</sub>, EtOH, 16 h, then for <b>63b</b>:HCl in ether; (vi) RCO<sub>2</sub>H, TBTU, NMM, DMA, 1 h; (vii) 4N HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>. For R groups see tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0025.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 2h; (ii) KOC(O)CF<sub>3</sub>, CuI, NMP, 150 °C, 5h; (iii) Pd/C, H<sub>2</sub>, EtOH, o/n; (iv) <i>N</i>-phenyltrifluoromethanesulfonimide, DIEA, DMF, o/n; (v) <b>16</b>, 2M K<sub>2</sub>CO<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, 110 °C, 30 min; (vi) ClSO<sub>3</sub>H, 0 to 100 °C, 2h; (vii) Na<sub>2</sub>SO<sub>3</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, THF, 70 °C, 1 h then MeI, 50 °C, o/n; (viii) AcCl, MeOH, 50 °C, o/n; (ix) Br<sub>2</sub>, CHCl<sub>3</sub>, 30 min; (x) KOtBu, MeI, THF, 72 h.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0026.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of the NHE1 inhibitor <b>1</b> illustrating its four structural domains. From left to right, these are the heteroaryl amide (yellow), piperazine linker (red), aryl core (green), and the acylguanidine (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of the minimized conformations of the four NHE-1 inhibitors <b>1</b> (turquoise), <b>2</b> (green), <b>3</b> (yellow), and <b>4</b> (pink), illustrating the different positioning of the left-hand side aryl moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the minimized conformations of <b>1</b> (turquoise) with <b>5</b> (salmon), <b>6</b> (beige), and <b>7</b> (gray), illustrating the relatively good overlap of the core aryl and far left-hand side substructures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of the minimized conformations of the piperidine derivative <b>14</b> (gray) with <b>1</b> (turquoise), illustrating near-perfect overlay for both the right-hand side aryl acylgaunidine and the left-hand side aryl amide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/medium/jm-2012-00601d_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0017.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Left ventricular developed pressure (LVDP) and left ventricular end-diastolic pressure (LVEDP) for compound <b>60</b>. Data were analyzed using a repeated-measures ANOVA followed by a post hoc Tukey’s test, <i>N</i> = 6, for all groups. For LVDP, values indicate the percentage recovery from baseline values obtained immediately before initiating ischemia. Preischemic baseline values for LVDP (in mm Hg) were 63 ± 5, 61 ± 7, and 59 ± 5 nM for control, and 10 and 100 nM compound <b>60</b>-treated hearts, respectively. Absolute values are shown for LVEDP, which were initially adjusted to approximately 5 mmHg as indicated in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. *<i>P</i> < 0.05 from compound <b>60</b>-free group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300601d/production/images/large/jm-2012-00601d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300601d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i144">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Karmazyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumoto, K.</span><span> </span><span class="NLM_article-title">The myocardial Na<sup>+</sup>–H<sup>+</sup> exchanger: Structure, regulation, and its role in heart disease</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=777-786&issue=9&author=M.+Karmazynauthor=X.+T.+Ganauthor=R.+A.+Humphreysauthor=H.+Yoshidaauthor=K.+Kusumoto&title=The+myocardial+Na%2B%E2%80%93H%2B+exchanger%3A+Structure%2C+regulation%2C+and+its+role+in+heart+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarmazyn%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DX.%2BT.%26aulast%3DHumphreys%26aufirst%3DR.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DKusumoto%26aufirst%3DK.%26atitle%3DThe%2520myocardial%2520Na%252B%25E2%2580%2593H%252B%2520exchanger%253A%2520Structure%252C%2520regulation%252C%2520and%2520its%2520role%2520in%2520heart%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D1999%26volume%3D85%26issue%3D9%26spage%3D777%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Orlowski, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandasamy, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shull, G. E.</span><span> </span><span class="NLM_article-title">Molecular cloning of putative members of the Na/H exchanger gene family: cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=9331-9339&author=J+Orlowskiauthor=R.+A.+Kandasamyauthor=G.+E.+Shull&title=Molecular+cloning+of+putative+members+of+the+Na%2FH+exchanger+gene+family%3A+cDNA+cloning%2C+deduced+amino+acid+sequence%2C+and+mRNA+tissue+expression+of+the+rat+Na%2FH+exchanger+NHE-1+and+two+structurally+related+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrlowski%26aufirst%3DJ%26aulast%3DKandasamy%26aufirst%3DR.%2BA.%26aulast%3DShull%26aufirst%3DG.%2BE.%26atitle%3DMolecular%2520cloning%2520of%2520putative%2520members%2520of%2520the%2520Na%252FH%2520exchanger%2520gene%2520family%253A%2520cDNA%2520cloning%252C%2520deduced%2520amino%2520acid%2520sequence%252C%2520and%2520mRNA%2520tissue%2520expression%2520of%2520the%2520rat%2520Na%252FH%2520exchanger%2520NHE-1%2520and%2520two%2520structurally%2520related%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D9331%26epage%3D9339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fliegel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, J. R. B.</span><span> </span><span class="NLM_article-title">Molecular biology of the cardiac sodium/hydrogen exchanger</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1995&pages=155-159&issue=2&author=L.+Fliegelauthor=J.+R.+B.+Dyck&title=Molecular+biology+of+the+cardiac+sodium%2Fhydrogen+exchanger"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFliegel%26aufirst%3DL.%26aulast%3DDyck%26aufirst%3DJ.%2BR.%2BB.%26atitle%3DMolecular%2520biology%2520of%2520the%2520cardiac%2520sodium%252Fhydrogen%2520exchanger%26jtitle%3DCardiovasc.%2520Res.%26date%3D1995%26volume%3D29%26issue%3D2%26spage%3D155%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neely, J. R.</span><span> </span><span class="NLM_article-title">Role of intracellular Na<sup>+</sup> in Ca2<sup>+</sup> overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H–Na and Na–Ca exchange</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1989&pages=1045-1056&author=M.+Taniauthor=J.+R.+Neely&title=Role+of+intracellular+Na%2B+in+Ca2%2B+overload+and+depressed+recovery+of+ventricular+function+of+reperfused+ischemic+rat+hearts.+Possible+involvement+of+H%E2%80%93Na+and+Na%E2%80%93Ca+exchange"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTani%26aufirst%3DM.%26aulast%3DNeely%26aufirst%3DJ.%2BR.%26atitle%3DRole%2520of%2520intracellular%2520Na%252B%2520in%2520Ca2%252B%2520overload%2520and%2520depressed%2520recovery%2520of%2520ventricular%2520function%2520of%2520reperfused%2520ischemic%2520rat%2520hearts.%2520Possible%2520involvement%2520of%2520H%25E2%2580%2593Na%2520and%2520Na%25E2%2580%2593Ca%2520exchange%26jtitle%3DCirc.%2520Res.%26date%3D1989%26volume%3D65%26spage%3D1045%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Haigney, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakatta, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, H. S.</span><span> </span><span class="NLM_article-title">Dependence of hypoxic cellular calcium loading on Na<sup>+</sup>–Ca<sup>2+</sup> exchange</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=547-557&author=M.+C.+Haigneyauthor=H.+Miyataauthor=E.+G.+Lakattaauthor=M.+D.+Sternauthor=H.+S.+Silverman&title=Dependence+of+hypoxic+cellular+calcium+loading+on+Na%2B%E2%80%93Ca2%2B+exchange"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaigney%26aufirst%3DM.%2BC.%26aulast%3DMiyata%26aufirst%3DH.%26aulast%3DLakatta%26aufirst%3DE.%2BG.%26aulast%3DStern%26aufirst%3DM.%2BD.%26aulast%3DSilverman%26aufirst%3DH.%2BS.%26atitle%3DDependence%2520of%2520hypoxic%2520cellular%2520calcium%2520loading%2520on%2520Na%252B%25E2%2580%2593Ca2%252B%2520exchange%26jtitle%3DCirc.%2520Res.%26date%3D1992%26volume%3D71%26spage%3D547%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Allen, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.-H.</span><span> </span><span class="NLM_article-title">Role of the cardiac Na<sup>+</sup>/H<sup>+</sup> exchanger during ischemia and reperfusion</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">934</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=934-941&issue=4&author=D.+G.+Allenauthor=X.-H.+Xiao&title=Role+of+the+cardiac+Na%2B%2FH%2B+exchanger+during+ischemia+and+reperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DD.%2BG.%26aulast%3DXiao%26aufirst%3DX.-H.%26atitle%3DRole%2520of%2520the%2520cardiac%2520Na%252B%252FH%252B%2520exchanger%2520during%2520ischemia%2520and%2520reperfusion%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D57%26issue%3D4%26spage%3D934%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">[Na<sup>+</sup>]<sub>i</sub> and the driving force of the Na<sup>+</sup>/Ca<sup>2+</sup>-exchanger in heart failure</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=986-995&author=A.+Baartscheerauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=%5BNa%2B%5Di+and+the+driving+force+of+the+Na%2B%2FCa2%2B-exchanger+in+heart+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3D%255BNa%252B%255Di%2520and%2520the%2520driving%2520force%2520of%2520the%2520Na%252B%252FCa2%252B-exchanger%2520in%2520heart%2520failure%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D57%26spage%3D986%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borren, M. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">Increased Na<sup>+</sup>/H<sup>+</sup>-exchange activity is the cause of increased [Na<sup>+</sup>]<sub>i</sub> in heart failure and underlies disturbed calcium handling</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=1015-1024&issue=4&author=A.+Baartscheerauthor=M.+M.+C.+Borrenauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=Increased+Na%2B%2FH%2B-exchange+activity+is+the+cause+of+increased+%5BNa%2B%5Di+in+heart+failure+and+underlies+disturbed+calcium+handling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DBorren%26aufirst%3DM.%2BM.%2BC.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3DIncreased%2520Na%252B%252FH%252B-exchange%2520activity%2520is%2520the%2520cause%2520of%2520increased%2520%255BNa%252B%255Di%2520in%2520heart%2520failure%2520and%2520underlies%2520disturbed%2520calcium%2520handling%26jtitle%3DCardiovasc.%2520Res.%26date%3D2003%26volume%3D57%26issue%3D4%26spage%3D1015%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Avkiran, M.</span><span> </span><span class="NLM_article-title">Rational basis for use of sodium–hydrogen exchange inhibitors in myocardial ischemia</span> <span class="citation_source-journal">Am. J. Cardiol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">10G</span><span class="NLM_x">–</span> <span class="NLM_lpage">18G</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=10G-18G&issue=10&author=M.+Avkiran&title=Rational+basis+for+use+of+sodium%E2%80%93hydrogen+exchange+inhibitors+in+myocardial+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvkiran%26aufirst%3DM.%26atitle%3DRational%2520basis%2520for%2520use%2520of%2520sodium%25E2%2580%2593hydrogen%2520exchange%2520inhibitors%2520in%2520myocardial%2520ischemia%26jtitle%3DAm.%2520J.%2520Cardiol%26date%3D1999%26volume%3D83%26issue%3D10%26spage%3D10G%26epage%3D18G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Avkiran, M.</span><span> </span><span class="NLM_article-title">Protection of the myocardium during ischemia and reperfusion: Na<sup>+</sup>/H<sup>+</sup> exchange inhibition versus ischemic preconditioning</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2469</span><span class="NLM_x">–</span> <span class="NLM_lpage">2472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1999&pages=2469-2472&author=M.+Avkiran&title=Protection+of+the+myocardium+during+ischemia+and+reperfusion%3A+Na%2B%2FH%2B+exchange+inhibition+versus+ischemic+preconditioning"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvkiran%26aufirst%3DM.%26atitle%3DProtection%2520of%2520the%2520myocardium%2520during%2520ischemia%2520and%2520reperfusion%253A%2520Na%252B%252FH%252B%2520exchange%2520inhibition%2520versus%2520ischemic%2520preconditioning%26jtitle%3DCirculation%26date%3D1999%26volume%3D100%26spage%3D2469%26epage%3D2472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Avkiran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marber, M. S.</span><span> </span><span class="NLM_article-title">Na<sup>+</sup>/H<sup>+</sup> exchange inhibitors for cardioprotective therapy: progress, problems and prospects</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0735-1097%2802%2901693-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11869836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVGltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=747-753&author=M.+Avkiranauthor=M.+S.+Marber&title=Na%2B%2FH%2B+exchange+inhibitors+for+cardioprotective+therapy%3A+progress%2C+problems+and+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Na+/H+ exchange inhibitors for cardioprotective therapy: Progress, problems, and prospects</span></div><div class="casAuthors">Avkiran, Metin; Marber, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-753</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Extensive pre-clin. work indicates that inhibition of the sarcolemmal Na+/H+ exchanger (NHE) affords significant protection to myocardium subjected to ischemia and reperfusion, predominantly through reduced intracellular accumulation of Na+ and consequently Ca2+.  In contrast, recent clin. studies with the NHE inhibitors cariporide and eniporide in patients with evolving myocardial infarction (MI) and those at risk of MI have provided mixed and somewhat contradictory data.  The exptl. evidence suggests that the key mechanism through which NHE inhibitors afford protection consists in slowing the progression of myocardial injury during ischemia and thereby enhancing myocardial salvage by reperfusion.  It follows from this that, to obtain max. cardioprotective benefit, (1) the NHE inhibitor must be present in jeopardized myocardium, at a concn. sufficient to inhibit NHE activity, before (or as soon as possible after) the onset of ischemia, and (2) ischemia must be terminated by timely reperfusion.  Thus, in the GUARDIAN trial, the cardioprotective efficacy of cariporide was limited to the subset of high-risk patients who underwent coronary artery bypass graft surgery, in whom both prerequisites could be readily fulfilled.  In contrast, no cardioprotective benefit was obsd. in the ESCAMI trial, in which eniporide was administered late as an adjunct to reperfusion therapy in patients with evolving MI.  Ongoing clin. studies will det. whether NHE inhibition will find therapeutic application in the setting of cardiac surgery, while pre-clin. investigations continue to test the potential of NHE inhibitors in the treatment of other cardiovascular diseases such as heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWcVgAPjBM7Vg90H21EOLACvtfcHk0likcZ4hqW8atw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVGltb0%253D&md5=fb18063cf713069d0c5547f079032789</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0735-1097%2802%2901693-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0735-1097%252802%252901693-5%26sid%3Dliteratum%253Aachs%26aulast%3DAvkiran%26aufirst%3DM.%26aulast%3DMarber%26aufirst%3DM.%2BS.%26atitle%3DNa%252B%252FH%252B%2520exchange%2520inhibitors%2520for%2520cardioprotective%2520therapy%253A%2520progress%252C%2520problems%2520and%2520prospects%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2002%26volume%3D39%26spage%3D747%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Engelhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klambt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of Na<sup>+</sup>–H<sup>+</sup> exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=814-819&author=S.+Engelhardtauthor=L.+Heinauthor=U.+Kellerauthor=K.+Klambtauthor=M.+J.+Lohse&title=Inhibition+of+Na%2B%E2%80%93H%2B+exchange+prevents+hypertrophy%2C+fibrosis%2C+and+heart+failure+in+beta%281%29-adrenergic+receptor+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DS.%26aulast%3DHein%26aufirst%3DL.%26aulast%3DKeller%26aufirst%3DU.%26aulast%3DKlambt%26aufirst%3DK.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520Na%252B%25E2%2580%2593H%252B%2520exchange%2520prevents%2520hypertrophy%252C%2520fibrosis%252C%2520and%2520heart%2520failure%2520in%2520beta%25281%2529-adrenergic%2520receptor%2520transgenic%2520mice%26jtitle%3DCirc.%2520Res.%26date%3D2001%26volume%3D19%26spage%3D814%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gumina, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buerger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eickmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daemmgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span> </span><span class="NLM_article-title">Inhibition of the Na<sup>–</sup>/H<sup>–</sup> exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2519</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1999&pages=2519-2526&author=R.+J.+Guminaauthor=E.+Buergerauthor=C.+Eickmeierauthor=J.+Mooreauthor=J.+Daemmgenauthor=G.+J.+Gross&title=Inhibition+of+the+Na%E2%80%93%2FH%E2%80%93+exchanger+confers+greater+cardioprotection+against+90+minutes+of+myocardial+ischemia+than+ischemic+preconditioning+in+dogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGumina%26aufirst%3DR.%2BJ.%26aulast%3DBuerger%26aufirst%3DE.%26aulast%3DEickmeier%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DDaemmgen%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520Na%25E2%2580%2593%252FH%25E2%2580%2593%2520exchanger%2520confers%2520greater%2520cardioprotection%2520against%252090%2520minutes%2520of%2520myocardial%2520ischemia%2520than%2520ischemic%2520preconditioning%2520in%2520dogs%26jtitle%3DCirculation%26date%3D1999%26volume%3D100%26spage%3D2519%26epage%3D2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Camillión de Hurtado, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portiansky, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebolledo, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cingolani, H. E.</span><span> </span><span class="NLM_article-title">Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na<sup>+</sup>/H<sup>+</sup>-exchanger</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=862-868&issue=4&author=M.+C.+Camilli%C3%B3n+de+Hurtadoauthor=E.+L.+Portianskyauthor=N.+G.+Perezauthor=O.+R.+Rebolledoauthor=H.+E.+Cingolani&title=Regression+of+cardiomyocyte+hypertrophy+in+SHR+following+chronic+inhibition+of+the+Na%2B%2FH%2B-exchanger"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamilli%25C3%25B3n%2Bde%2BHurtado%26aufirst%3DM.%2BC.%26aulast%3DPortiansky%26aufirst%3DE.%2BL.%26aulast%3DPerez%26aufirst%3DN.%2BG.%26aulast%3DRebolledo%26aufirst%3DO.%2BR.%26aulast%3DCingolani%26aufirst%3DH.%2BE.%26atitle%3DRegression%2520of%2520cardiomyocyte%2520hypertrophy%2520in%2520SHR%2520following%2520chronic%2520inhibition%2520of%2520the%2520Na%252B%252FH%252B-exchanger%26jtitle%3DCardiovasc.%2520Res.%26date%3D2002%26volume%3D53%26issue%3D4%26spage%3D862%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Can, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmazyn, M.</span><span> </span><span class="NLM_article-title">Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">H381</span><span class="NLM_x">–</span> <span class="NLM_lpage">H387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=H381-H387&issue=1&author=L.+Chenauthor=C.+X.+Chenauthor=X.+T.+Canauthor=N.+Beierauthor=W.+Scholzauthor=M.+Karmazyn&title=Inhibition+and+reversal+of+myocardial+infarction-induced+hypertrophy+and+heart+failure+by+NHE-1+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%2BX.%26aulast%3DCan%26aufirst%3DX.%2BT.%26aulast%3DBeier%26aufirst%3DN.%26aulast%3DScholz%26aufirst%3DW.%26aulast%3DKarmazyn%26aufirst%3DM.%26atitle%3DInhibition%2520and%2520reversal%2520of%2520myocardial%2520infarction-induced%2520hypertrophy%2520and%2520heart%2520failure%2520by%2520NHE-1%2520inhibition%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2004%26volume%3D286%26issue%3D1%26spage%3DH381%26epage%3DH387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">Chronic inhibition of Na<sup>+</sup>/H<sup>+</sup>-exchanger attenuates cardiac hypertrophy and prevents cellular remodelling in heart failure</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=83-92&issue=1&author=A.+Baartscheerauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=Chronic+inhibition+of+Na%2B%2FH%2B-exchanger+attenuates+cardiac+hypertrophy+and+prevents+cellular+remodelling+in+heart+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3DChronic%2520inhibition%2520of%2520Na%252B%252FH%252B-exchanger%2520attenuates%2520cardiac%2520hypertrophy%2520and%2520prevents%2520cellular%2520remodelling%2520in%2520heart%2520failure%26jtitle%3DCardiovasc.%2520Res.%26date%3D2005%26volume%3D65%26issue%3D1%26spage%3D83%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chahine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bkaily, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Khoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, W..</span><span> </span><span class="NLM_article-title">NHE-1-dependent intracellular sodium overload in hypertrophic hereditary cardiomyopathy: prevention by NHE-1 inhibitor</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2Fj.yjmcc.2005.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=15808834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivF2ju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=571-582&issue=4&author=M.+Chahineauthor=G.+Bkailyauthor=M.+Naderauthor=J.+Al-Khouryauthor=D.+Jacquesauthor=N.+Beierauthor=W..+Scholz&title=NHE-1-dependent+intracellular+sodium+overload+in+hypertrophic+hereditary+cardiomyopathy%3A+prevention+by+NHE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">NHE-1-dependent intracellular sodium overload in hypertrophic hereditary cardiomyopathy and prevention by NHE-1 inhibitor</span></div><div class="casAuthors">Chahine, Mirna; Bkaily, Ghassan; Nader, Moni; Al-Khoury, Johny; Jacques, Danielle; Beier, Norbert; Scholz, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">571-582</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The purpose of this study was to verify whether myocardial intracellular Na+ overload may take place in the hereditary cardiomyopathic hamster (CMH), as a result of an increased activity of the Na+-H+ exchanger isoform-1 (NHE-1).  Our results showed that simultaneous intracellular Na+ and Ca2+ overloads as well as an increase of NHE-1 protein level took place during the development of necrosis and hypertrophy in the CMH.  Treatment of 30-day-old CMHs during the development of necrosis and in the absence of hypertrophy with the specific NHE-1 inhibitor EMD87580 (EMD) for 50 days significantly prevented the increase of NHE-1 protein level and intracellular Na+ and Ca2+ overloads as well as necrosis.  Treatment of CMHs during the development of hypertrophy with EMD for 198 days prevented the development of both necrosis and hypertrophy.  In conclusion, our results suggest that NHE-1 overexpression as well as Na+ and Ca2+ overloads do take place during the development of necrosis and hypertrophy in hereditary CMHs.  Moreover, our results suggest that the blockade of NHE-1 by EMD87580 prevents these diseases by preventing the increase of Na+ influx through the NHE-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmpQ7ZAz-FrVg90H21EOLACvtfcHk0ljFXEoL7UK3HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivF2ju78%253D&md5=a064d1a21c6c2270468586fc42521fd8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2005.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2005.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DChahine%26aufirst%3DM.%26aulast%3DBkaily%26aufirst%3DG.%26aulast%3DNader%26aufirst%3DM.%26aulast%3DAl-Khoury%26aufirst%3DJ.%26aulast%3DJacques%26aufirst%3DD.%26aulast%3DBeier%26aufirst%3DN.%26aulast%3DScholz%26aufirst%3DW..%26atitle%3DNHE-1-dependent%2520intracellular%2520sodium%2520overload%2520in%2520hypertrophic%2520hereditary%2520cardiomyopathy%253A%2520prevention%2520by%2520NHE-1%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2005%26volume%3D38%26issue%3D4%26spage%3D571%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Baartscheer, A.</span><span> </span><span class="NLM_article-title">Chronic inhibition of the Na<sup>+</sup>/H<sup>+</sup>-exchanger in the heart</span> <span class="citation_source-journal">Curr. Vasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.2174%2F157016106775203117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=16472174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=23-29&issue=1&author=A.+Baartscheer&title=Chronic+inhibition+of+the+Na%2B%2FH%2B-exchanger+in+the+heart"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic inhibition of Na+/H+-exchanger in the heart</span></div><div class="casAuthors">Baartscheer, Antonius</div><div class="citationInfo"><span class="NLM_cas:title">Current Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">CVPUAY</span>;
        ISSN:<span class="NLM_cas:issn">1570-1611</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The incidence and prevalence of heart failure (HF) has increased over the last decades.  The main reasons for this increase are the ageing population and an increase in survival rate after myocardial infarction and other cardiovascular diseases.  Although, pharmacotherapy has significantly improved survival, the prognosis of HF is still rather poor.  Total mortality is high and approx. half of the deaths are sudden and unexpected.  Angiotensin-converting-enzyme (ACE)-inhibitors generally given with diuretic and digoxin are the std. treatment for patients with HF.  Despite the established benefits of ACE-inhibitors there is a need for new pharmacol. tools for the treatment of HF.  Recent exptl. evidence has shown that activity of the Na+/H+-exchanger in the heart (NHE-1) is increased in HF.  Because NHE-1 exchanges intracellular H+ for extracellular Na+ in a one by one stoichiometry, the intracellular ionic changes resulting from increased activity, will be a increased pHi and intracellular sodium ([Na+]i).  Activation of NHE-1 results only in a small increase in pHi, under physiol. conditions where bicarbonate-dependent mechanisms are active.  However, a considerable increase in [Na+]i was always present.  The elevation of [Na+]i might be responsible for the increase of intracellular calcium ([Ca2+]i) levels mediated by the Na+/Ca2+-exchanger (NCX).  Increases in [Na+]i, pHi and [Ca2+]i, features of cardiac myocytes isolated from failing hearts, are recognized as a cell growth signal And thus may play a role in the hypertrophic response, cellular remodeling and finally the development of HF.  Acute application of cariporide, an inhibitor of NHE-1, on failing myocytes not only normalized [Na+]i but also cytoplasmic and sarcoplasmic reticulum calcium handling and the propensity to develop delayed after depolarizations (DAD's).  In several animal models of HF it has been shown the chronic inhibition of NHE-1 attenuates the development of hypertrophy and whole heart remodeling.  Recently, in a vol. and pressure overload model of HF in rabbits it has been demonstrated that chronic treatment also prevents the development of HF and cellular ionic and electrophysiol. remodeling.  Therefore, chronic treatment with an inhibitor of NHE-1 might prove beneficial in patients at risk of developing HF, esp. when given at an early stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTF9ZhIacbbVg90H21EOLACvtfcHk0ljFXEoL7UK3HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGhtw%253D%253D&md5=aafde0cf7aaeddf12da1e9a12ca14a73</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F157016106775203117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016106775203117%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26atitle%3DChronic%2520inhibition%2520of%2520the%2520Na%252B%252FH%252B-exchanger%2520in%2520the%2520heart%26jtitle%3DCurr.%2520Vasc.%2520Pharmacol.%26date%3D2006%26volume%3D4%26issue%3D1%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Baartscheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardziyenka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belterman, C. N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Borren, M. M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkerk, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coronel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiolet, J. W. T.</span><span> </span><span class="NLM_article-title">Chronic inhibition of the Na<sup>+</sup>/H<sup>+</sup> exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1038%2Fbjp.2008.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=18493245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1266-1275&issue=6&author=A.+Baartscheerauthor=M.+Hardziyenkaauthor=C.+A.+Schumacherauthor=C.+N.+W.+Beltermanauthor=M.+M.+G.+J.+van+Borrenauthor=A.+O.+Verkerkauthor=R.+Coronelauthor=J.+W.+T.+Fiolet&title=Chronic+inhibition+of+the+Na%2B%2FH%2B+exchanger+causes+regression+of+hypertrophy%2C+heart+failure%2C+and+ionic+and+electrophysiological+remodelling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic inhibition of the Na+/H+-exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling</span></div><div class="casAuthors">Baartscheer, A.; Hardziyenka, M.; Schumacher, C. A.; Belterman, C. N. W.; van Borren, M. M. G. J.; Verkerk, A. O.; Coronel, R.; Fiolet, J. W. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1266-1275</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Increased activity of the Na+/H+-exchanger (NHE-1) in heart failure underlies raised [Na+]i causing disturbances of calcium handling.  Inhibition of NHE-1, initiated at the onset of pressure/vol. overload, prevents development of hypertrophy, heart failure and remodelling.  We hypothesized that chronic inhibition of NHE-1, initiated at a later stage, would induce regression of hypertrophy, heart failure, and ionic and electrophysiol. remodelling.  Exptl. approach: Development of heart failure in rabbits was monitored electrocardiog. and echocardiog., after one or three months.  Cardiac myocytes were also isolated.  One group of animals were treated with cariporide (inhibitor of NHE-1) in the diet after one month.  Cytoplasmic calcium, sodium and action potentials were measured with fluorescent markers and sarcoplasmic reticulum calcium content by rapid cooling.  Calcium after-transients were elicited after rapid pacing.  Sodium channel current (INa) was measured using patch-clamp techniques.  Key results: Hypertrophy and heart failure developed after one month and progressed during the next two months.  After one month, dietary treatment with cariporide was initiated.  Two months of treatment reduced hypertrophy and heart failure, duration of action potential QT-interval and QRS, and restored sodium and calcium handling and the incidence of calcium after-transients.  In cardiac myocytes, parameters of INa were not changed by cariporide.  Conclusion and implications: In rabbit hearts with hypertrophy and signs of heart failure one month after induction of pressure/vol. overload, two months of dietary treatment with the NHE-1 inhibitor cariporide caused regression of hypertrophy, heart failure and ionic and electrophysiol. remodelling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKUQOxvIBuRrVg90H21EOLACvtfcHk0ljFXEoL7UK3HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCjtLw%253D&md5=1a6d78ffa2adc9db4f63a1f54a702f5d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.189%26sid%3Dliteratum%253Aachs%26aulast%3DBaartscheer%26aufirst%3DA.%26aulast%3DHardziyenka%26aufirst%3DM.%26aulast%3DSchumacher%26aufirst%3DC.%2BA.%26aulast%3DBelterman%26aufirst%3DC.%2BN.%2BW.%26aulast%3Dvan%2BBorren%26aufirst%3DM.%2BM.%2BG.%2BJ.%26aulast%3DVerkerk%26aufirst%3DA.%2BO.%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DFiolet%26aufirst%3DJ.%2BW.%2BT.%26atitle%3DChronic%2520inhibition%2520of%2520the%2520Na%252B%252FH%252B%2520exchanger%2520causes%2520regression%2520of%2520hypertrophy%252C%2520heart%2520failure%252C%2520and%2520ionic%2520and%2520electrophysiological%2520remodelling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26issue%3D6%26spage%3D1266%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mraiche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karmazyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fliegel, L.</span><span> </span><span class="NLM_article-title">Activated NHE1 is required to induce early cardiac hypertrophy in mice</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1007%2Fs00395-011-0161-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=21359875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2011&pages=603-616&author=F.+Mraicheauthor=T.+Okaauthor=X.+T.+Ganauthor=M.+Karmazynauthor=L.+Fliegel&title=Activated+NHE1+is+required+to+induce+early+cardiac+hypertrophy+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activated NHE1 is required to induce early cardiac hypertrophy in mice</span></div><div class="casAuthors">Mraiche, Fatima; Oka, Tatsujiro; Gan, Xiaohong T.; Karmazyn, Morris; Fliegel, Larry</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-616</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The Na+/H+ exchanger isoform 1 (NHE1) has been implicated as being causal in cardiac hypertrophy and the protein level and activity are elevated in the diseased myocardium.  However, it is unclear whether mere elevation of the protein is sufficient for cardiac pathol., or whether activation of the protein is required.  In this study, we examd. the comparative effects of elevation of wild type and activated NHE1.  Two mouse transgenic models that expressed either a wild type NHE1 protein or an activated NHE1 protein were characterized.  Expression of activated NHE1 caused significant increases in heart wt. to body wt., apoptosis, cross-sectional area, interstitial fibrosis and decreased cardiac performance.  Expression of wild type NHE1 caused a much milder pathol.  When we examd. 2 or 10-wk-old mouse hearts, there was neither elevation of calcineurin levels nor increased phosphorylation of ERK or p38 in either NHE1 transgenic mouse line.  Expression of activated NHE1 in intact mice caused an increased sensitivity to phenylephrine-induced hypertrophy.  Our results show that expression of activated NHE1 promotes cardiac hypertrophy to a much greater degree than elevated levels of wild type NHE1 alone.  In addn., expression of activated NHE1 promotes greater sensitivity to neurohormonal stimulation.  The results suggest that activation of NHE1 is a key component that accentuates NHE1-induced myocardial pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra0p9akEQtbbVg90H21EOLACvtfcHk0ljFXEoL7UK3HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVaitr4%253D&md5=bea6accf5067d82005259f0adaf017c5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00395-011-0161-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-011-0161-4%26sid%3Dliteratum%253Aachs%26aulast%3DMraiche%26aufirst%3DF.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DGan%26aufirst%3DX.%2BT.%26aulast%3DKarmazyn%26aufirst%3DM.%26aulast%3DFliegel%26aufirst%3DL.%26atitle%3DActivated%2520NHE1%2520is%2520required%2520to%2520induce%2520early%2520cardiac%2520hypertrophy%2520in%2520mice%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2011%26volume%3D106%26spage%3D603%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Touret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanneur, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godart, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dammgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Counillon, L.</span><span> </span><span class="NLM_article-title">Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x"> (</span><span class="NLM_issue">2–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0014-2999%2802%2902824-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=12524140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVer" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2003&pages=151-158&issue=2%E2%80%933&author=N.+Touretauthor=V.+Tanneurauthor=H.+Godartauthor=R.+Seidlerauthor=N.+Takiauthor=E.+Burgerauthor=J.+Dammgenauthor=L.+Counillon&title=Characterization+of+sabiporide%2C+a+new+specific+NHE-1+inhibitor+exhibiting+slow+dissociation+kinetics+and+cardioprotective+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects</span></div><div class="casAuthors">Touret, Nicolas; Tanneur, Valerie; Godart, Helene; Seidler, Randolph; Taki, Naoyuki; Burger, Erich; Dammgen, Jurgen; Counillon, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Sabiporide, a new benzoguanidine, was characterized on fibroblasts stably expressing the Na+/H+ exchanger isoforms NHE-1, NHE-2 and NHE-3. 2.  22Na+ uptake expts. show that this compd. possesses a Ki of 5 ± 1.2 x 10-8 M for NHE-1, and discriminates efficiently between the NHE-1, -2 and -3 isoforms (K for NHE-2: 3 ± 0.9 x 10-6 M, and K >1 mM for NHE-3).  Similar Ki values are obtained on rat cardiomyocytes and human platelets expressing NHE-1 (Ki's of 7 ± 1 × 10-9 and 2.7 ± 0.4 × 10-8 M resp.).  Interestingly, when compared with amiloride and cariporide, sabiporide inhibition persists even after this mol. had been rinsed out (half time of 7 h for sabiporide, and of 1 and 2.5 min for amiloride and cariporide, resp.), the decay of all these mols. exhibiting a complex multiexponential behavior.  Thus, sabiporide, which possesses remarkable cardioprotective properties, is a specific NHE-1 inhibitor possessing unique binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2_rkDHJTJcrVg90H21EOLACvtfcHk0li8MwEuLjgSJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVer&md5=9f3eb7cc5d0996fca429174f2b3e4a18</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902824-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902824-8%26sid%3Dliteratum%253Aachs%26aulast%3DTouret%26aufirst%3DN.%26aulast%3DTanneur%26aufirst%3DV.%26aulast%3DGodart%26aufirst%3DH.%26aulast%3DSeidler%26aufirst%3DR.%26aulast%3DTaki%26aufirst%3DN.%26aulast%3DBurger%26aufirst%3DE.%26aulast%3DDammgen%26aufirst%3DJ.%26aulast%3DCounillon%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520sabiporide%252C%2520a%2520new%2520specific%2520NHE-1%2520inhibitor%2520exhibiting%2520slow%2520dissociation%2520kinetics%2520and%2520cardioprotective%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D459%26issue%3D2%25E2%2580%25933%26spage%3D151%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Knight, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacAndrew, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellery, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marala, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, R.t.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, W. R.</span><span> </span><span class="NLM_article-title">A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11259552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2001&pages=254-259&issue=1&author=D.+R.+Knightauthor=A.+H.+Smithauthor=D.+M.+Flynnauthor=J.+T.+MacAndrewauthor=S.+S.+Elleryauthor=J.+X.+Kongauthor=R.+B.+Maralaauthor=R.t.+Westerauthor=A.+Guzman-Perezauthor=R.+J.+Hillauthor=W.+P.+Mageeauthor=W.+R.+Tracey&title=A+novel+sodium-hydrogen+exchanger+isoform-1+inhibitor%2C+zoniporide%2C+reduces+ischemic+myocardial+injury+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo</span></div><div class="casAuthors">Knight, Delvin R.; Smith, Andrew H.; Flynn, David M.; Macandrew, Joseph T.; Ellery, Suzanne S.; Kong, Jimmy X.; Marala, Ravi B.; Wester, Ronald T.; Guzman-Perez, Angel; Hill, Roger J.; Magee, William P.; Tracey, W. Ross</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">254-259</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The cardioprotective efficacy of zoniporide (CP-597,396), a novel, potent, and selective inhibitor of the sodium-hydrogen exchanger isoform 1 (NHE-1), was evaluated both in vitro and in vivo using rabbit models of myocardial ischemia-reperfusion injury.  In these models, myocardial injury was elicited with 30 min of regional ischemia and 120 min of reperfusion.  Zoniporide elicited a concn.-dependent redn. in infarct size (EC50 of 0.25 nM) in the isolated heart (Langendorff) and reduced infarct size by 83% (50 nM).  This compd. was 2.5- to 20-fold more potent than either eniporide or cariporide (EC50 of 0.69 and 5.11 nM, resp.), and reduced infarct size to a greater extent than eniporide (58% redn. in infarct size).  In open-chest, anesthetized rabbits, zoniporide also elicited a dose-dependent redn. in infarct size (ED50 of 0.45 mg/kg/h) and inhibited NHE-1-mediated platelet swelling (max. inhibition 93%).  Furthermore, zoniporide did not cause any in vivo hemodynamic (mean arterial pressure, heart rate, rate pressure product) changes.  Zoniporide represents a novel class of potent NHE-1 inhibitors with potential utility for providing clin. cardioprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2jLqF30VgvbVg90H21EOLACvtfcHk0li8MwEuLjgSJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVSrsbk%253D&md5=2cdde108aa2640c1617a21e4e2ac3b2a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DD.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BH.%26aulast%3DFlynn%26aufirst%3DD.%2BM.%26aulast%3DMacAndrew%26aufirst%3DJ.%2BT.%26aulast%3DEllery%26aufirst%3DS.%2BS.%26aulast%3DKong%26aufirst%3DJ.%2BX.%26aulast%3DMarala%26aufirst%3DR.%2BB.%26aulast%3DWester%26aufirst%3DR.t.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DMagee%26aufirst%3DW.%2BP.%26aulast%3DTracey%26aufirst%3DW.%2BR.%26atitle%3DA%2520novel%2520sodium-hydrogen%2520exchanger%2520isoform-1%2520inhibitor%252C%2520zoniporide%252C%2520reduces%2520ischemic%2520myocardial%2520injury%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D297%26issue%3D1%26spage%3D254%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scholz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albus, U.</span><span> </span><span class="NLM_article-title">Development of the Na<sup>+</sup>/H<sup>+</sup> exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial</span> <span class="citation_source-journal">J. Thromb. Thrombolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1023%2FA%3A1008998716063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=10481216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFOrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=61-69&issue=1&author=W.+Scholzauthor=A.+Jesselauthor=U.+Albus&title=Development+of+the+Na%2B%2FH%2B+exchange+inhibitor+cariporide+as+a+cardioprotective+drug%3A+from+the+laboratory+to+the+GUARDIAN+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial</span></div><div class="casAuthors">Scholz, Wolfgang; Jessel, Andreas; Albus, Udo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-69</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 27 refs. on the development of cariporide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpe6RKfrF3wrVg90H21EOLACvtfcHk0li8MwEuLjgSJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFOrsL8%253D&md5=21a44f58482116bf0ec25928a0fac0d7</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008998716063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008998716063%26sid%3Dliteratum%253Aachs%26aulast%3DScholz%26aufirst%3DW.%26aulast%3DJessel%26aufirst%3DA.%26aulast%3DAlbus%26aufirst%3DU.%26atitle%3DDevelopment%2520of%2520the%2520Na%252B%252FH%252B%2520exchange%2520inhibitor%2520cariporide%2520as%2520a%2520cardioprotective%2520drug%253A%2520from%2520the%2520laboratory%2520to%2520the%2520GUARDIAN%2520trial%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D1999%26volume%3D8%26issue%3D1%26spage%3D61%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karmazyn, M.</span><span> </span><span class="NLM_article-title">Pharmacology and clinical assessment of cariporide for the treatment of coronary artery diseases</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1099</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1099-1108&issue=5&author=M.+Karmazyn&title=Pharmacology+and+clinical+assessment+of+cariporide+for+the+treatment+of+coronary+artery+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarmazyn%26aufirst%3DM.%26atitle%3DPharmacology%2520and%2520clinical%2520assessment%2520of%2520cariporide%2520for%2520the%2520treatment%2520of%2520coronary%2520artery%2520diseases%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26issue%3D5%26spage%3D1099%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yeshmina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marban, E.</span><span> </span><span class="NLM_article-title">Cariporide (HOE642), a selective Na<sup>+</sup>–H<sup>+</sup> exchange inhibitor, inhibits the mitochondrial death pathway</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">2275</span><span class="NLM_x">–</span> <span class="NLM_lpage">2281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2003&pages=2275-2281&author=T.+Yeshminaauthor=M.+Akaoauthor=S.+P.+Jonesauthor=E.+Marban&title=Cariporide+%28HOE642%29%2C+a+selective+Na%2B%E2%80%93H%2B+exchange+inhibitor%2C+inhibits+the+mitochondrial+death+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYeshmina%26aufirst%3DT.%26aulast%3DAkao%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BP.%26aulast%3DMarban%26aufirst%3DE.%26atitle%3DCariporide%2520%2528HOE642%2529%252C%2520a%2520selective%2520Na%252B%25E2%2580%2593H%252B%2520exchange%2520inhibitor%252C%2520inhibits%2520the%2520mitochondrial%2520death%2520pathway%26jtitle%3DCirculation%26date%3D2003%26volume%3D108%26spage%3D2275%26epage%3D2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zeymer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryapranata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monassier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opolski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmanis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linssen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebbe, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machnig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhaus, K. L.</span><span> </span><span class="NLM_article-title">The Na<sup>+</sup>/H<sup>+</sup> exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1644</span><span class="NLM_x">–</span> <span class="NLM_lpage">1650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0735-1097%2801%2901608-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11704395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVyhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1644-1650&author=U.+Zeymerauthor=H.+Suryapranataauthor=J.+P.+Monassierauthor=G.+Opolskiauthor=J.+Daviesauthor=G.+Rasmanisauthor=G.+Linssenauthor=U.+Tebbeauthor=R.+Schroderauthor=R.+Tiemannauthor=T.+Machnigauthor=K.+L.+Neuhaus&title=The+Na%2B%2FH%2B+exchange+inhibitor+eniporide+as+an+adjunct+to+early+reperfusion+therapy+for+acute+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial</span></div><div class="casAuthors">Zeymer, Uwe; Suryapranata, Harry; Monassier, Jean Pierre; Opolski, Grzegorz; Davies, John; Rasmanis, Gundars; Linssen, Gerard; Tebbe, Ulrich; Schroder, Rolf; Tiemann, Rolf; Machnig, Thomas; Neuhaus, Karl-Ludwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1644-1650</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We conducted an international, prospective, randomized, double-blind, placebo-controlled phase 2 trial in patients undergoing thrombolytic therapy or primary angioplasty for acute ST-elevation myocardial infarction (MI) to investigate the effect of eniporide on infarct size and clin. outcome.  Exptl. studies suggest that the activity of the Na+/H+ exchange (NHE) plays an important role in the unfavorable sequels of myocardial ischemia and reperfusion.  Eniporide specifically inhibits the NHE-1 isoform and has been shown to limit infarct size in exptl. models.  The primary efficacy end point was the infarct size measured by the cumulative release of alpha-hydroxybutyrate dehydrogenase (alpha-HDBH) (area under the curve [AUC] 0 to 72 h).  In stage 1, 50, 100, 150 or 200 mg eniporide given as a 10-min infusion before start of reperfusion therapy were compared with placebo in 430 patients, and in stage 2, 100 and 150 mg eniporide were compared with placebo in 959 patients.  In stage 1, the administration of 100 mg and 150 mg eniporide resulted in smaller infarct sizes (mean alpha-HBDH AUC in U/mL × h, placebo: 44.2, 100 mg eniporide: 40.2, 150 mg eniporide: 33.9), esp. in the angioplasty group.  In contrast, in stage 2 there was no difference in the enzymic infarct size between the three groups (placebo: 41.2, 100 mg eniporide: 43.0, 150 mg eniporide: 41.5).  Overall there was no effect of eniporide on clin. outcome (death, cardiogenic shock, heart failure, life-threatening arrhythmias).  However, there was a significant redn. of the incidence of heart failure in patients reperfused late (>4 h).  In this large study administration of the NHE-1 inhibitor eniporide, before reperfusion therapy in patients with acute ST elevation MI, did not limit infarct size or improve clin. outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhuAOlR56VaLVg90H21EOLACvtfcHk0liBS--O9NVMgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVyhtbk%253D&md5=a53736cb6dd567f09dd30726b1cf335e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0735-1097%2801%2901608-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0735-1097%252801%252901608-4%26sid%3Dliteratum%253Aachs%26aulast%3DZeymer%26aufirst%3DU.%26aulast%3DSuryapranata%26aufirst%3DH.%26aulast%3DMonassier%26aufirst%3DJ.%2BP.%26aulast%3DOpolski%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DRasmanis%26aufirst%3DG.%26aulast%3DLinssen%26aufirst%3DG.%26aulast%3DTebbe%26aufirst%3DU.%26aulast%3DSchroder%26aufirst%3DR.%26aulast%3DTiemann%26aufirst%3DR.%26aulast%3DMachnig%26aufirst%3DT.%26aulast%3DNeuhaus%26aufirst%3DK.%2BL.%26atitle%3DThe%2520Na%252B%252FH%252B%2520exchange%2520inhibitor%2520eniporide%2520as%2520an%2520adjunct%2520to%2520early%2520reperfusion%2520therapy%2520for%2520acute%2520myocardial%2520infarction%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2001%26volume%3D38%26spage%3D1644%26epage%3D1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gumina, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchampach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buerger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eickmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daemmgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span> </span><span class="NLM_article-title">Na<sup>+</sup>/H<sup>+</sup> exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes</span> <span class="citation_source-journal">Am. J. Physiol.: Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1563</span><span class="NLM_x">–</span> <span class="NLM_lpage">1570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2000&pages=1563-1570&issue=4&author=R.+J.+Guminaauthor=J.+Auchampachauthor=R.+Wangauthor=E.+Buergerauthor=C.+Eickmeierauthor=J.+Mooreauthor=J.+Daemmgenauthor=G.+J.+Gross&title=Na%2B%2FH%2B+exchange+inhibition-induced+cardioprotection+in+dogs%3A+effects+on+neutrophils+versus+cardiomyocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGumina%26aufirst%3DR.%2BJ.%26aulast%3DAuchampach%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DBuerger%26aufirst%3DE.%26aulast%3DEickmeier%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DDaemmgen%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26atitle%3DNa%252B%252FH%252B%2520exchange%2520inhibition-induced%2520cardioprotection%2520in%2520dogs%253A%2520effects%2520on%2520neutrophils%2520versus%2520cardiomyocytes%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Heart%2520Circ.%2520Physiol.%26date%3D2000%26volume%3D279%26issue%3D4%26spage%3D1563%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation reactions of five-membered aromatic heterocyclic rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&issue=3&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+reactions+of+five-membered+aromatic+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0liBS--O9NVMgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520reactions%2520of%2520five-membered%2520aromatic%2520heterocyclic%2520rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26issue%3D3%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0li3shfAMTkkOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mukaiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saigo, K.</span><span> </span><span class="NLM_article-title">A convenient method for the synthesis of carboxylic esters</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&pages=1045-1048&author=T.+Mukaiyamaauthor=M.+Usuiauthor=E.+Shimadaauthor=K.+Saigo&title=A+convenient+method+for+the+synthesis+of+carboxylic+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukaiyama%26aufirst%3DT.%26aulast%3DUsui%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DE.%26aulast%3DSaigo%26aufirst%3DK.%26atitle%3DA%2520convenient%2520method%2520for%2520the%2520synthesis%2520of%2520carboxylic%2520esters%26jtitle%3DChem.%2520Lett.%26date%3D1975%26spage%3D1045%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Saigo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, T.</span><span> </span><span class="NLM_article-title">New method for the preparation of carboxylic esters</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1977&pages=1863-1866&author=K.+Saigoauthor=M.+Usuiauthor=K.+Kikuchiauthor=E.+Shimadaauthor=T.+Mukaiyama&title=New+method+for+the+preparation+of+carboxylic+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaigo%26aufirst%3DK.%26aulast%3DUsui%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DE.%26aulast%3DMukaiyama%26aufirst%3DT.%26atitle%3DNew%2520method%2520for%2520the%2520preparation%2520of%2520carboxylic%2520esters%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1977%26volume%3D50%26spage%3D1863%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saigo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama., T.</span><span> </span><span class="NLM_article-title">A facile synthesis of carboxamides by using 1-methyl-2-halo pyridinium iodides as coupling reagents</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&pages=1163-1166&author=E.+Baldauthor=K.+Saigoauthor=T.+Mukaiyama.&title=A+facile+synthesis+of+carboxamides+by+using+1-methyl-2-halo+pyridinium+iodides+as+coupling+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBald%26aufirst%3DE.%26aulast%3DSaigo%26aufirst%3DK.%26aulast%3DMukaiyama.%26aufirst%3DT.%26atitle%3DA%2520facile%2520synthesis%2520of%2520carboxamides%2520by%2520using%25201-methyl-2-halo%2520pyridinium%2520iodides%2520as%2520coupling%2520reagents%26jtitle%3DChem.%2520Lett.%26date%3D1975%26spage%3D1163%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Baumgarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gericke, R.</span><span> </span><span class="NLM_article-title">(2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na<sup>+</sup>/H<sup>+</sup> antiporter Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2017</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960768n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2017-2034&author=M.+Baumgarthauthor=N.+Beierauthor=R.+Gericke&title=%282-Methyl-5-%28methylsulfonyl%29benzoyl%29guanidine+Na%2B%2FH%2B+antiporter+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm960768n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960768n%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgarth%26aufirst%3DM.%26aulast%3DBeier%26aufirst%3DN.%26aulast%3DGericke%26aufirst%3DR.%26atitle%3D%25282-Methyl-5-%2528methylsulfonyl%2529benzoyl%2529guanidine%2520Na%252B%252FH%252B%2520antiporter%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2017%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahmad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarco, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorso, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span> </span><span class="NLM_article-title">Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3302</span><span class="NLM_x">–</span> <span class="NLM_lpage">3310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010100v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3302-3310&author=S.+Ahmadauthor=L.+M.+Doweykoauthor=S.+Dugarauthor=N.+Grazierauthor=K.+Nguauthor=S.+C.+Wuauthor=K.+J.+Yostauthor=B.-C.+Chenauthor=J.+Z.+Gougoutasauthor=J.+D.+DiMarcoauthor=S.-J.+Lanauthor=B.+J.+Gavinauthor=A.+J.+Chenauthor=C.+R.+Dorsoauthor=R.+Serafinoauthor=M.+Kirbyauthor=K.+S.+Atwal&title=Arylcyclopropanecarboxyl+guanidines+as+novel%2C+potent%2C+and+selective+inhibitors+of+the+sodium+hydrogen+exchanger+isoform-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fjm010100v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010100v%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DL.%2BM.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DGrazier%26aufirst%3DN.%26aulast%3DNgu%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DS.%2BC.%26aulast%3DYost%26aufirst%3DK.%2BJ.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DLan%26aufirst%3DS.-J.%26aulast%3DGavin%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DA.%2BJ.%26aulast%3DDorso%26aufirst%3DC.%2BR.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DArylcyclopropanecarboxyl%2520guanidines%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitors%2520of%2520the%2520sodium%2520hydrogen%2520exchanger%2520isoform-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3302%26epage%3D3310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ahmad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen., B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective, and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=177-180&author=S.+Ahmadauthor=K.+Nguauthor=D.+W.+Combsauthor=S.+C.+Wuauthor=S.+D.+Weinsteinauthor=W.+Liuauthor=B.-C.+Chen.author=G.+Chandrasenaauthor=C.+Dorsoauthor=M.+Kirbyauthor=K.+S.+Atwal&title=Aminoimidazoles+as+bioisosteres+of+acylguanidines%3A+novel%2C+potent%2C+selective%2C+and+orally+bioavailable+inhibitors+of+the+sodium+hydrogen+exchanger+isoform-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DNgu%26aufirst%3DK.%26aulast%3DCombs%26aufirst%3DD.%2BW.%26aulast%3DWu%26aufirst%3DS.%2BC.%26aulast%3DWeinstein%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen.%26aufirst%3DB.-C.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DDorso%26aufirst%3DC.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DAminoimidazoles%2520as%2520bioisosteres%2520of%2520acylguanidines%253A%2520novel%252C%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520sodium%2520hydrogen%2520exchanger%2520isoform-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D177%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorso, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1<i>H</i>-imidazol-4-yl)piperidin-1-yl)pyrimidine analogues as potent, highly selective, and orally bioavailable NHE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4796</span><span class="NLM_x">–</span> <span class="NLM_lpage">4799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4796-4799&author=K.+S.+Atwalauthor=S.+V.+O%E2%80%99Neilauthor=S.+Ahmadauthor=L.+Doweykoauthor=M.+Kirbyauthor=C.+R.+Dorsoauthor=G.+Chandrasenaauthor=B.-C.+Chenauthor=R.+Zhaoauthor=R.+Zahler&title=Synthesis+and+biological+activity+of+5-aryl-4-%284-%285-methyl-1H-imidazol-4-yl%29piperidin-1-yl%29pyrimidine+analogues+as+potent%2C+highly+selective%2C+and+orally+bioavailable+NHE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DDorso%26aufirst%3DC.%2BR.%26aulast%3DChandrasena%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DZahler%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%25205-aryl-4-%25284-%25285-methyl-1H-imidazol-4-yl%2529piperidin-1-yl%2529pyrimidine%2520analogues%2520as%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520bioavailable%2520NHE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4796%26epage%3D4799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, B. S.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-heteroaryl-2-amino-5-methylimidazole analogs as NHE-1 inhibitors</span> <span class="citation_source-journal">Bull. Korean Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2621</span><span class="NLM_x">–</span> <span class="NLM_lpage">2624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.5012%2Fbkcs.2009.30.11.2621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFylt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2621-2624&issue=11&author=S.+Leeauthor=K.+Yangauthor=B.+H.+Leeauthor=B.+S.+Yoon&title=Synthesis+and+biological+evaluation+of+4-heteroaryl-2-amino-5-methylimidazole+analogs+as+NHE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of 4-heteroaryl-2-amino-5-methylimidazole analogs as NHE-1 inhibitors</span></div><div class="casAuthors">Lee, Sunkyung; Yi, Kyu Yang; Lee, Byung Ho; Yoon, Boo Soon</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2621-2625</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">To identify a non-acylguanidine NHE-1 inhibitor, an acylguanidne group was replaced with an imidazole group in the potent sodium hydrogen exchanger type 1 (NHE-1) inhibitors with furan or benzothiophene core template, found from the authors' previous studies.  4-(2-Furyl)- and 4-(benzothienyl)-2-amino-5-methylimidazoles were synthesized and evaluated biol.  All these imidazoles presented potent NHE-1 inhibitory activity similar to the corresponding acylguanidines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJCqDe1fz7xbVg90H21EOLACvtfcHk0lj4rcuzSFXcng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFylt7fE&md5=79fd3cbea24a5d0a71b8c83e8b61ba68</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2009.30.11.2621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2009.30.11.2621%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DYoon%26aufirst%3DB.%2BS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-heteroaryl-2-amino-5-methylimidazole%2520analogs%2520as%2520NHE-1%2520inhibitors%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2009%26volume%3D30%26issue%3D11%26spage%3D2621%26epage%3D2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span> </span><span class="NLM_article-title">Calculating partition coefficient by atom-additive method</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=47-66&author=R.+Wangauthor=Y.+Gaoauthor=L.+Lai&title=Calculating+partition+coefficient+by+atom-additive+method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DCalculating%2520partition%2520coefficient%2520by%2520atom-additive%2520method%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D19%26spage%3D47%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trigg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manners, C. N.</span><span> </span><span class="NLM_article-title">Development of a generalized, quantitative physicochemical model of CYP3A4 inhibition for use in early drug discovery</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=652-655&issue=5&author=R.+J.+Rileyauthor=A.+J.+Parkerauthor=S.+Triggauthor=C.+N.+Manners&title=Development+of+a+generalized%2C+quantitative+physicochemical+model+of+CYP3A4+inhibition+for+use+in+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BJ.%26aulast%3DTrigg%26aufirst%3DS.%26aulast%3DManners%26aufirst%3DC.%2BN.%26atitle%3DDevelopment%2520of%2520a%2520generalized%252C%2520quantitative%2520physicochemical%2520model%2520of%2520CYP3A4%2520inhibition%2520for%2520use%2520in%2520early%2520drug%2520discovery%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26issue%3D5%26spage%3D652%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Langendorff, O.</span><span> </span><span class="NLM_article-title">Geschichtliche Betrachtungen zur Methodedes überlebenden Warmblüterherzens. Muench</span> <span class="citation_source-journal">Med. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1903</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1903&pages=508-509&author=O.+Langendorff&title=Geschichtliche+Betrachtungen+zur+Methodedes+%C3%BCberlebenden+Warmbl%C3%BCterherzens.+Muench"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLangendorff%26aufirst%3DO.%26atitle%3DGeschichtliche%2520Betrachtungen%2520zur%2520Methodedes%2520%25C3%25BCberlebenden%2520Warmbl%25C3%25BCterherzens.%2520Muench%26jtitle%3DMed.%2520Wochenschr.%26date%3D1903%26volume%3D50%26spage%3D508%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zimmer, H.-G.</span><span> </span><span class="NLM_article-title">The isolated perfused heart and its pioneers</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=11390791" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=203-210&author=H.-G.+Zimmer&title=The+isolated+perfused+heart+and+its+pioneers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DH.-G.%26atitle%3DThe%2520isolated%2520perfused%2520heart%2520and%2520its%2520pioneers%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1998%26volume%3D13%26spage%3D203%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Schmuck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickert, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merschky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudaczek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machon, U. A</span><span> </span><span class="NLM_article-title">Facile and Efficient Multi-Gram Synthesis of <i>N</i>-Protected 5-(Guanidinocarbonyl)-1<i>H</i>-pyrrole-2-carboxylic Acids</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=324-329&author=C.+Schmuckauthor=V.+Bickertauthor=M.+Merschkyauthor=L.+Geigerauthor=D.+Rupprechtauthor=J.+Dudaczekauthor=P.+Wichauthor=T.+Rehmauthor=U.+A+Machon&title=Facile+and+Efficient+Multi-Gram+Synthesis+of+N-Protected+5-%28Guanidinocarbonyl%29-1H-pyrrole-2-carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmuck%26aufirst%3DC.%26aulast%3DBickert%26aufirst%3DV.%26aulast%3DMerschky%26aufirst%3DM.%26aulast%3DGeiger%26aufirst%3DL.%26aulast%3DRupprecht%26aufirst%3DD.%26aulast%3DDudaczek%26aufirst%3DJ.%26aulast%3DWich%26aufirst%3DP.%26aulast%3DRehm%26aufirst%3DT.%26aulast%3DMachon%26aufirst%3DU.%2BA%26atitle%3DFacile%2520and%2520Efficient%2520Multi-Gram%2520Synthesis%2520of%2520N-Protected%25205-%2528Guanidinocarbonyl%2529-1H-pyrrole-2-carboxylic%2520Acids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26spage%3D324%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pérez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimeno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Fuente, M. R.</span><span> </span><span class="NLM_article-title">New H-bonded complexes and their supramolecular liquid-crystalline organizations</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=826-833&author=A.+P%C3%A9rezauthor=N.+Gimenoauthor=F.+Veraauthor=M.+B.+Rosauthor=J.+L.+Serranoauthor=M.+R.+De+la+Fuente&title=New+H-bonded+complexes+and+their+supramolecular+liquid-crystalline+organizations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DA.%26aulast%3DGimeno%26aufirst%3DN.%26aulast%3DVera%26aufirst%3DF.%26aulast%3DRos%26aufirst%3DM.%2BB.%26aulast%3DSerrano%26aufirst%3DJ.%2BL.%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DM.%2BR.%26atitle%3DNew%2520H-bonded%2520complexes%2520and%2520their%2520supramolecular%2520liquid-crystalline%2520organizations%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26spage%3D826%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span> </span><span class="NLM_article-title">Installation of the pyrrolyl-2-carboxyl pharmacophore by CouN1 and CouN7 in the late biosynthetic steps of the aminocoumarin antibiotics clorobiocin and coumermycin A1</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">8568</span><span class="NLM_x">–</span> <span class="NLM_lpage">8578</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi060784e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=8568-8578&author=S.+Garneau-Tsodikovaauthor=A.+Staponauthor=D.+Kahneauthor=C.+T.+Walsh&title=Installation+of+the+pyrrolyl-2-carboxyl+pharmacophore+by+CouN1+and+CouN7+in+the+late+biosynthetic+steps+of+the+aminocoumarin+antibiotics+clorobiocin+and+coumermycin+A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi060784e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060784e%26sid%3Dliteratum%253Aachs%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26aulast%3DStapon%26aufirst%3DA.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DInstallation%2520of%2520the%2520pyrrolyl-2-carboxyl%2520pharmacophore%2520by%2520CouN1%2520and%2520CouN7%2520in%2520the%2520late%2520biosynthetic%2520steps%2520of%2520the%2520aminocoumarin%2520antibiotics%2520clorobiocin%2520and%2520coumermycin%2520A1%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D8568%26epage%3D8578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kleeman, H.-W</span>; <span> </span><span class="NLM_article-title">Substituted benzoylguanidines, method for production and use thereof as medicament or diagnostic and medicament comprising the same</span>. World Patent Application WO 2006/050830,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.-W+Kleeman&title=Substituted+benzoylguanidines%2C+method+for+production+and+use+thereof+as+medicament+or+diagnostic+and+medicament+comprising+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKleeman%26aufirst%3DH.-W%26atitle%3DSubstituted%2520benzoylguanidines%252C%2520method%2520for%2520production%2520and%2520use%2520thereof%2520as%2520medicament%2520or%2520diagnostic%2520and%2520medicament%2520comprising%2520the%2520same%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&issue=7&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lhrScVHgoq6Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D7%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wohnsland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span> </span><span class="NLM_article-title">High-throughput permeability pH profile and high-throughput alkane/water log <i>P</i> with artificial membranes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&issue=6&author=F.+Wohnslandauthor=B.+Faller&title=High-throughput+permeability+pH+profile+and+high-throughput+alkane%2Fwater+log+P+with+artificial+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh-throughput%2520permeability%2520pH%2520profile%2520and%2520high-throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D6%26spage%3D923%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, H.</span><span> </span><span class="NLM_article-title">Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2Fj.vascn.2005.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=15936217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVClsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=123-135&issue=1&author=L.+Guoauthor=H.+Guthrie&title=Automated+electrophysiology+in+the+preclinical+evaluation+of+drugs+for+potential+QT+prolongation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation</span></div><div class="casAuthors">Guo, Liang; Guthrie, Heather</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-135</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction. The human ether-a-go-go-related gene (hERG) potassium channel plays a major role in the elec. conductances involved in human heart repolarization.  Drugs that decrease hERG K+ currents are at risk to produce a prolongation of the cardiac action potential, resulting in an increase of the QT interval.  Drug-induced QT prolongation or acquired long QT (aLQT) can lead to a fatal arrhythmia known as Torsade de Pointes (TdP).  Electrophysiol. methods are the best approach to evaluate potential drug candidates for hERG current inhibition.  Here we identify limitations with the PatchXpress 7000A automated electrophysiol. instrument and describe hERG protocol optimizations necessary for reliable preclin. assessment.  Methods. The PatchXpress 7000A automated electrophysiol. system was used to evaluate a group of drugs with known hERG activity under voltage clamp conditions.  We used a recombinant cell line expressing hERG, and assessed the inhibition of hERG K+ currents at different drug concns.  These data were used to det. hERG IC50 values and compare assay parameters under different recording conditions.  Results. We found that due to limitations with the PatchXpress 7000A instrument, repeated compd. addns. were crit. for achieving steady state drug concns. that generated data comparable to std. patch clamp methods, particularly when similar voltage pulse protocols were implemented.  Some discrepancies were obsd. between the PatchXpress 7000A and std. patch clamp techniques including shifts in IC50 values for very hydrophobic compds.  Most hERG IC50 values were within 3-fold of std. patch clamp IC50 values.  Discussion. Automation of electrophysiol. technologies has greatly improved the throughput of assessing lead drug candidates for hERG liability.  To maintain hERG data quality comparable to std. patch clamp techniques, the PatchXpress 7000A instrument limitations should be recognized and protocols optimized accordingly to ensure accuracy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkk2yRVCS66bVg90H21EOLACvtfcHk0ljCWZ7ti1Jh-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVClsLc%253D&md5=c0695ae1fe20822f0fab15ec040540ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2005.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2005.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DGuthrie%26aufirst%3DH.%26atitle%3DAutomated%2520electrophysiology%2520in%2520the%2520preclinical%2520evaluation%2520of%2520drugs%2520for%2520potential%2520QT%2520prolongation%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2005%26volume%3D52%26issue%3D1%26spage%3D123%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ames, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durston, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. D.</span><span> </span><span class="NLM_article-title">Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2281</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=2281-2285&issue=8&author=B.+N.+Amesauthor=W.+E.+Durstonauthor=E.+Yamasakiauthor=F.+D.+Lee&title=Detection+of+carcinogens+as+mutagens%3A+bacterial+tester+strains+with+R+factor+plasmids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DDurston%26aufirst%3DW.%2BE.%26aulast%3DYamasaki%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DF.%2BD.%26atitle%3DDetection%2520of%2520carcinogens%2520as%2520mutagens%253A%2520bacterial%2520tester%2520strains%2520with%2520R%2520factor%2520plasmids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1973%26volume%3D70%26issue%3D8%26spage%3D2281%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ohno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunouchi, M.</span><span> </span><span class="NLM_article-title">Alternative methods for mechanistic studies in toxicology.: screening of hepatotoxicity of pesticides using freshly isolated and primary cultured hepatocytes and non-liver-derived cells, SIRC cells</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102–103</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2FS0378-4274%2898%2900250-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=10022315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1egsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102%E2%80%93103&publication_year=1998&pages=569-573&author=Y.+Ohnoauthor=A.+Miyajimaauthor=M.+Sunouchi&title=Alternative+methods+for+mechanistic+studies+in+toxicology.%3A+screening+of+hepatotoxicity+of+pesticides+using+freshly+isolated+and+primary+cultured+hepatocytes+and+non-liver-derived+cells%2C+SIRC+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative methods for mechanistic studies in toxicology. Screening of hepatotoxicity of pesticides using freshly isolated and primary cultured hepatocytes and non-liver-derived cells, SIRC cells</span></div><div class="casAuthors">Ohno, Y.; Miyajima, A.; Sunouchi, M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102-103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">569-573</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">We constructed a screening battery for the evaluation of hepatotoxicity using freshly isolated and primary cultured rat hepatocytes (abbreviated to FIH and PCH, resp.) and rabbit eye derived cell line, SIRC cells.  Effects on cell viability and drug metabolizing enzyme activities were examd. by several pesticides and compared to those of in vivo.  Among the pesticides studied, prometryn and ametryn showed cytotoxicity on PCH at lower concn. than on SIRC cells.  Cytotoxicities of these chems. on FIH were inhibited by metyrapone.  They also increased rat serum AST in vivo.  On the other hand, cytotoxicities of IBP, elsan, alanycarb, benfuracarb, and swep in PCH were obsd. at similar concn. to those in SIRC cells.  Linuron, nitrofen, and chlomethoxyfen increased ethoxycoumarin O-deethylation activities by almost similar concn. to those of benzo(a)pyrene.  Linuron also induced ethoxycoumarin O-deethylation activity in vivo.  These findings indicated that a battery of in vitro tests consisting of FIH, PCH and SIRC cells was useful to screen the hepatotoxicity of pesticides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUakAdWQ7WNbVg90H21EOLACvtfcHk0ljCWZ7ti1Jh-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1egsrg%253D&md5=8a38399a47ee1b4a255c7e9ae7b672fa</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0378-4274%2898%2900250-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4274%252898%252900250-1%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DY.%26aulast%3DMiyajima%26aufirst%3DA.%26aulast%3DSunouchi%26aufirst%3DM.%26atitle%3DAlternative%2520methods%2520for%2520mechanistic%2520studies%2520in%2520toxicology.%253A%2520screening%2520of%2520hepatotoxicity%2520of%2520pesticides%2520using%2520freshly%2520isolated%2520and%2520primary%2520cultured%2520hepatocytes%2520and%2520non-liver-derived%2520cells%252C%2520SIRC%2520cells%26jtitle%3DToxicol.%2520Lett.%26date%3D1998%26volume%3D102%25E2%2580%2593103%26spage%3D569%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stryd, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. L.</span><span> </span><span class="NLM_article-title">Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">82–83</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1016%2F0378-4274%2895%2903547-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=8597037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADyaK28Xht1Wku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82%E2%80%9383&publication_year=1995&pages=107-115&author=R.+G.+Ulrichauthor=J.+A.+Baconauthor=C.+T.+Cramerauthor=G.+W.+Pengauthor=D.+K.+Petrellaauthor=R.+P.+Strydauthor=E.+L.+Sun&title=Cultured+hepatocytes+as+investigational+models+for+hepatic+toxicity%3A+practical+applications+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development</span></div><div class="casAuthors">Ulrich, Roger G.; Bacon, James A.; Cramer, Clay T.; Peng, Geoffrey W.; Petrella, Diane K.; Stryd, Ronald P.; Sun, Elena L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">82/83</span>
        (<span class="NLM_cas:issue">1-6</span>),
    <span class="NLM_cas:pages">107-15</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 28 refs.  Drugs can fail at any phase during discovery, preclin. or clin. development due to unacceptable levels of toxicity, and liver is commonly the principle target organ.  Investigational toxicol. methods, using appropriate models and hypotheses, can often resolve problems, identify toxic chem. substituents and salvage therapeutic discovery programs.  While in vivo models are used to investigate hepatic drug effects in the context of toxicokinetics and systemic influences, cell culture models provide in vitro systems for investigating specific mechanisms in a precisely controlled environment.  Using primary hepatocytes isolated from lab. animals, we have explored several drug-induced hepatic disorders that surfaced during different phases of drug discovery and development.  Addnl., the use of human hepatocytes has allowed us to address concerns for human exposure, examine human relevance of animal data, and provide perspective on problems encountered in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRPAL4iwK6urVg90H21EOLACvtfcHk0ljCWZ7ti1Jh-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1Wku7s%253D&md5=6d18fa490e602fef2e9fa596ecf8930c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2895%2903547-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252895%252903547-8%26sid%3Dliteratum%253Aachs%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DBacon%26aufirst%3DJ.%2BA.%26aulast%3DCramer%26aufirst%3DC.%2BT.%26aulast%3DPeng%26aufirst%3DG.%2BW.%26aulast%3DPetrella%26aufirst%3DD.%2BK.%26aulast%3DStryd%26aufirst%3DR.%2BP.%26aulast%3DSun%26aufirst%3DE.%2BL.%26atitle%3DCultured%2520hepatocytes%2520as%2520investigational%2520models%2520for%2520hepatic%2520toxicity%253A%2520practical%2520applications%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DToxicol.%2520Lett.%26date%3D1995%26volume%3D82%25E2%2580%259383%26spage%3D107%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Horakova, K.</span><span> </span><span class="NLM_article-title">The use of cell culture systems for the assessment of general cellular toxicity and to detect the nature and location of free radical damage</span> <span class="citation_source-journal">Gen. Physiol. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=10703721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVGquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=63-69&author=K.+Horakova&title=The+use+of+cell+culture+systems+for+the+assessment+of+general+cellular+toxicity+and+to+detect+the+nature+and+location+of+free+radical+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The use of cell culture systems for the assessment of general cellular toxicity and to detect the nature and location of free radical damage</span></div><div class="casAuthors">Horakova, K.</div><div class="citationInfo"><span class="NLM_cas:title">General Physiology and Biophysics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">Focus Issue</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">GPBIE2</span>;
        ISSN:<span class="NLM_cas:issn">0231-5882</span>.
    
            (<span class="NLM_cas:orgname">Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  In the process of developing compds. to counteract the damaging effects of free radicals in biol. systems it is important to det. the type and the intracellular location of specific toxic events.  For that purpose cultured cells are used, because a properly designed cell culture system allows to assess specific damage at the cellular and subcellular level and can contribute to an evaluation of the biochem. of free radical damage.  A wide range of changes in cellular activities resulting from oxidative injury in vitro have been demonstrated.  Data from many labs. indicate that cell culture system coupled with appropriate anal. techniques can be used to explore cellular and biochem. details of damage induced by free radicals.  The type of reactive oxygen species used to generate the radicals, the rate of radical prodn., and the location of action of the toxic species must be taken into account to understand the biochem. of the system.  An effort is made to analyze the considerable progress made in the development of appropriate in vitro models and end-points for use in testing and characterizing the nature and location of free radical cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqiseKNI_BWLVg90H21EOLACvtfcHk0ljaQn3_0KHWEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVGquro%253D&md5=2af177469402c08a6fd2ab46aca6f0dc</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorakova%26aufirst%3DK.%26atitle%3DThe%2520use%2520of%2520cell%2520culture%2520systems%2520for%2520the%2520assessment%2520of%2520general%2520cellular%2520toxicity%2520and%2520to%2520detect%2520the%2520nature%2520and%2520location%2520of%2520free%2520radical%2520damage%26jtitle%3DGen.%2520Physiol.%2520Biophys.%26date%3D1999%26volume%3D18%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Klaassen, C. D.</span> <span class="citation_source-book">The Basic Science of Poisons</span>,; <span class="NLM_edition">3rd</span> ed.; <span class="NLM_contrib-group">Klaassen, C. D.; Amdur, M. O.; ; Doull, J.</span>, Eds.; <span class="NLM_publisher-name">MacMillan Publishing Co.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">16</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1986&pages=16&author=C.+D.+Klaassenauthor=C.+D.+Klaassen&author=M.+O.+Amdur&author=J.+Doull&title=The+Basic+Science+of+Poisons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26btitle%3DThe%2520Basic%2520Science%2520of%2520Poisons%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26pub%3DMacMillan%2520Publishing%2520Co%26date%3D1986%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Casartelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristofori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivellente, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Negro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masotto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutinelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfante, V</span><span> </span><span class="NLM_article-title">A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1023%2FA%3A1024778329320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=12945744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVKls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=161-176&issue=3&author=A.+Casartelliauthor=M.+Bonatoauthor=P.+Cristoforiauthor=F.+Crivellenteauthor=G.+Dal+Negroauthor=I.+Masottoauthor=C.+Mutinelliauthor=K.+Valkoauthor=V+Bonfante&title=A+cell-based+approach+for+the+early+assessment+of+the+phospholipidogenic+potential+in+pharmaceutical+research+and+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development</span></div><div class="casAuthors">Casartelli, A.; Bonato, M.; Cristofori, P.; Crivellente, F.; Dal Negro, G.; Masotto, I.; Mutinelli, C.; Valko, K.; Bonfante, V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-176</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Phospholipidosis is a term commonly used to indicate a phospholipid storage disorder; in affected cells, phospholipids accumulate in lysosomes that acquire a multilamellar morphol. appearance.  Cationic amphiphilic drugs (CADs) are suggested to induce phospholipidosis by direct interaction of xenobiotics with intracellular phospholipids or by the action of xenobiotics on the synthesis and metab. of phospholipids.  To date, electron microscopy (EM) represents the most reliable and the preferred method for the demonstration of phospholipidotic cell damage.  Nevertheless, EM has a low throughput, it is expensive, and it is not suitable for screening purposes.  We discuss here the assessment of the phospholipidogenic potential of drugs using a cell culture-based model.  In this test, intracellular phospholipids of treated U-937 cells (a human monocyte-derived cell line) were measured using the fluorescent probe Nile red.  Eleven CADs reported to induce phospholipidosis in vivo and eight non-phospholipidogenic drugs were tested.  Results obtained with the U-937 model confirmed the phospholipidogenic potential of drugs tested as described in the literature.  Results have also been correlated with data obtained with a phys.-chem. model (chromatog. hydrophobicity index measurement).  Good correlation was obtained, confirming that the phys.-chem. properties of CADs play a crucial role in the development of phospholipidosis.  This work demonstrates that the U-937 model is a rapid and sensitive method for the detn. of phospholipidosis-mediated cell damage.  The specificity and the predictive potency obsd. make this method suitable for screening purposes in pharmaceutical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKIl4wT9QifrVg90H21EOLACvtfcHk0ljaQn3_0KHWEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVKls7s%253D&md5=e24933960174cb4390dbd6832c973c60</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1023%2FA%3A1024778329320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1024778329320%26sid%3Dliteratum%253Aachs%26aulast%3DCasartelli%26aufirst%3DA.%26aulast%3DBonato%26aufirst%3DM.%26aulast%3DCristofori%26aufirst%3DP.%26aulast%3DCrivellente%26aufirst%3DF.%26aulast%3DDal%2BNegro%26aufirst%3DG.%26aulast%3DMasotto%26aufirst%3DI.%26aulast%3DMutinelli%26aufirst%3DC.%26aulast%3DValko%26aufirst%3DK.%26aulast%3DBonfante%26aufirst%3DV%26atitle%3DA%2520cell-based%2520approach%2520for%2520the%2520early%2520assessment%2520of%2520the%2520phospholipidogenic%2520potential%2520in%2520pharmaceutical%2520research%2520and%2520drug%2520development%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2003%26volume%3D19%26issue%3D3%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Perico, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivellente, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faustinelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristofori, P</span><span> </span><span class="NLM_article-title">Flow cytometry, with double staining with Nile red and anti-CD3 antibody, to detect phospholipidosis in peripheral blood lymphocytes of rats treated with amiodarone</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300601d&amp;key=10.1007%2Fs10565-008-9114-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300601d&amp;key=19105033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300601d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKhtLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=587-598&issue=6&author=M.+E.+Pericoauthor=F.+Crivellenteauthor=I.+Faustinelliauthor=A.+Suozziauthor=P+Cristofori&title=Flow+cytometry%2C+with+double+staining+with+Nile+red+and+anti-CD3+antibody%2C+to+detect+phospholipidosis+in+peripheral+blood+lymphocytes+of+rats+treated+with+amiodarone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Flow cytometry, with double staining with Nile red and anti-CD3 antibody, to detect phospholipidosis in peripheral blood lymphocytes of rats treated with amiodarone</span></div><div class="casAuthors">Perico, Maria Elisa; Crivellente, Federica; Faustinelli, Ivo; Suozzi, Anna; Cristofori, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-598</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A flow cytometry method, to monitor peripheral lymphocytes phospholipidosis, has been set up using a single staining with Nile red and double staining with Nile red and anti-CD3 monoclonal antibody.  Blood has been collected from rats treated with amiodarone (phospholipidogenic antiarrhythmic drug).  By flow cytometer, it is possible to detect phospholipids, using Nile red, a probe for intracellular lipids staining, changing its fluorescence on the stained lipid basis.  CD3 antigen has been selected to focus on T cells, to evaluate whether these cells are the target of phospholipidosis amiodarone-dependent.  In the study A, Sprague-Dawley rats were treated with three different doses (75, 150, and 300 mg kg-1 day-1) of amiodarone or vehicle alone, for 14 days, followed by 14 days of recovery: Data obtained show that by flow cytometry, with Nile red alone, it is possible to detect a dose- and time-related response of phospholipidosis-pos. lymphocytes; a partial recovery is also assessed.  In the study B, Sprague-Dawley rats were treated with a single dose (300 mg kg-1 day-1) of amiodarone, for 14 days: Data obtained show that animals treated with amiodarone have a significant increase of phospholipidosis-pos. lymphocytes (p = 0.008), in particular of CD3+ cells (p = 0.0056).  Transmission electron microscopy anal. confirmed data obtained by flow cytometry.  This work shows that flow cytometry with Nile red could be a good tool to monitor ex vivo phospholipidosis in lymphocyte cells of animals treated with amiodarone: The phospholipidogenic effect is more evident focusing on CD3+ T lymphocytes, thus suggesting that these cells are probably the target of phospholipidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopzwXCRewGw7Vg90H21EOLACvtfcHk0lh6K50gZg8aXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKhtLnJ&md5=b9bedd86bc14a457ba17b0fec2a0d08a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs10565-008-9114-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10565-008-9114-6%26sid%3Dliteratum%253Aachs%26aulast%3DPerico%26aufirst%3DM.%2BE.%26aulast%3DCrivellente%26aufirst%3DF.%26aulast%3DFaustinelli%26aufirst%3DI.%26aulast%3DSuozzi%26aufirst%3DA.%26aulast%3DCristofori%26aufirst%3DP%26atitle%3DFlow%2520cytometry%252C%2520with%2520double%2520staining%2520with%2520Nile%2520red%2520and%2520anti-CD3%2520antibody%252C%2520to%2520detect%2520phospholipidosis%2520in%2520peripheral%2520blood%2520lymphocytes%2520of%2520rats%2520treated%2520with%2520amiodarone%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2009%26volume%3D25%26issue%3D6%26spage%3D587%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300601d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-16%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm300601d%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300601d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996c0e3fd83d88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
